2012-2017 NPPA decisions

1 March 2012 to 31 August 2017

This is a list of decisions on NPPA applications – both approvals and declines. We’ve withheld some decisions to maintain patient confidentiality.

Approximately 1/3 of all submitted applications didn’t met the underlying principles of NPPA (or the pre-requisites under the previous NPPA Policy). Applications that don’t meet the principles (or pre-requisites) aren’t assessed any further. They therefore don’t reach the point where we’d make funding decisions about them. Those applications don’t appear in this list, because no funding decision was made.

Drug	Indication	Outcome
0.45% saline	fluid replacement, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome	Approved
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome	Approved
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome	Approved
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome	Approved renewal
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome	Approved renewal
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome	Approved renewal
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome	Approved renewal
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome, hypertension	Approved
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome, Malnutrition	Approved
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome, Malnutrition	Approved
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome, Malnutrition	Approved renewal
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome, Malnutrition	Approved renewal
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome, metastatic adenocarcinoma prostate, Metastatic Bone Disease	Approved
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome, metastatic adenocarcinoma prostate, Metastatic Bone Disease	Approved renewal
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome, Small Cell lung Cancer	Approved
3,4 diaminopyridine	Lambert-Eaton myasthenic syndrome, Small Cell lung Cancer	Approved
4 - aminosalicylic acid	MDR tuberculosis	Approved
4-aminopyridine	downbeat nystagmus, opsoclonus myoclonus ataxia, Upbeat nystagmus	Approved
4-aminopyridine	episodic ataxia, migraine, CACNA 1 (calcium channel) gene abnormality	Approved
4-aminopyridine	relapsing remitting Multiple Sclerosis, hyperlipidaemia, hypertension	Declined
8-methoxypsoralen	cutaneous t cell lymphoma, mycosis fungoides, Early CD 30 transformation, Post transplant lymphoproliferative disorder (PTLD), Renal transplant 1987 for reflux nephropathy	Approved
abatacept	polyarticular juvenile idiopathic arthritis, refractory to other treatments	Approved
abatacept	polyarticular juvenile idiopathic arthritis, refractory to other treatments	Approved renewal
abiraterone	castrate resistant, metastatic cancer of prostate, bronchiectasis, GI bleed, leg oedema, ongoing DVT, previous CVA, tophaceous gout	Declined
aciclovir	viral encephalitis	Approved
acitretin oral suspension	pustular psoriasis	Approved
adalimumab	Behcet's disease, allergy to infliximab	Approved
adalimumab	Behcet's disease, allergy to infliximab	Approved renewal
adalimumab	Behcet's disease, allergy to infliximab	Approved renewal
adalimumab	Behcet's disease, allergy to infliximab	Approved renewal
adalimumab	Behcet's disease, autonomic neuropathy, GORD, hypertension, multiple pulmonary nodules, optic neuritis, Vertigo	Approved
adalimumab	Behcet's disease, autonomic neuropathy, GORD, hypertension, multiple pulmonary nodules, optic neuritis, Vertigo	Approved renewal
adalimumab	Behcet's disease, infusion reaction to infliximab, occlusive retinal vasculitis	Approved
adalimumab	Behcet's disease, occlusive retinal vasculitis, allergy to infliximab	Approved
adalimumab	Behcet's disease, occlusive retinal vasculitis, allergy to infliximab	Approved renewal
adalimumab	Behcet's disease, occlusive retinal vasculitis, retinitis, allergy to infliximab	Approved
adalimumab	Behcet's disease, occlusive retinal vasculitis, retinitis, allergy to infliximab	Approved renewal
adalimumab	Behcet's disease, occlusive retinal vasculitis, retinitis, allergy to infliximab	Approved renewal
adalimumab	Behcet's disease, uveitis, Mouth ulcers, oesophageal ulcers, polyarthralgia, vasculitis	Approved
adalimumab	Behcet's disease, uveitis, Mouth ulcers, oesophageal ulcers, polyarthralgia, vasculitis	Approved renewal
adalimumab	bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness	Approved
adalimumab	bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness	Approved renewal
adalimumab	bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness	Approved renewal
adalimumab	bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness	Approved renewal
adalimumab	bilateral chronic uveitis, panuveitis	Approved
adalimumab	chronic pityriasis rubra pilaris	Approved
adalimumab	cutaneous Crohns disease	Approved
adalimumab	cutaneous Crohns disease	Approved renewal
adalimumab	cystoid macular oedema, severe uveitis, cataract, uveitic sarcoidosis	Approved
adalimumab	cystoid macular oedema, severe uveitis, cataract, uveitic sarcoidosis	Approved renewal
adalimumab	funded alternative unsuitable, rheumatoid arthritis, liver fibrosis	Approved
adalimumab	hidradenitis suppurativa, unresponsive to alternatives	Approved
adalimumab	HLA B27 associated spondyloarthropathy, iritis, oligoarthritis	Approved
adalimumab	HLA B27 associated spondyloarthropathy, iritis, oligoarthritis	Approved renewal
adalimumab	infusion reaction to infliximab, severe uveitis, bilateral	Approved
adalimumab	juvenile idiopathic arthritis, uveitis	Approved renewal
adalimumab	juvenile idiopathic uveitis, cataract, cystoid macular oedema, keratopathy	Approved
adalimumab	occlusive retinal vasculitis, intolerance of infliximab	Approved
adalimumab	occlusive retinal vasculitis, intolerance of infliximab	Approved renewal
adalimumab	paradoxical inflammatory reaction to cerebral tuberculosis, allergy to infliximab, cerebral tuberculosis	Approved
adalimumab	paradoxical inflammatory reaction to cerebral tuberculosis, allergy to infliximab, cerebral tuberculosis	Approved renewal
adalimumab	punctate inner choroidopathy, uveitis, allergy to infliximab	Approved
adalimumab	severe idiopathic uveitis, obesity, social issues	Approved
adalimumab	severe idiopathic uveitis, obesity, social issues	Approved renewal
adalimumab	severe idiopathic uveitis, obesity, social issues	Approved renewal
aflibercept	age related macular degeneration, choroidal neovascularisation	Declined
aflibercept	choroidal neovascularisation	Approved
aflibercept	diabetic macular oedema, Addison's disease, refractory to other treatments, small cell lymphoma	Declined
aflibercept	diabetic macular oedema, diabetes type 2	Declined
aflibercept	diabetic macular oedema, macular oedema, diabetes	Approved renewal
aflibercept	macular oedema, choroidal neovascularisation	Approved renewal
aflibercept	macular oedema, choroidal neovascularisation	Approved renewal
aflibercept	macular oedema, retinal vein occlusion, diabetes type 2, open angle glaucoma	Declined
aflibercept	neovascular membranes	Approved renewal
albendazole	hydatid disease	Approved
albendazole	microsporidia keratosis	Approved
albendazole	Ruptured hydatid cyst of the liver	Approved
alemtuzumab	chronic lymphocytic leukaemia, fludarabine refractory	Approved
alemtuzumab	relapsing remitting Multiple Sclerosis	Declined
alpha tocopheryl acetate	Alagille's syndrome	Approved
alpha tocopheryl acetate	Alagille's syndrome, cholestasis, Liver disease	Approved
alpha tocopheryl acetate	alpha-1 antitrypsin deficiency, cholestatic jaundice	Approved
alpha tocopheryl acetate	anaemia, iron deficiency, seizures, Vitamin E deficiency	Approved
alpha tocopheryl acetate	autism, Cystic fibrosis	Approved
alpha tocopheryl acetate	biliary atresia	Approved
alpha tocopheryl acetate	biliary atresia	Approved
alpha tocopheryl acetate	biliary atresia	Approved
alpha tocopheryl acetate	biliary atresia	Approved
alpha tocopheryl acetate	biliary atresia	Approved
alpha tocopheryl acetate	biliary atresia	Approved
alpha tocopheryl acetate	biliary atresia, choledhocal cyst	Approved
alpha tocopheryl acetate	biliary atresia, cholestasis	Approved
alpha tocopheryl acetate	biliary atresia, cholestasis, malabsorption	Approved
alpha tocopheryl acetate	biliary atresia, cholestatic liver disease	Approved
alpha tocopheryl acetate	biliary atresia, neonate	Approved
alpha tocopheryl acetate	biliary atresia, Short Gut Syndrome	Approved
alpha tocopheryl acetate	biliary cirrhosis	Approved
alpha tocopheryl acetate	carnitine palmitoyl transferase II deficiency, Vitamin E deficiency	Approved
alpha tocopheryl acetate	cholestasis	Approved
alpha tocopheryl acetate	cholestasis	Approved
alpha tocopheryl acetate	cholestasis	Approved
alpha tocopheryl acetate	cholestasis, Cystic fibrosis, Liver disease	Approved
alpha tocopheryl acetate	cholestatic jaundice	Approved
alpha tocopheryl acetate	cholestatic jaundice	Approved
alpha tocopheryl acetate	cholestatic jaundice, Chronic lung disease, decreased gastrointestinal function, fat soluable vitamins deficiency, Liver disease, Premature birth, previous metabolic bone disease, pulmonary hypertension	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease	Approved
alpha tocopheryl acetate	cholestatic liver disease, biliary atresia	Approved
alpha tocopheryl acetate	cholestatic liver disease, biliary atresia	Approved renewal
alpha tocopheryl acetate	cirrhosis, Juvenile Xanthogranulomatosis, Liver disease	Approved
alpha tocopheryl acetate	cmt 1 disease	Approved
alpha tocopheryl acetate	congenital nephrotic syndrome	Approved
alpha tocopheryl acetate	conjugated hyperbilirubinemia	Approved
alpha tocopheryl acetate	conjugated hyperbilirubinemia	Approved
alpha tocopheryl acetate	conjugated hyperbilirubinemia	Approved
alpha tocopheryl acetate	conjugated hyperbilirubinemia	Approved
alpha tocopheryl acetate	conjugated hyperbilirubinemia	Approved
alpha tocopheryl acetate	conjugated hyperbilirubinemia	Approved
alpha tocopheryl acetate	conjugated hyperbilirubinemia	Approved
alpha tocopheryl acetate	conjugated hyperbilirubinemia	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic Fibrosis	Approved
alpha tocopheryl acetate	Cystic Fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Cystic fibrosis, liver disease or short gut syndrome	Approved
alpha tocopheryl acetate	Cystic fibrosis, pancreatic insufficiency	Approved
alpha tocopheryl acetate	Cystic fibrosis, Vitamin E deficiency	Approved
alpha tocopheryl acetate	Cystic fibrosis, Vitamin E deficiency	Approved renewal
alpha tocopheryl acetate	deranged liver enzymes, jaundice, myocarditis	Approved
alpha tocopheryl acetate	fat intolerance, low vit E, malabsorbtion syndrome, cervical cancer, Hepatitis C, hysterectomy, post irradiation bowel disease, recent bacterial endocarditis, recto-vaginal fistulae, urinary incontinence	Approved
alpha tocopheryl acetate	fat soluable vitamins deficiency, cholestatic jaundice	Approved
alpha tocopheryl acetate	infantile Refsum phenotype	Approved
alpha tocopheryl acetate	infantile Refsum phenotype	Approved renewal
alpha tocopheryl acetate	infantile Refsum phenotype, intellectual disability	Approved renewal
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	Liver disease	Approved
alpha tocopheryl acetate	liver disease or short gut syndrome	Approved
alpha tocopheryl acetate	liver disease or short gut syndrome	Approved
alpha tocopheryl acetate	liver disease or short gut syndrome	Approved
alpha tocopheryl acetate	liver disease or short gut syndrome, Alagille's syndrome, cholestasis	Approved
alpha tocopheryl acetate	liver disease or short gut syndrome, Vitamin E deficiency	Approved renewal
alpha tocopheryl acetate	Liver disease, Short Gut Syndrome	Approved
alpha tocopheryl acetate	Liver disease, Short Gut Syndrome	Approved
alpha tocopheryl acetate	liver dysfunction	Approved
alpha tocopheryl acetate	multiple vitamin deficiency	Approved
alpha tocopheryl acetate	multisystem langerhans cell histiocytosis, cholestasis, cirrhosis, Portal Hypertension	Approved
alpha tocopheryl acetate	neonatal cholestasis	Approved
alpha tocopheryl acetate	neonatal hepatitis	Approved
alpha tocopheryl acetate	neutropaenia	Approved
alpha tocopheryl acetate	progressive familial intrahepatic cholestasis	Approved
alpha tocopheryl acetate	severe cholestasis	Approved
alpha tocopheryl acetate	severe necrotising entercolitis, cholestatic, IVN related Liver disease, jaundice	Approved
alpha tocopheryl acetate	short gut syndrome	Approved
alpha tocopheryl acetate	short gut syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	short gut syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved
alpha tocopheryl acetate	Short Gut Syndrome	Approved renewal
alpha tocopheryl acetate	Short Gut Syndrome	Approved renewal
alpha tocopheryl acetate	short gut syndrome, biliary atresia	Approved
alpha tocopheryl acetate	TPN cholestasis	Approved
alpha tocopheryl acetate	Vitamin E deficiency	Approved
alpha tocopheryl acetate	Vitamin E deficiency	Approved
alpha tocopheryl acetate	Vitamin E deficiency	Approved
alpha tocopheryl acetate	Vitamin E deficiency, Cystic fibrosis	Approved
alpha tocopheryl acetate	Vitamin E deficiency, Cystic fibrosis	Approved
alpha tocopheryl acetate	Vitamin E deficiency, Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Vitamin E deficiency, Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Vitamin E deficiency, Cystic fibrosis	Approved renewal
alpha tocopheryl acetate	Vitamin E deficiency, liver disease or short gut syndrome	Approved
alpha tocopheryl acetate	Vitamin E deficiency, liver disease or short gut syndrome	Approved
alpha tocopheryl acetate	Vitamin E deficiency, liver disease or short gut syndrome	Approved
alpha tocopheryl acetate	Vitamin E deficiency, Liver disease, Short Gut Syndrome	Approved
alpha tocopheryl acetate		Approved
amikacin	MAIC infection, mycobacterium abscessus pulmonary infection, chronic renal impairment	Approved
amikacin	MDR tuberculosis	Approved
amikacin	multidrug-resistant TB	Approved
amikacin	multidrug-resistant tuberculosis	Approved
amiloride	chronic kidney disease, multiple drug intolerances, Renal Artery Stenosis, resistant hypertension	Approved
amiloride	hypercalciuria, recurrent nephrolithiasis	Approved
amiloride	hypertension	Approved
amiloride	hypertension, primary hyperaldosteronism	Approved
amiloride	primary hyperaldosteronism, intolerance to spironolactone	Approved
amiloride	refractory to treatment hypertension, diabetes type 2, intolerance to alternatives, Renal Artery Stenosis	Approved
amino acid formula	aminoadipic semialdehyde (AASA) dehydrogenase deficiency, pyridoxine dependant epilepsy, developmental delay	Approved
amino acid formula	glutaric aciduria type 1	Approved
amino acid formula	Maple syrup urine disease	Approved
amino acid formula	tyrosinaemia type I	Approved
amiodarone hydrochloride	Shone's syndrome, atrial ectopic beats, norwood procedure performed	Approved
amiodarone hydrochloride	supraventricular tachycardia	Approved
amphotericin	Allergic bronchopulmonary aspergillosis, Cystic fibrosis	Approved
amphotericin	persitent candida vulvovaginitis	Approved
anakinra	autoinflammatory syndrome	Approved renewal
anakinra	Bilateral chronic bronchiectasis, Hypertension, Reaction to tocilizumab, systemic onset juvenile idiopathic arthritis	Approved
anakinra	cryopyrin-associated periodic syndrome (CAPS)	Approved
anakinra	cryopyrin-associated periodic syndrome (CAPS)	Approved renewal
anakinra	PAPA syndrome	Approved
anakinra	periodic fever syndrome	Approved
anakinra	periodic fever syndrome, failure to thrive	Approved
anakinra	persistent idiopathic pericarditis	Approved
anakinra	Schnitzler syndrome	Approved
anamix	methylmalonic acidemia	Approved renewal
androstanolone	microphallus, Partial Androgen Insensitivity Syndrome	Approved
androstanolone	microphallus, Partial Androgen Insensitivity Syndrome	Approved
androstanolone	microphallus, Partial Androgen Insensitivity Syndrome	Approved renewal
arginine	Citrullinaemia type 1	Approved renewal
arginine	MELAS, epilepsy, fatigue, muscular weakness, Weight Loss	Approved
arginine	OTC Deficiency, learing impairment, recurrent encephalopathy	Approved
arginine	OTC Deficiency, urea cycle disorder	Approved
aripiprazole	aggression, agitation, Autistic Spectrum Disorder, intellectual disability, obesity	Approved
aripiprazole	Autistic Spectrum Disorder, intellectual disability, anxiety, severe obesity	Approved
aripiprazole	PTSD, eating disorder, multiple suicide attempts, severe affect dysregulation	Approved
atenolol	supraventricular tachycardia	Approved
atenolol	ectopic atrial tachycardia	Approved
atenolol	junctional tachycardia, hypoplastic right ventricle, tricuspid atresia	Approved
atenolol	supraventricular tachycardia	Approved
atenolol	SVT, flecainide toxicity, Wolff-Parkinson-White syndrome	Approved
atenolol	Wolff-Parkinson-White syndrome	Approved
atomoxetine	severe postural hypotension, severe vasovagal syncope	Approved
atomoxetine	severe postural hypotension, severe vasovagal syncope	Approved renewal
atropine	excessive salivation, cognitive impairment, distal arthrogryposis syndrome, epilepsy, Excessive drooling	Approved renewal
azacitidine	acute myeloblastic leukaemia, myelodysplasia, scheduled MUD transplant delayed	Approved
azacitidine	myelodysplastic syndrome, Refractory Cytopenai with Multilineage Dysplasia (RCMD), multiple skin tumours, xeroderma pigmentosum	Approved
azithromycin	bronchiolitis obliterans syndrome, Graft Versus Host Disease	Approved
azithromycin	bronchiolitis obliterans, domiciliary oxygen, possibly secondary to adenovirus, Premature birth	Declined
azithromycin	bronchiolitis obliterans, Hodgkin's lymphoma, post bone marrow transplant	Approved
azithromycin	cryptosporidium, bronchiectasis, Cholecystitis, cirrhosis, Congenital Immune Deficiency, malabsorption, Malnutrition, osteoporosis	Approved
azithromycin	diffuse panbronchiolitis	Approved
azithromycin	Graft versus host disease of lungs, history of acute lymphoblastic leukemia, history of allogeneic bone marrow transplant	Approved
azithromycin	MAIC infection, diverticular disease, hypertension	Approved
azithromycin	Mycobacterium Avium Intracellulare infection	Approved
azithromycin	mycobacterium chelonae osteomyelitis	Approved
azithromycin	mycobacterium xenopi infection	Approved
azithromycin	prophylaxis to prevent infection, acquired gamma-interferon autoantibodies, recurrent atypical mycobacterial infections	Approved
azithromycin	Radiation Pneumonitis, High Risk Neuroblastoma	Approved
azithromycin	Severe bronchiectasis, asthma	Approved
azithromycin	Severe bronchiectasis, asthma	Approved renewal
baclofen	dystonia, Dopamine-2-receptor antibody encephalitis, spasticity	Approved
bedaquiline	MDR tuberculosis, pulmonary tuberculosis	Approved
bendamustine	mantle cell lymphoma	Approved
benzathine penicillin	prophylaxis, Rheumatic Heart Disease, anaphylaxis to funded alternatives	Approved
benzathine penicillin	secondary prevention of rheumatic fever	Approved
benzathine penicillin	secondary prevention of rheumatic fever	Approved renewal
benzbromarone	allopurinol hypersensitivity, chronic kidney disease, severe tophaceous gout	Approved
benzbromarone	Chronic Severe Tophaceous Gout, Chronic Renal Failure, heart failure	Approved
benzbromarone	chronic tophaceous gout	Approved
benzbromarone	chronic tophaceous gout	Approved
benzbromarone	chronic tophaceous gout, chronic renal impairment, hypertension, ischaemic heart disease	Approved
benzbromarone	chronic tophaceous gout, Giant Cell Myocarditis, impaired left ventricle dysfunction, ventricular tachycardia	Approved
benzbromarone	gout, heart transplant	Approved
benzbromarone	severe tophaceous gout, CCF, chronic kidney disease, polycythaemia rubra vera	Approved
benzbromarone	severe tophaceous gout, renal transplant	Approved
betaine	Homocysteinuria, ataxia, dizziness, Ulcerative Colitis, vitamin B6 responsiveness, vitamin D deficiency	Approved
betamethasone	encephalopathy, severe intellectual disability, spasticity, status epilepticus	Approved
betamethasone sodium phosphate	oral graft vs host disease post stem cell transplant, Chronic Myeloid Leukaemia	Approved
bevacizumab	cerebral radionecrosis	Approved
bevacizumab	Colorectal Cancer, kras wild type	Approved
bevacizumab	Hereditary hemorrhagic telangiectasia	Approved renewal
bevacizumab	Laryngeal and Subglottic Papillomatosis, Scleroderma	Approved
bevacizumab	Laryngeal and Subglottic Papillomatosis, Scleroderma	Approved renewal
bevacizumab	Laryngeal and Subglottic Papillomatosis, Scleroderma	Approved renewal
bevacizumab	neurofibromatosis type 2	Approved
bevacizumab	recurrent glioblastoma multiforme	Declined
bevacizumab	recurrent gondal stromal mixed ovarian tumour	Declined
bevacizumab	recurrent respiratory papillomatosis	Approved
bevacizumab	recurrent respiratory papillomatosis	Approved
bevacizumab	recurrent respiratory papillomatosis	Approved
bevacizumab	recurrent respiratory papillomatosis	Approved
bevacizumab	recurrent respiratory papillomatosis	Approved
bevacizumab	recurrent respiratory papillomatosis	Approved
bevacizumab	recurrent respiratory papillomatosis	Approved
bevacizumab	recurrent respiratory papillomatosis	Approved
bevacizumab	recurrent respiratory papillomatosis	Approved
bevacizumab	recurrent respiratory papillomatosis	Approved renewal
bevacizumab	recurrent respiratory papillomatosis	Approved renewal
bevacizumab	recurrent respiratory papillomatosis, atrial fibrillation, Right Heart Failure	Approved
bevacizumab	recurrent respiratory papillomatosis, severe dysphonia	Approved
bicalutamide	testotoxicosis (Male limited gonadotropin-independent precocious puberty), growth advancement, high testosterone levels, severe virilisation	Approved
bimatoprost	glaucoma, Unable to tolerate funded medicaton	Approved
biotin	basal ganglia disease, Biotin Deficiency, Metabolic disorder, autism, brain damage, global development delay, NG Feeding	Approved renewal
biotin	basal ganglia disease, Biotin Deficiency, Metabolic disorder, autism, brain damage, global development delay, NG Feeding	Approved renewal
biotin	Biotin Deficiency, Metabolic disorder, autism, brain damage, global development delay, NG Feeding	Approved
biotin	biotinidase deficiency	Approved
biotin	epileptic encephalopathy, infantile spasms	Approved
biotin	holocarboxylase synthetase deficiency	Approved
biotin	holocarboxylase synthetase deficiency	Approved
biotin	holocarboxylase synthetase deficiency	Approved
biotin	holocarboxylase synthetase deficiency	Approved
biotin	holocarboxylase synthetase deficiency	Approved renewal
biotin	holocarboxylase synthetase deficiency	Approved renewal
biotin	holocarboxylase synthetase deficiency	Approved renewal
biotin	holocarboxylase synthetase deficiency	Approved renewal
biotin	holocarboxylase synthetase deficiency, antenatal therapy	Approved
biotin	multiple carboxylase deficiency, Hypertrophic cardiomyopathy, possible mitochondrial disorder	Approved
boric acid	metronidazole resistant trichomoniasis	Approved
bosentan	pulmonary arterial hypertension	Approved
bosentan	pulmonary arterial hypertension	Approved renewal
bosentan	raynaud's syndrome, recurrent ulceration, ulceration of digits, risk of amputation	Approved
bosutinib	Chronic Myeloid Leukaemia, paroxysmal af, Peripheral Vascular disease, Pleural Effusion	Declined
brentuximab	bridge to transplant, relapsed Hodgkin's lymphoma	Approved
brentuximab vedotin	anaplastic large cell lymphoma relapse, bridge to transplant	Approved
brentuximab vedotin	bridge to transplant, relapsed Hodgkin's lymphoma	Approved
brentuximab vedotin	Hodgkin's lymphoma, post autologous bone marrow transplant	Approved
brentuximab vedotin	Hodgkin's lymphoma, relapsed/refractory	Approved
brentuximab vedotin	mycosis fungoides, nodular phase, multiple relapses, refractory to chemotherapy	Declined
brentuximab vedotin	primary refractory Hodgkin lymphoma, bridge to transplant, planned allogeneic SCT post autograft	Approved
brentuximab vedotin	relapsed Hodgkin's lymphoma	Approved
brentuximab vedotin	relapsed Hodgkin's lymphoma, conditioning for stem cell transplant	Approved
brimonidine	allergy to preservative, glaucoma	Approved
brimonidine	glaucoma, intolerance to funded alternative	Approved
brimonidine	glaucoma, intolerance to funded alternative	Approved renewal
budesonide	autoimmune hepatitis, Dermatitis herpetiformis, obesity	Approved
budesonide	autoimmune hepatitis, diabetes type 2, Necrotic Lesions	Approved
budesonide	autoimmune hepatitis, diabetes, severe osteoporosis	Approved
budesonide	autoimmune hepatitis, sclerosing cholangitis, unacceptable side effects of prednisone	Approved
budesonide	autoimmune hepatitis, sclerosing cholangitis, unacceptable side effects of prednisone	Approved renewal
budesonide	common variable immunodeficiency	Approved
budesonide	common variable immunodeficiency	Approved renewal
budesonide	common variable immunodeficiency	Approved renewal
budesonide	common variable immunodeficiency, protein losing enteropathy	Approved renewal
budesonide	Immunosuppressive Therapy, unacceptable side effects of prednisone, Chronic Idiopathic Intestinal Pseudo-obstruction, Intestinal transplant	Approved
budesonide	Immunosuppressive Therapy, unacceptable side effects of prednisone, Chronic Idiopathic Intestinal Pseudo-obstruction, Intestinal transplant	Approved renewal
budesonide	protein losing enteropathy	Approved
budesonide	protein losing enteropathy	Approved
budesonide	protein losing enteropathy, complex congenital heart disease, hypoalbuminaemia, oedema, Post Fontan procedure	Approved
budesonide	protein losing enteropathy, Post Fontan procedure	Approved
budesonide cr	protein losing enteropathy, hypoalbuminaemia, Post Fontan procedure	Approved
bumetanide	complex congenital cardiac disease, Post Fontan procedure	Approved
bumetanide	complex congenital heart disease, Post Fontan procedure	Approved
bumetanide	complex congenital heart disease, post surgical chylothorax	Approved
bumetanide	Post Fontan procedure, complex congenital cardiac disease	Approved
bumetanide oral suspension	post surgical chylothorax, congenital cardiac condition, Post Fontan procedure	Approved
bupivacaine hydrochloride	uncontrolled cancer pain, metastatic lung cancer	Approved
bupivacaine/fentanyl	severe pain, metastatic carcinoma, parietal subdural haemorrhage	Approved
bupivacaine/morphine/clonidine	pain, Myeloma, pathological fracture	Approved
buprenorphine	progressive familial myopathy, gastrointestinal failure, Growth Failure, severe pain, TPN dependent pseudo-obstruction, vitamin D deficiency	Approved
buprenorphine (Subutex)	opioid dependence, opiod substitution programme, pregnant	Approved
cabergoline	Cushing's Disease, hypercorticolism	Approved
cabergoline	non-functioning pituitary adenoma, not surgically resectable, visual impairment	Approved
calcitriol	autosomal recessive polycystic kidney disease, End stage renal failure, gastrointestinal malabsorbtion, osteitis fibrosa cystica	Approved
calcium hydroxyapatite	dysphonia, hypophonia, vascular disease	Approved
calcium hydroxyapatite	Glottal insufficiency	Approved
calcium hydroxyapatite	Glottal insufficiency	Approved
calcium hydroxyapatite	Glottal insufficiency	Approved
calcium hydroxyapatite	Glottal insufficiency	Approved
calcium phosphate	diabetes type 2, mucositus, supraglottic tumour	Approved
calcium phosphate	infection, carcinoma of the tonsil	Approved
calcium phosphate	mucositis	Approved
calcium phosphate	mucositis	Approved
calcium phosphate	mucositis	Approved
calcium phosphate	mucositis	Approved
calcium phosphate	mucositis, squamous cell carcinoma	Approved
calcium phosphate	oral mucositis	Approved
calcium phosphate	oral mucositis	Approved
calcium phosphate	oral mucositis	Approved
calcium phosphate	oral mucositis	Approved
calcium phosphate	oral mucositis	Approved
calcium phosphate	oral mucositis	Approved
calcium phosphate	oral mucositis, carcinoma of the tonsil	Approved
calcium phosphate	oral mucositis, carcinoma of tongue, radiation treatment	Approved
calcium phosphate	oral mucositis, chemotherapy, Radiotherapy	Approved
calcium phosphate	oral mucositis, Radiotherapy	Approved
calcium phosphate	oral mucositis, radiotherapy, squamous cell carcinoma of subglottic space	Approved
calcium phosphate	oral mucositis, squamous cell carcinoma left tonsil, undergoing chemotherapy and radiotherapy	Approved
calcium phosphate	oral mucositis, squamous cell carcinoma of subglottic space	Approved
calcium phosphate	oral mucositis, squamous cell carcinoma of subglottic space	Approved
calcium phosphate	radiation induced oral mucositis	Approved
calcium phosphate	radiation induced oral mucositis	Approved
calcium phosphate	radiation induced oral mucositis, squamous cell carcinoma	Approved
calcium phosphate	squamous cell carcinoma, Mucosal radiation toxicity, Oral Chemotherapy, oral mucositis	Approved
captopril	cystine stones, nephrolithiasis	Approved
captopril	mitral regurgitation, mitral stenosis, Autistic Spectrum Disorder, elevated pulmonary arterial pressures, pulmonary hypertension	Approved renewal
carbohydrate free mixture	congenital glucose galactose malabsorption	Approved
carbohydrate free mixture	congenital glucose galactose malabsorption	Approved renewal
carbohydrate free mixture	enteropathy, intestinal failure, carbohydrate intolerance, failure to thrive, fructose intolerance, glucose intolerance, secretory diarrhoea, TPN dependent	Approved
carbomer	sicca syndrome, rheumatoid arthritis	Approved
carmellose sodium	dry eyes, graft vs host disease	Approved
carmellose sodium eye drops	bilateral corneal transplant, atopy, keratoconus, stem cell deficiency	Approved
carmustine wafer	astrocytoma	Approved
carmustine wafer	relapsed oligodendroglioma	Approved
carnitine	carnitine deficiency	Approved
carnitine	carnitine deficiency	Approved
carnitine	carnitine deficiency	Approved renewal
carnitine	carnitine deficiency	Approved renewal
carnitine	carnitine deficiency, low L-carnitine levels post sodium valproate, Congenital Ponto-Cerebellar Hypolasia, nasogastric tube	Approved
carnitine	carnitine deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency	Approved
carnitine	carnitine palmitoyl transferase II deficiency	Approved
carnitine	holocarboxylase synthetase deficiency	Approved
caspofungin	candida lusitaniae infection, Glycogen Storage Disease type 1b, immunosuppressed, infected portacath, neutropaenia	Approved
caspofungin	disseminated aspergillosis, Acute Lymphoblastic Leukaemia	Approved
cefuroxime	microbial keratitis	Approved
celecoxib	previous resection, pulmonary inflammatory myofibroblastic tumour, nasogastric tube	Approved renewal
celecoxib	Rheumatoid Arthritis	Declined
cetuximab	liver metastases, lung metastases, lymph node spread, metastatic squamous cell carcinoma, primary skin cancer, diabetes type 2, hyperlipidaemia, hypertension	Declined
chloral hydrate	lissencephaly, cerebal palsy, epilepsy, severe sleep disorder, spastic quadriplegia	Approved
chloral hydrate	seizure disorder, cerebral palsy, Incontinence, intellectual handicap, scoliosis, spastic quadriplegia	Approved
chloral hydrate	severe sleep disorder, Complex Mitochondrial Disorder, gastrotomy fed, global development delay	Approved
chloral hydrate	severe sleep disorder, FOX G1 Syndrome, gastrotomy fed, global development delay	Approved renewal
chloral hydrate	severe sleep disorder, FOX G1 Syndrome, gastrotomy fed, global development delay	Approved renewal
chloramphenicol	allergic eye disease, corneal ulcers, Herpes Simplex Keratitis	Approved
cholic acid	infantile Refsum phenotype, peroxisomal biogenesis defect, Zellweger spectrum disorder	Approved
cinacalcet	autonomous hyperparathyroidism, Cardiomyopathy, diabetes type 2, haemodialysis	Approved
cinacalcet	autonomous hyperparathyroidism, end stage renal disease	Approved
cinacalcet	autonomous hyperparathyroidism, end-stage renal failure on dialysis, Peripheral Vascular disease	Approved
cinacalcet	autosomal recessive polycystic kidney disease, bone marrow fibrosis, congenital hepatic fibrosis, End stage renal failure, failure to thrive, hypersplenism, oesophageal varicies, Portal Hypertension, Severe hyperthyroidism	Approved
cinacalcet	Calciphylaxis, Coronary Artery Disease, diabetes type 2, diabetic nephropathy, end stage renal disease, hyperparathyroidism, Peripheral Vascular disease	Approved
cinacalcet	Calciphylaxis, dialysis, end stage renal failure, hyperparathyroidism	Approved
cinacalcet	Calciphylaxis, hypercalcaemia, hyperphosphataemia, Severe ulceration of both legs, Atrial fibrillation, end stage kidney disease, gout, Insulin-Dependent Diabetes Mellitus, necrotic skin ulceration, non ST elevation myocardial infarction, secondary hyperparathyroidism, smoker, VF cardiac arrest	Approved
cinacalcet	Calciphylaxis, tertiary hyperparathyroidism, diabetic nephropathy, haemodialysis, severe peripheral vascular disease	Approved
cinacalcet	Calciphylaxis, tertiary hyperparathyroidism, parathyroidectomy	Approved
cinacalcet	Calciphylaxis, tertiary hyperparathyroidism, parathyroidectomy	Approved renewal
cinacalcet	Dialysis, hyperparathyroidism, renal failure	Approved
cinacalcet	Dialysis, hyperparathyroidism, renal failure	Approved renewal
cinacalcet	Dialysis, hyperparathyroidism, renal failure	Approved renewal
cinacalcet	ESRF, IgA nephropathy, parathyromatosis, transplant planned, hypertension, limited vascular access	Approved
cinacalcet	hypercalcaemia	Approved
cinacalcet	hypercalcaemia, metastatic pancreatic neuroendocrine tumour	Approved
cinacalcet	hypercalcaemia, primary hyperparathyroidism	Approved
cinacalcet	hypercalcaemia, primary hyperparathyroidism	Approved
cinacalcet	hypercalcaemia, primary hyperparathyroidism	Approved
cinacalcet	hypercalcaemia, primary hyperparathyroidism, atrial fibrillation, B cell lymphoma, cognitive impairment, gout, parkinson's disease, previous PE, Prostate cancer	Approved
cinacalcet	hyperparathyroidism	Approved
cinacalcet	hyperparathyroidism	Approved
cinacalcet	hyperparathyroidism	Approved renewal
cinacalcet	hyperparathyroidism	Approved renewal
cinacalcet	hyperparathyroidism, autonomous hyperparathyroidism, end stage renal failure, surgery contraindicated	Approved
cinacalcet	hyperparathyroidism, autonomous hyperparathyroidism, end stage renal failure, surgery contraindicated	Approved renewal
cinacalcet	hyperparathyroidism, autonomous hyperparathyroidism, previous surgery, surgery contraindicated, unsuccessful parathyroid surgery	Approved
cinacalcet	hyperparathyroidism, diabetes type 2, end stage renal failure, hypertension, pulmonary tuberculosis	Approved
cinacalcet	hyperparathyroidism, diabetes type 2, end stage renal failure, hypertension, pulmonary tuberculosis	Approved renewal
cinacalcet	hyperparathyroidism, ectopic tissue	Approved
cinacalcet	hyperparathyroidism, ectopic tissue	Approved renewal
cinacalcet	hyperparathyroidism, failed surgery, post renal transplant	Approved renewal
cinacalcet	hyperparathyroidism, IgA nephropathy, post kidney transplant	Approved
cinacalcet	hyperparathyroidism, infected SVC clot, SVC stenosis	Approved
cinacalcet	Pancreatic neuroendocrine tumor	Approved
cinacalcet	Pancreatic neuroendocrine tumor	Approved renewal
cinacalcet	Pancreatic neuroendocrine tumor	Approved renewal
cinacalcet	Pancreatic neuroendocrine tumor	Approved renewal
cinacalcet	pancreatic neuroendocrine tumour, severe treatment resistant hypercalcaemia	Approved renewal
cinacalcet	parathyroid adenoma, primary hyperparathyroidism, severe treatment resistant hypercalcaemia, bridge to surgery, chronic renal impairment, heart failure	Approved
cinacalcet	Parathyroid carcinoma with recurrence	Approved
cinacalcet	primary hypercalcaemia, unfit for surgery	Approved
cinacalcet	primary hyperparathyroidism	Approved renewal
cinacalcet	primary hyperparathyroidism, atrial fibrillation, hypercalcaemia, previous CVAs, renal impairment	Approved
cinacalcet	primary hyperparathyroidism, awaiting surgery, hypercalcaemia, metastatic melanoma	Approved
cinacalcet	primary hyperparathyroidism, congestive heart failure, gout, hypercalcaemia, hypercholesterolaemia, hypertension, osteoporosis, renal failure	Approved
cinacalcet	primary hyperparathyroidism, congestive heart failure, gout, hypercalcaemia, hypercholesterolaemia, hypertension, osteoporosis, renal failure	Approved renewal
cinacalcet	primary hyperparathyroidism, dementia, surgery contraindicated	Approved
cinacalcet	primary hyperparathyroidism, dementia, surgery contraindicated	Approved renewal
cinacalcet	primary hyperparathyroidism, dementia, surgery contraindicated	Approved renewal
cinacalcet	primary hyperparathyroidism, failed surgery	Approved
cinacalcet	primary hyperparathyroidism, failed surgery	Approved renewal
cinacalcet	primary hyperparathyroidism, heart disease, lung disease, parathyroid adenoma	Approved
cinacalcet	primary hyperparathyroidism, heart disease, lung disease, parathyroid adenoma	Approved renewal
cinacalcet	primary hyperparathyroidism, hypercalcaemia	Approved
cinacalcet	primary hyperparathyroidism, hypercalcaemia	Approved
cinacalcet	primary hyperparathyroidism, hypercalcaemia	Approved renewal
cinacalcet	primary hyperparathyroidism, hypercalcaemia	Approved renewal
cinacalcet	primary hyperparathyroidism, hyperlipidaemia, hypertension, impaired glucose tolerance, ischaemic heart disease	Approved
cinacalcet	primary hyperparathyroidism, hyperlipidaemia, hypertension, impaired glucose tolerance, ischaemic heart disease	Approved renewal
cinacalcet	primary hyperparathyroidism, IHD, Pancreatic neuroendocrine tumor, renal impairment	Approved
cinacalcet	primary hyperparathyroidism, tertiary hyperparathyroidism, diabetes type 2, dilated cardiomyopathy, hypertension, obesity, Renal Impairment	Approved
cinacalcet	primary hyperparathyroidism, unfit for surgery, bipolar disease, Diabetes Insipidus, diabetes type 2, ischaemic bowel	Approved
cinacalcet	primary hyperparathyroidism, unsuccessful parathyroid surgery	Approved
cinacalcet	secondary hyperparathyroidism, bone pain, ESRF on Dialysis, unfit for surgery	Approved
cinacalcet	secondary hyperparathyroidism, bone pain, ESRF on Dialysis, unfit for surgery	Approved renewal
cinacalcet	secondary hyperparathyroidism, bronchiectasis, CF related diabetes, Cystic fibrosis, end stage kidney disease, liver transplant, severe chronic lung disease, surgery contraindicated, tertiary hyperparathyroidism	Approved
cinacalcet	secondary hyperparathyroidism, diabetes type 2, dilated cardiomyopathy, end stage renal failure, haemodialysis, long QT syndrome, obesity, Osteoarthritis	Approved
cinacalcet	secondary hyperparathyroidism, diabetes type 2, dilated cardiomyopathy, end stage renal failure, haemodialysis, long QT syndrome, obesity, Osteoarthritis	Approved renewal
cinacalcet	secondary hyperparathyroidism, dialysis dependent, ischaemic heart disease, kidney failure, Myasthenia gravis	Approved
cinacalcet	secondary hyperparathyroidism, end stage renal failure, haemodialysis, tertiary hyperparathyroidism	Approved
cinacalcet	secondary hyperparathyroidism, post renal transplant, unfit for surgery	Approved
cinacalcet	secondary hyperparathyroidism, post renal transplant, unfit for surgery	Approved renewal
cinacalcet	secondary hyperparathyroidism, unfit for surgery	Approved
cinacalcet	secondary hyperparathyroidism, unfit for surgery	Approved renewal
cinacalcet	severe hyperparathyroidism, aortic valve disease, cardiac disease, end stage renal failure, Endocarditis, ineligible for transplant, on warfarin, previous stroke, unfit for surgery	Approved
cinacalcet	severe hyperparathyroidism, back pain, occlusion subclavian vein, renal failure, SLE	Approved
cinacalcet	severe hyperparathyroidism, back pain, occlusion subclavian vein, renal failure, SLE	Approved renewal
cinacalcet	severe hyperparathyroidism, back pain, occlusion subclavian vein, renal failure, SLE	Approved renewal
cinacalcet	severe hyperparathyroidism, diabetes type 2, end stage renal failure, haemodialysis, ischaemic heart disease, obesity	Approved
cinacalcet	severe hyperparathyroidism, diabetes type 2, end stage renal failure, haemodialysis, ischaemic heart disease, obesity	Approved renewal
cinacalcet	severe hyperparathyroidism, end stage renal failure, ESRD, gout, obesity	Approved
cinacalcet	severe hyperparathyroidism, end stage renal failure, haemodialysis, unfit for surgery	Approved
cinacalcet	severe hyperparathyroidism, ESRD, haemodialysis, Peripheral Vascular disease, severe ischaemic heart disease	Approved
cinacalcet	severe hyperparathyroidism, ESRD, haemodialysis, Peripheral Vascular disease, severe ischaemic heart disease	Approved renewal
cinacalcet	severe hyperparathyroidism, surgery contraindicated	Approved
cinacalcet	severe hyperparathyroidism, surgery contraindicated	Approved renewal
cinacalcet	severe hyperparathyroidism, surgery contraindicated	Approved renewal
cinacalcet	Severe hyperthyroidism, Calciphylaxis, diabetes type 2, ESRF on Dialysis, gout, IHD, no venous access, obesity, Peripheral Vascular disease, probable uterine fibroid mass, renal calculus	Approved
cinacalcet	Severe hyperthyroidism, Calciphylaxis, diabetes type 2, ESRF on Dialysis, gout, IHD, no venous access, obesity, Peripheral Vascular disease, probable uterine fibroid mass, renal calculus	Approved renewal
cinacalcet	Severe hyperthyroidism, Coronary Artery Disease, end stage renal failure, polycystic kidney disease	Approved
cinacalcet	severe secondary hyperparathyroidism, aortic stenosis, end stage renal failure	Approved
cinacalcet	severe secondary hyperparathyroidism, aortic stenosis, end stage renal failure	Approved renewal
cinacalcet	severe secondary hyperparathyroidism, diabetes mellitus, end stage renal failure, ischaemic cardiomyopathy, Peripheral Vascular disease	Approved
cinacalcet	severe secondary hyperparathyroidism, diabetes mellitus, end stage renal failure, ischaemic cardiomyopathy, Peripheral Vascular disease	Approved renewal
cinacalcet	severe secondary hyperparathyroidism, diabetes mellitus, end stage renal failure, ischaemic cardiomyopathy, Peripheral Vascular disease	Approved renewal
cinacalcet	severe secondary hyperparathyroidism, diabetes, end stage renal failure, Severe Ischaemic Heart Disease	Approved
cinacalcet	severe secondary hyperparathyroidism, diabetes, end stage renal failure, Severe Ischaemic Heart Disease	Approved renewal
cinacalcet	severe secondary hyperparathyroidism, diabetes, end stage renal failure, severe ischaemic heart disease	Approved renewal
cinacalcet	severe secondary hyperparathyroidism, end stage renal disease, surgery contraindicated	Approved
cinacalcet	severe secondary hyperparathyroidism, end stage renal failure, unfit for surgery	Approved
cinacalcet	severe secondary hyperparathyroidism, end stage renal failure, unfit for surgery	Approved renewal
cinacalcet	severe secondary hyperparathyroidism, severe treatment resistant hypercalcaemia, end stage renal failure, Right Heart Failure	Approved
cinacalcet	severe secondary hyperparathyroidism, surgery contraindicated, coronary disease, dialysis dependent, ESRF secondary to focal glomerulosclerosis, previous CABG, severe peripheral vascular disease	Approved
cinacalcet	severe secondary hyperparathyroidism, surgery contraindicated, coronary disease, dialysis dependent, ESRF secondary to focal glomerulosclerosis, previous CABG, severe peripheral vascular disease	Approved renewal
cinacalcet	severe treatment resistant hypercalcaemia, end stage renal failure due to hypertension, ischaemic heart disease, post renal transplant, recurrent bacteraemia, recurrent urinary tract infections, tertiary hyperparathyroidism	Approved
cinacalcet	severe treatment resistant hypercalcaemia, pre-operative treatment, primary hyperparathyroidism	Approved
cinacalcet	tertiary hyperparathyroidism	Approved
cinacalcet	tertiary hyperparathyroidism	Approved
cinacalcet	tertiary hyperparathyroidism	Approved renewal
cinacalcet	tertiary hyperparathyroidism	Approved renewal
cinacalcet	tertiary hyperparathyroidism	Approved renewal
cinacalcet	tertiary hyperparathyroidism, atrial fibrillation, diabetic nephropathy, dialysis, ESRD, severe peripheral vascular disease	Approved
cinacalcet	tertiary hyperparathyroidism, atrial fibrillation, diabetic nephropathy, dialysis, ESRD, severe peripheral vascular disease	Approved renewal
cinacalcet	tertiary hyperparathyroidism, atrial fibrillation, diabetic nephropathy, dialysis, ESRD, severe peripheral vascular disease	Approved renewal
cinacalcet	tertiary hyperparathyroidism, cardiac disease, ESRD, Peripheral Vascular disease	Approved
cinacalcet	tertiary hyperparathyroidism, Cardiomyopathy, ESRF, hypertension, musculoskeletal pain, severe emphysema, surgery contraindicated	Approved
cinacalcet	tertiary hyperparathyroidism, Cardiomyopathy, ESRF, hypertension, musculoskeletal pain, severe emphysema, surgery contraindicated	Approved renewal
cinacalcet	tertiary hyperparathyroidism, Coronary Artery Disease, diabetic nephropathy, ESRF, surgery contraindicated	Approved
cinacalcet	tertiary hyperparathyroidism, coronary disease, diabetes type 2, ESRF secondary to FSGS, hypertension, myopathy	Approved
cinacalcet	tertiary hyperparathyroidism, diabetes type 2, IHD, previous CVA	Approved
cinacalcet	tertiary hyperparathyroidism, diabetes type 2, IHD, previous CVA	Approved renewal
cinacalcet	tertiary hyperparathyroidism, diabetes type 2, IHD, previous CVA	Approved renewal
cinacalcet	tertiary hyperparathyroidism, diabetes, ESRD	Approved
cinacalcet	tertiary hyperparathyroidism, diabetic nephropathy, end stage renal failure, ischaemic heart disease	Approved
cinacalcet	tertiary hyperparathyroidism, diabetic nephropathy, end stage renal failure, ischaemic heart disease	Approved renewal
cinacalcet	tertiary hyperparathyroidism, end stage kidney failure, hypercalcaemia	Approved
cinacalcet	tertiary hyperparathyroidism, end stage renal disease	Approved
cinacalcet	tertiary hyperparathyroidism, ESRF on Dialysis, ischaemic heart disease, painful extra-skeletal calcium deposits	Approved
cinacalcet	tertiary hyperparathyroidism, ESRF on Dialysis, ischaemic heart disease, painful extra-skeletal calcium deposits	Approved renewal
cinacalcet	tertiary hyperparathyroidism, ESRF, surgery contraindicated	Approved
cinacalcet	tertiary hyperparathyroidism, heart failure	Approved
cinacalcet	tertiary hyperparathyroidism, heart failure	Approved renewal
cinacalcet	tertiary hyperparathyroidism, hypercalcaemia, severe renal osteodystrophy	Approved
cinacalcet	tertiary hyperparathyroidism, hypercalcaemia, severe renal osteodystrophy	Approved renewal
cinacalcet	tertiary hyperparathyroidism, hypertension, polyarticular gout	Approved
cinacalcet	tertiary hyperparathyroidism, hypertension, polyarticular gout	Approved renewal
cinacalcet	tertiary hyperparathyroidism, infected SVC clot, SVC stenosis	Approved renewal
cinacalcet	tertiary hyperparathyroidism, infected SVC clot, SVC stenosis	Approved renewal
cincalcet	tertiary hyperparathyroidism, diabetes, ESRD, renal arterial disease	Approved
cincalcet	tertiary hyperparathyroidism, diabetes, ESRD, renal arterial disease	Approved renewal
ciprofloxacin	recurrent UTI, unable to swallow these pills	Approved
cisapride	cerebral palsy, constipation, enteral feeds, pain	Approved
cisapride	obstruction PU5, gut dysmotility, intolerance to feed, Renal Impairment, single dysplastic kidney, Vomiting	Approved
cisapride	oesophageal dysmotility, dysphagia, GORD	Approved
cisapride	oesophageal dysmotility, dysphagia, GORD	Approved renewal
cisapride	poor antroduodenal motility, Hirschsprung's disease, intolerance to feed, jejunal obstruction	Approved
citric acid 12 g + magnesium oxide 3.5 g + picosulfate sodium 10 mg oral liquid	Chronic severe constipation, constipation secondary to clozapine, Schizoaffective disorder	Approved
citric acid with magnesium oxide and sodium picosulfate	abdominal pain, Encopresis, slow transit constipation	Approved
citric acid with magnesium oxide and sodium picosulfate	Chronic severe constipation	Approved
clarithromycin	Nocardiosis, prophylaxis, immunocompromised	Approved
clindamycin	desquamative inflammatory vaginitis	Approved
clindamycin clotrimazole	desquamative inflammatory vaginitis	Approved
clindamycin clotrimazole	desquamative inflammatory vaginitis	Approved
clindamycin clotrimazole	desquamative inflammatory vaginitis	Approved
clindamycin clotrimazole	desquamative inflammatory vaginitis	Approved renewal
clinigel lubricating jelly	persitent candida vulvovaginitis	Approved
clofarabine	Langerhans cell histiocytosis	Approved
clofazimine	Cystic fibrosis, mycobacterium abscessus pulmonary infection	Approved
clofazimine	leprosy	Approved
clofazimine	MDR tuberculosis	Approved
clofazimine	multibacillary leprosy, peripheral neuropathy	Approved
coagucheck testing strips	on warfarin, cerebral palsy, epilepsy, pericardial effusion, Pleural Effusion, Rheumatic Heart Disease, valve replacement	Approved
co-enzyme q	autosomal recessive cerebellar atrophy	Approved
co-enzyme q	autosomal recessive cerebellar atrophy	Approved renewal
coenzyme q 10	alpers' disease, mitochondrial disorder, gastrostomy feeding, Neuropathic pain, partial epilepsy	Approved renewal
co-enzyme q10	autosomal recessive cerebellar atrophy	Approved
co-enzyme q10	autosomal recessive cerebellar atrophy	Approved renewal
co-enzyme q10	heart failure, hyperkalaemia, MELAS, Pleural Effusion	Approved
co-enzyme q10	heart failure, hyperkalaemia, MELAS, Pleural Effusion	Approved renewal
colesevelam	bile salt diarrhoea	Approved
colesevelam	bile salt diarrhoea post cholecystectomy, Coeliac disease, multiple food intolerances	Approved
colesevelam	bile salt diarrhoea post cholecystectomy, Coeliac disease, multiple food intolerances	Approved renewal
colesevelam	bile salt diarrhoea post cholecystectomy, Coeliac disease, multiple food intolerances	Approved renewal
colistin	Resistant Pseudomonas infection, Pseudomonas Chest Infection	Approved
condoms	contraception, funded alternative unsuitable	Approved
crisantaspase	NK/T cell lymphoma	Approved
crizotinib	metastatic lung adenocarcinoma, ALK positive	Declined
custodiol htk	aortic valve replacement	Approved
custodiol htk	aortic valve replacement, cardiac surgery, coronary artery bypass grafting, mitral valve replacement	Approved
custodiol htk	AVR, CABG	Approved
custodiol htk	cardiac surgery	Approved
custodiol htk	cardiac surgery	Approved
custodiol htk	cardiac surgery	Approved
custodiol htk	cardiac surgery	Approved
custodiol htk	cardiac surgery	Approved
custodiol htk	cardiac surgery	Approved
custodiol htk	cardiac surgery	Approved
custodiol htk	cardiac surgery, aortic arch repair, transluminal repair of aorta	Approved
custodiol htk	cardiac surgery, aortic regurgitation, mitral regurgitation, Valve Replacement	Approved
custodiol htk	cardiac surgery, aortic valve replacement, Congestive Heart Failure, mitral stenosis, Rheumatic Heart Disease	Approved
custodiol htk	cardiac surgery, aortic valve replacement, mitral valve replacement, tricuspid valve replacement	Approved
custodiol htk	cardiac surgery, Bentall's procedure	Approved
custodiol htk	cardiac surgery, Congestive Heart Failure	Approved
custodiol htk	cardiac surgery, coronary artery bypass grafting	Approved
custodiol htk	cardiac surgery, PAH	Approved
custodiol htk	coronary artery bypass graft, mitral valve replacement	Approved
custodiol htk	triple valve replacement	Approved
custodiol htk	triple valve replacement	Approved
custodiol htk	upcoming aortic valve replacement surgery	Approved
cyanocobalamin	transcobalamin deficiency	Approved
cyanocobalamin	transcobalamin deficiency	Approved
cyanocobalamin	vitamin B 12 deficiency, on warfarin, Post Fontan procedure, protein losing enteropathy	Approved
cycloserine	MDR tuberculosis	Approved
cycloserine	MDR tuberculosis	Approved
cycloserine	multidrug-resistant TB	Approved
cycloserine	multidrug-resistant tuberculosis	Approved
cycloserine	suspected MDR tuberculosis	Approved
cyclosporin	atopic conjunctivitis, dry eye	Approved
cyclosporin	atopic keratoconjunctivitis	Approved
cyclosporin	atopic keratoconjunctivitis	Approved
cyclosporin	atopic keratoconjunctivitis	Approved
cyclosporin	bilateral corneal ulcers, severe acute graft versus host disease, bone marrow transplant	Approved
cyclosporin	Blepharitis, terrien's marginal deterioration, corneal neovascularisation	Approved
cyclosporin	breakdown of corneal transplant, keratoconus, peripheral corneal vascularisation	Approved
cyclosporin	Chronic hyposecretory dry eyes, juvenile rheumatoid arthritis	Approved
cyclosporin	Chronic hyposecretory dry eyes, juvenile rheumatoid arthritis	Approved renewal
cyclosporin	conjunctivitis sicca, severe dry eye syndrome	Approved renewal
cyclosporin	conjunctivitis sicca, severe dry eye syndrome	Approved renewal
cyclosporin	corneal graft rejection	Approved
cyclosporin	corneal graft rejection, keratoconus	Approved
cyclosporin	corneal graft rejection, keratoconus	Approved renewal
cyclosporin	dry eyes	Approved
cyclosporin	dry eyes	Approved
cyclosporin	dry eyes	Approved renewal
cyclosporin	dry eyes	Approved renewal
cyclosporin	graft versus host disease, severe dry eyes, corneal transplant, intolerance to ocular steroids	Approved
cyclosporin	Graft vs Host Disease, Blepharitis	Approved
cyclosporin	Graft vs Host Disease, bone marrow transplant, conjunctivitis, leukaemia	Approved
cyclosporin	keratoconjunctivitis	Approved
cyclosporin	keratoconjunctivitis sicca	Approved
cyclosporin	keratoconjunctivitis sicca	Approved
cyclosporin	keratoconjunctivitis sicca	Approved
cyclosporin	keratoconjunctivitis sicca	Approved
cyclosporin	keratoconjunctivitis sicca	Approved renewal
cyclosporin	keratoconjunctivitis sicca	Approved renewal
cyclosporin	keratoconjunctivitis sicca	Approved renewal
cyclosporin	keratoconjunctivitis sicca	Approved renewal
cyclosporin	keratoconjunctivitis sicca	Approved renewal
cyclosporin	keratoconjunctivitis sicca	Approved renewal
cyclosporin	keratoconjunctivitis sicca	Approved renewal
cyclosporin	keratoconjunctivitis sicca	Approved renewal
cyclosporin	keratoconjunctivitis sicca	Approved renewal
cyclosporin	keratoconjunctivitis sicca, glaucoma	Approved
cyclosporin	keratoconjunctivitis sicca, glaucoma	Approved renewal
cyclosporin	keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis	Approved
cyclosporin	keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis	Approved renewal
cyclosporin	keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis	Approved renewal
cyclosporin	keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis	Approved renewal
cyclosporin	keratoconjunctivitis sicca, severe dry eye syndrome	Approved
cyclosporin	keratoconjunctivitis sicca, severe dry eyes	Approved
cyclosporin	keratoconjunctivitis sicca, severe dry eyes	Approved renewal
cyclosporin	keratoconus, corneal graft rejection, prophylaxis, recurrent corneal graft	Approved renewal
cyclosporin	keratoconus, corneal graft rejection, prophylaxis, recurrent corneal graft	Approved renewal
cyclosporin	keratoconus, recurrent corneal graft	Approved renewal
cyclosporin	ocular inflammation, photophobia, thyroid eye disease	Approved
cyclosporin	ocular rosacea, corneal neovascularisation, limbal stem cell deficiency	Approved
cyclosporin	recurrent corneal graft, hsv recurrence, keratitis	Approved
cyclosporin	severe allergic conjunctivitis, Vernal Keratoconjunctivitis	Approved
cyclosporin	severe allergic eye disease, vernal catarrh, vernal conjunctivitis	Approved
cyclosporin	severe atopic keratoconjunctivitis	Approved
cyclosporin	severe atopic keratoconjunctivitis, glaucoma	Approved
cyclosporin	severe dry eye syndrome	Approved
cyclosporin	severe dry eye syndrome	Approved
cyclosporin	severe dry eye syndrome, Blepharitis, meibomian gland dysfunction	Approved
cyclosporin	severe dry eye syndrome, sjogrens syndrome	Approved
cyclosporin	severe dry eye syndrome, sjogrens syndrome	Approved renewal
cyclosporin	severe dry eye syndrome, sjogrens syndrome, Blepharitis, meibomian gland dysfunction	Approved
cyclosporin	severe dry eye syndrome, Trichiasis	Approved
cyclosporin	severe dry eyes, sjogrens syndrome	Approved
cyclosporin	severe dry eyes, sjogrens syndrome	Approved renewal
cyclosporin	severe dry eyes, sjogrens syndrome	Approved renewal
cyclosporin	severe steroid dependant allergic eye disease	Approved
cyclosporin	severe steroid dependant allergic eye disease	Approved renewal
cyclosporin	severe vernal keratoconjunctivitis	Approved
cyclosporin	severe vernal keratoconjunctivitis	Approved
cyclosporin	sjogrens syndrome	Approved
cyclosporin	sjogrens syndrome	Approved
cyclosporin	sjogrens syndrome	Approved renewal
cyclosporin	sjogrens syndrome	Approved renewal
cyclosporin	sjogrens syndrome, corneal epithelial defect, keratoconjunctivitis sicca	Approved
cyclosporin	sjogrens syndrome, corneal epithelial defect, keratoconjunctivitis sicca	Approved renewal
cyclosporin	sjogrens syndrome, corneal epithelial defect, keratoconjunctivitis sicca	Approved renewal
cyclosporin	sjogrens syndrome, Fibromyalgia, systemic lu	Approved renewal
cyclosporin	Unable to produce tears, Blepharitis	Approved
cyclosporin	vernal allergic eye disease	Approved
cyclosporin	Vernal Keratoconjunctivitis	Approved
cyclosporin	Vernal Keratoconjunctivitis	Approved
cyclosporin	Vernal Keratoconjunctivitis	Approved
cyclosporin	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis, asthma, eczema, hayfever, ocular hypertension	Approved
cyclosporin	Vernal Keratoconjunctivitis, asthma, eczema, hayfever, ocular hypertension	Approved renewal
cyclosporin	Vernal Keratoconjunctivitis, corneal ectasia	Approved
cyclosporin 0.2%	Vernal Keratoconjunctivitis	Approved renewal
cyclosporin eye	chronic dry eye, thyroid-related orbitopathy	Approved
cyclosporin eye	severe dry eye syndrome	Approved
cyclosporin eye	sjogrens syndrome, Fibromyalgia, systemic lu	Approved
cyclosporin eye	sjogrens syndrome, Fibromyalgia, systemic lu	Approved renewal
cyclosporin eye	Vernal Keratoconjunctivitis	Approved
cyclosporin eye	Vernal Keratoconjunctivitis	Approved
cyclosporin eye	Vernal Keratoconjunctivitis, allergic eye disease	Approved renewal
cyclosporin eye drops	keratoconjunctivitis sicca	Approved
cyclosporin eye drops	keratoconjunctivitis sicca	Approved
cyclosporin eye drops	keratoconjunctivitis sicca	Approved renewal
cyclosporin eye drops	keratoconjunctivitis sicca, meibomian gland dysfunction	Approved
cyclosporin eye drops	keratoconus, corneal graft rejection	Approved
cyclosporin eye drops	keratoconus, recurrent corneal graft	Approved
cyclosporin eye drops	severe vernal keratoconjunctivitis	Approved
cyclosporin eye drops	severe vernal keratoconjunctivitis	Approved
cyclosporin eye drops	severe vernal keratoconjunctivitis	Approved renewal
cyclosporin eye drops	severe vernal keratoconjunctivitis	Approved renewal
cyclosporin eye drops	Stevens-Johnson Syndrome, bilateral forniceal scarring, chronic ocular discomfort, cicatricial conjunctivitis, corneal grafting, Trichiasis	Approved
cyclosporin eye drops	Vernal Keratoconjunctivitis	Approved
cyclosporin eye drops	Vernal Keratoconjunctivitis	Approved
cyclosporin eye drops	Vernal Keratoconjunctivitis	Approved
cyclosporin eye ointment	atopic keratoconjunctivitis, meibomian gland dysfunction	Approved
cyclosporin eye ointment	corneal epithelial defect, ocular inflammation, allergies, keratitis, photophobia	Approved
cyclosporin eye ointment	filamentary keratitis, ocular dry eyes	Approved
cyclosporin eye ointment	filamentary keratitis, ocular dry eyes	Approved renewal
cyclosporin eye ointment	keratoconjunctivitis sicca, glaucoma, melbomium gland dysfunction	Approved
cyclosporin eye ointment	ocular rosacea, corneal neovascularisation, limbal stem cell deficiency	Approved renewal
cyclosporin eye ointment	refractory dry eye	Approved
cyclosporin eye ointment	severe dry eye syndrome	Approved
cyclosporin eye ointment	severe dry eye syndrome	Approved renewal
cyclosporin eye ointment	severe dry eye syndrome	Approved renewal
cyclosporin eye ointment	severe dry eyes, facial nerve palsy, neurotrophic cornea secondary to herpes zoster opthalmicus, Rheumatoid Arthritis, sjogrens syndrome	Approved
cyclosporin eye ointment	severe steroid dependant vernal keratoconjunctivitis	Approved
cyclosporin eye ointment	sjogrens syndrome, severe dry eyes	Approved
cyclosporin eye ointment	Vernal Keratoconjunctivitis, asthma, eczema	Approved
cyclosporin eye ointment	Vernal Keratoconjunctivitis, asthma, eczema	Approved renewal
cyclosporin eye ointment	Vernal Keratoconjunctivitis, limbitis, shield ulcer	Approved
cyclosporin ointment	conjunctivitis	Approved
cyclosporin ointment	conjunctivitis sicca, severe dry eye syndrome	Approved
cyclosporin ointment	dry eyes	Approved
cyclosporin ointment	herpes zoster, keratouveitis, severe dry eye syndrome	Approved
cyclosporin ointment	keratoconjunctivitis sicca	Approved
cyclosporin ointment	severe allergic conjunctivitis	Approved
cyclosporin ointment	sjogrens syndrome, keratoconjunctivitis sicca	Approved
cyclosporin ointment	Vernal Keratoconjunctivitis, allergic eye disease	Approved
cyclosporin ointment	Vernal Keratoconjunctivitis, limbitis, shield ulcer	Approved renewal
cyclosporin ointment, 0.2%	atopic keratoconjunctivitis	Approved
cyclosporin ointment, 0.2%	Vernal Keratoconjunctivitis	Approved
cyclosporin ointment, 0.2%	Vernal Keratoconjunctivitis, steroid side effects	Approved
cyclosporin ointment, 0.2%	Vernal Keratoconjunctivitis, steroid side effects	Approved renewal
cyclosporin ointment, 0.2%	Vernal Keratoconjunctivitis, steroid side effects	Approved renewal
cyclosporin ophthalmic emulsion	sjogrens syndrome, keratitis	Approved renewal
cyclosporine ophthalmic emulsion	sjogrens syndrome, keratitis	Approved
cyproheptadine	cyclical vomiting, Alagille's syndrome, complex congenital heart disease, tetralogy of fallot repair	Approved
cyproheptadine	Cyclical vomiting, Hydrocephalus, VP shunt	Approved
cysteamine	Cystinosis	Approved
cysteamine	Cystinosis	Approved renewal
cysteamine	Cystinosis, Chronic Renal Failure	Approved renewal
cysteamine eye drops	Cystinosis, Chronic Renal Failure	Approved
cysteamine hcl	Cystinosis, cystine corneal deposits, failure to thrive, renal fanconi syndrome	Approved
dabigatran	deep vein thrombosis, pulmonary embolism, Immobile, Motor Neurone disease	Approved
d-alpha tocopheryl acetate	cholestasis	Approved
dantrolene	Motor Neurone disease, spasm, spasticity, spinal myelopathy	Approved
dantrolene	spasticity	Approved
dantrolene	spasticity, cerebral palsy	Approved
dantrolene	spasticity, stroke	Approved
daptomycin	allergy to antibiotics, septic arthritis right hip	Approved
daptomycin	infected prosthetic knee joint, vancomycin resistant staphylococcus aureus	Approved
daptomycin	infected thrombus, MRSA, Septicaemia	Approved
dasatinib	Philadelphia positive acute lymphoblastic leukemia	Approved
dasatinib	Philidelphia positive acute lymphoblastic leukemia, Hodgkin's B cell lymphoma in remission, ischaemic heart disease	Approved
deferasirox	Blackfan-Diamond Syndrome, transfusion dependent iron overload	Approved
deferasirox	Blackfan-Diamond Syndrome, transfusion dependent iron overload	Approved renewal
deferasirox	Fanconi Anaemia, bone marrow aplasia	Approved
deferasirox	transfusion iron overload, t cell LGL	Approved
deferiprone	iron overload	Approved
deferiprone	superficial siderosis	Approved
deferiprone	superficial siderosis	Approved
deferiprone	superficial siderosis of CNS, cerebellar ataxia, deafness, erectile dysfunction, myelopathy	Approved
deferiprone	transfusion dependent iron overload, Severe Aplastic Anaemia	Approved
deflazacort	Duchenne Muscular Dystrophy	Approved
deflazacort	Duchenne Muscular Dystrophy	Approved renewal
delta-9-tetrahydrocannabinol and cannabidiol	Intractable epilepsy, myoclonic seizures, tonic clonic seizures, Behaviour disorder, Chromosomal abnormality, intellectual disability	Declined
delta-9-tetrahydrocannabinol and cannabidiol	Intractable epilepsy, myoclonic seizures, tonic clonic seizures, Behaviour disorder, Chromosomal abnormality, intellectual disability	Declined
delta-9-tetrahydrocannabinol and cannabidiol	muscle spasm and pain	Declined
delta-9-tetrahydrocannabinol and cannabidiol	Severe epilepsy	Declined
demeclocycline	hyponatraemia secondary to SIADH	Approved
demeclocycline	hyponatraemia, SIADH, Small Cell lung Cancer	Approved
demeclocycline	hyponatraemmia, Small Cell lung Cancer	Approved
denosumab	giant cell tumour of the bone	Approved
denosumab	giant cell tumour of the bone	Approved
denosumab	giant cell tumour of the bone	Approved
denosumab	giant cell tumour of the bone	Approved
denosumab	giant cell tumour of the bone	Approved renewal
denosumab	giant cell tumour of the bone	Approved renewal
denosumab	giant cell tumour of the bone	Approved renewal
denosumab	multicentric carpotarsal osteolysis	Approved
desmopressin	addictive behaviour, diabetes insipidus, Langerhans cell histiocytosis	Approved
desmopressin	central diabetes insipidus	Approved
desmopressin	central diabetes insipidus, central adrenal insufficiency, central hypothyroidism, Septo-optic dysplasia	Approved
desmopressin	diabetes insipidus	Approved
desmopressin	diabetes insipidus secondary to brain tumour	Approved
desmopressin	diabetes insipidus, Hypopituitarism, Nasal obstruction, somnolence	Approved
desmopressin	diabetes insipidus, nasal surgery, requires lower dose	Approved
desmopressin	severe epistaxis, Hereditary hemorrhagic telangiectasia	Approved
desmopressin tablet	addictive behaviour, diabetes insipidus, Langerhans cell histiocytosis	Approved
desmopressin tablet	central diabetes insipidus, Langerhans cell histiocytosis	Approved
desmopressin tablet	central diabetes insipidus, Wegener's Granulomatosis	Approved
desmopressin tablet	diabetes insipidus, blindness, suprasellar tumour	Approved
dexamethasone	bilateral multifocal choroiditis, panuveitis, cystoid macular oedema, secondary glaucoma, vasoproliferative tumors	Approved
dexamethasone	cystoid macular oedema	Approved
dexamethasone	cystoid macular oedema, uveitis, Psoriatic Arthritis	Approved
dexamethasone	ocular inflammation, steroid resistance	Approved
dexamethasone	ocular inflammation, steroid resistance	Approved renewal
dexamethasone	retinal vein occlusion	Approved
dexamethasone	retinal vein occlusion	Approved renewal
dexrazoxane	cardioprotective agent, metastatic osteosarcoma	Approved
dextromethorphan	non-ketotic hyperglycinaemia	Approved
diazoxide	generalised seizures, cognitive impairment, convulsions, glucose transporter abnormality	Approved
diazoxide	generalised seizures, cognitive impairment, convulsions, glucose transporter abnormality	Approved
diazoxide	Genetic testing re undiagnosed syndrome, Recurrent hypoglycaemia secondary to hyperinsulinism	Approved
diazoxide	hypoglycaemia due to insulinoma	Approved
diazoxide	Hypoglycaemia in infant, impaired LV function	Approved
diazoxide	hypoglycaemia, gastric bypass, Hyperinsulinaemia	Approved
diazoxide	hypoglycaemia, Insulinoma	Approved
diazoxide	Insulinoma	Approved
diazoxide	Insulinoma	Approved
diazoxide	Insulinoma, spontaneous hypoglycaemia	Approved
diazoxide	metastatic insulinoma	Approved
diazoxide (ECP)	hyperinsulinism, hypoglycaemia	Approved
dienogest	invasive endometriosis, refractory to surgery	Approved
diethylcarbamazine	Filariasis	Approved
dihydrotestosterone	androgen insensitivity syndrome	Approved
diloxanide	amoebic liver abscess	Approved
diloxanide	intestinal amebiasis	Approved
diloxanide	invasive amoebiasis, cellulitis, entamoeba histolytica intestinal colonisation	Approved
diloxanide fuorate	amoebic liver abscess, entamoeba histolytica liver abscess	Approved
dimercaptosuccinic acid	lead toxicity	Approved
diphtheria, tetanus and pertussis vaccine	post allogeneic stem cell transplant	Approved
diptheria, tetanus and pertussis	acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient	Approved
diptheria, tetanus and pertussis	pertussis infections, Dee pertussis transmission to infant	Approved
dipyridamole	congenital nephrotic syndrome, VTE prophylaxis	Approved
dornase alfa	chronic infection with burkholderia cepecia, Cystic fibrosis	Approved
dornase alfa	chronic obstructive asthma, bronchiolitis	Approved
dornase alfa	Cystic fibrosis	Approved
dornase alfa	Cystic fibrosis	Approved
dornase alfa	Cystic fibrosis, chronic pseudomonas	Approved
dornase alfa	Cystic fibrosis, lung disease	Approved
dornase alfa	Cystic fibrosis, pancreatic insufficiency	Approved
dornase alfa	Cystic fibrosis, pancreatic insufficiency	Approved renewal
droperidol	anxiety, G tube, J tube, progressive gut failure, severe abdominal pain, TPN dependent	Approved
droxidopa	intractable postural hypotension, autonomic neuropathy, Familial Amyloid Polyneuropathy due to a mutation in TTR	Approved
duloxetine	Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved
duloxetine	Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved renewal
duloxetine	Major Depressive disorder, psychotic symptoms, long QT syndrome	Approved renewal
duloxetine	pain, erythromelalgia	Approved
eculizumab	atypical haemolytic uraemic syndrome	Declined
eculizumab	atypical haemolytic uraemic syndrome, chronic anaemia, intravascular haemolysis	Declined
eltrombopag	amegakaryocytic thrombocytopaenia	Approved
eltrombopag	angio immunoblastic T cell lymphoma, aplastic anaemia	Approved
eltrombopag	angio immunoblastic T cell lymphoma, aplastic anaemia	Approved renewal
eltrombopag	angio immunoblastic T cell lymphoma, aplastic anaemia	Approved renewal
eltrombopag	aplastic anaemia	Approved
eltrombopag	aplastic anaemia	Approved
eltrombopag	Aplastic Anaemia	Declined
eltrombopag	aplastic anaemia, Thrombocytopaenia	Approved
eltrombopag	aplastic anaemia, Thrombocytopaenia	Declined renewal
eltrombopag	aplastic anaemia, transfusion dependent, high dose cyclophosphamide, severe neutropaenia	Approved
eltrombopag	bone marrow failure, Severe Aplastic Anaemia, refractory pseudomonal sepsis	Approved
eltrombopag	chronic immune mediated thrombocytopaenia	Approved
eltrombopag	chronic immune thrombocytopenia	Approved
eltrombopag	chronic immune thrombocytopenia	Approved renewal
eltrombopag	idiopathic thrombocytopaenic purpura	Approved
eltrombopag	idiopathic thrombocytopaenic purpura, low platelet count, aortic valve replacement, B cell non-hodgkin's lymphoma, upcoming major surgery	Approved
eltrombopag	immune thrombocytopaenia, Hepatitis B, hyptertension, Recurrent bladder tumours	Approved
eltrombopag	immune thrombocytopaenia, Hepatitis B, hyptertension, Recurrent bladder tumours, surgery contraindicated	Approved renewal
eltrombopag	immune thrombocytopaenia, severe steroid effect	Approved
eltrombopag	immune thrombocytopaenia, severe steroid effect	Approved renewal
eltrombopag	immune thrombocytopaenic purpura	Approved
eltrombopag	immune thrombocytopaenic purpura	Approved
eltrombopag	immune thrombocytopaenic purpura, SLE	Approved
eltrombopag	immune thrombocytopaenic purpura, SLE	Approved renewal
eltrombopag	leukaemia, immune thrombocytopaenia	Approved renewal
eltrombopag	Refractory ITP	Approved
eltrombopag	Refractory ITP	Approved
eltrombopag	Refractory ITP, chronic renal impairment, ischaemic heart disease	Approved
eltrombopag	Refractory ITP, nasal mucosal ulceration, SLE, splenectomy, Thrombocytopaenia	Approved
eltrombopag	Refractory ITP, nasal mucosal ulceration, SLE, splenectomy, Thrombocytopaenia	Approved renewal
eltrombopag	Refractory ITP, Underlying CLL	Approved
eltrombopag	refractory thrombocytopaenia, Underlying CLL	Approved
eltrombopag	Severe Aplastic Anaemia	Approved
eltrombopag	Severe Aplastic Anaemia	Approved
eltrombopag	Severe Aplastic Anaemia	Approved
eltrombopag	Severe Aplastic Anaemia	Approved
eltrombopag	Severe Aplastic Anaemia, bone marrow failure	Approved
eltrombopag	Severe Aplastic Anaemia, bronchiectasis, hypogammaglobulinaemia, thymoma	Approved
eltrombopag	Severe Aplastic Anaemia, rare platelet match, risk of iron overload	Approved
emsogen	carnitine-acylcarnitine translocase deficiency, eosinophilic oesophagitis, hyperammonaemia, Autistic Spectrum Disorder, epilepsy, intellectual disability, multiple food allergies	Approved
energivit	Citrullinaemia type 1	Approved renewal
energivit	methylmalonic acidemia	Approved
energivit	methylmalonic acidemia, brain injury, hyperammonaemia	Approved
energivit	OTC Deficiency, Ornithine transcarbamylase deficiency, urea cycle disorder	Approved
energivit	Propionic Acidaemia	Approved
enfuvirtide	resistant HIV	Approved
enoxaparin	Adenocarcinoma of the stomach, aortic regurgitation, mitral valve replacement, Rheumatic Heart Disease, st jude's aortic valve replacement	Approved
enoxaparin	antiphospholipid syndrome, Chest Pain, pulmonary hypertension, unstable INR	Approved
enoxaparin	antiphospholipid syndrome, thromboses on warfarin, venous thrombosis	Approved
enoxaparin	antiphospholipid syndrome, thromboses on warfarin, venous thrombosis	Approved renewal
enoxaparin	antiphospholipid syndrome, thromboses on warfarin, venous thrombosis	Approved renewal
enoxaparin	aortic valve disease, warfarin interaction, latent TB	Approved
enoxaparin	artery thrombosis, atrial fibrillation, TPN dependent	Approved
enoxaparin	Atrial fibrillation, hypertension, lower extremety DVT, previous asbestos exposure	Approved
enoxaparin	basilar artery occlusion, No resolution on warfarin, recurrent stroke syndromes	Approved
enoxaparin	bilateral dvt	Approved
enoxaparin	bilateral pulmonary emboli, deep vein thrombosis, thrombus on dabigatran, warfarin resistance	Approved
enoxaparin	bilateral pulmonary emboli, PEG tube with gastroparesis/malabsorption oral meds	Approved
enoxaparin	Calciphylaxis, end stage renal failure, long term anticoagulation, mechanical aortic valve replacement	Approved
enoxaparin	Calciphylaxis, long term anticoagulation, end stage renal disease, mitral valve replacement	Approved
enoxaparin	cerebral haemorrhages, familial cavernoma syndrome, inferior vena cava filter, large bilateral pulmonary emboli, severe essential hypertension	Approved
enoxaparin	chronic loculated left sided pleural effusion, Crohn's disease, primary sclerosing cholangitis, pulmonary embolism	Approved
enoxaparin	Crohn's diease, Chronic Renal Failure, enterocutaneous fistulae, renal vein thrombosis	Approved
enoxaparin	deep vein thrombosis	Approved
enoxaparin	deep vein thrombosis, bilateral pulmonary emboli, factor VII deficiency	Approved
enoxaparin	deep vein thrombosis, diverticulitis, Malnutrition, pneumonia	Approved
enoxaparin	deep vein thrombosis, hip fracture, impaired mobility	Approved
enoxaparin	deep vein thrombosis, hip fracture, impaired mobility	Approved renewal
enoxaparin	deep vein thrombosis, Multiple Sclerosis	Approved
enoxaparin	DVT prophylaxis, PEG feeding	Approved
enoxaparin	hepatic vein thrombosis, Budd Chiari Syndrome, thromboses on warfarin	Approved
enoxaparin	high risk of deep vein thrombosis, risk of PE, R humeral fracture, Right distal radius fracture	Approved
enoxaparin	increased risk of DVT due to immobilisation, previous DVT and PE	Approved
enoxaparin	inferior mesenteric artery thrombosis, chronic diarrhoea, short bowel syndome, small bowel infarction	Approved
enoxaparin	intolerance to warfarin, DVTs, pulmonary embolism	Approved
enoxaparin	IVC thrombosis, venous thrombus of inferior vena cava, spontaneous VTE extending into the heart	Approved
enoxaparin	lower limb deep vein thrombosis, chronic abdominal pain, ileal conduit and ACE, poorly functioning poracath in situ, recurrent infection, recurrent rectal bleeding, Spina Bifida, very poor venous access	Approved
enoxaparin	multiple pulmonary embolisms, risk of bleeding on warfarin, tetraplegia, unstable INR	Approved
enoxaparin	multiple thrombi, thromboembolic disease, stroke	Approved
enoxaparin	non compliance on warfarin, pregnant, Rheumatic Heart Disease, upcoming aortic valve replacement surgery	Approved
enoxaparin	portal vein thrombosis, atrial fibrillation, previous stroke	Approved
enoxaparin	post-operative PE, IVF Therapy, polycythaemia	Approved
enoxaparin	post-operative PE, IVF Therapy, polycythaemia	Approved renewal
enoxaparin	pulmonary embolism	Approved
enoxaparin	pulmonary embolism	Approved
enoxaparin	pulmonary embolism, COPD, epistaxis, LLL pneumonia, recurrent haemoptysis	Approved
enoxaparin	pulmonary embolism, deep vein thrombosis, warfarin contraindicated (risk of overdose)	Approved
enoxaparin	pulmonary embolism, diabetes type 2, HSV skin lesions, hypertension, tuberculosis	Approved
enoxaparin	pulmonary embolism, Headache	Approved
enoxaparin	pulmonary embolism, intolerance to warfarin	Approved
enoxaparin	pulmonary embolism, Multiple previous haemorraghic CVA, shoulder replacement	Approved
enoxaparin	pulmonary embolism, previous stroke	Approved
enoxaparin	pulmonary embolism, pseudoseizures, recurrent DVTs, thalamic bleed	Approved
enoxaparin	pulmonary embolism, pseudoseizures, recurrent DVTs, thalamic bleed	Approved
enoxaparin	recurrent DVTs, intolerance to dabigatran, intolerance to warfarin	Approved
enoxaparin	recurrent DVTs, intolerance to dabigatran, intolerance to warfarin	Approved renewal
enoxaparin	recurrent PE, antiphospholipid antibody syndrome	Approved
enoxaparin	recurrent PE, intolerance to warfarin	Approved
enoxaparin	recurrent pulmonary emboli	Approved
enoxaparin	recurrent pulmonary emboli	Approved renewal
enoxaparin	recurrent venous thromboembolism	Approved
enoxaparin	recurrent VTE, failed on warfarin	Approved
enoxaparin	recurrent VTE, failed on warfarin	Approved renewal
enoxaparin	recurrent VTE, failed on warfarin	Approved renewal
enoxaparin	recurrent VTE, Immobile, Motor Neurone disease, unable to swallow	Approved
enoxaparin	relapsed multiple myeloma	Approved
enoxaparin	right basilic vein thrombosis, very poor venous access	Approved
enoxaparin	risk of bleeding on warfarin, Atrial fibrillation, congestive heart failure, prosthetic heart valve, Rheumatic Heart Disease, unstable INR	Approved
enoxaparin	risk of bleeding on warfarin, haematoma, Metastatic liver cancer, post aortic valve replacement	Approved
enoxaparin	risk of thrombosis, chemotherapy, chronic atrial fibrillation, endometrial cancer, rheumatic valvular disease, unstable INR	Approved
enoxaparin	Short Gut Syndrome, intestinal failure, sepsis, venous thrombosis	Approved
enoxaparin	st jude's aortic valve replacement, Depression, fatigue	Approved
enoxaparin	stroke prevention in atrial fibrillation, GI cancer	Approved
enoxaparin	superior mesenteric artery occlusion, atrial fibrillation, TPN dependent	Approved
enoxaparin	SVC Obstruction, bilateral lung transplant, Cystic fibrosis	Approved
enoxaparin	systemic lupus erythematosus, haematoma, lupus nephritis, SLE	Approved
enoxaparin	thromboembolic CVAs, Atrial fibrillation	Approved
enoxaparin	thromboembolic disease	Approved
enoxaparin	thromboembolic disease	Approved
enoxaparin	thromboembolic disease	Approved renewal
enoxaparin	thromboembolic disease	Approved renewal
enoxaparin	Thrombus, infarct	Approved
enoxaparin	venous thrombosis	Approved
enoxaparin	venous thrombosis	Approved renewal
entecavir	HBsAg chronic carriage, cytotoxic chemotherapy	Approved
entecavir	Hepatitis B	Approved
entecavir	Hepatitis B, chronic hepatitis B virus cirrhosis, lamivudine resitant hepatitis B, liver fibrosis	Approved
eplerenone	Cardiac Failure, Left Ventricular Dysfunction	Approved
eplerenone	Cardiac Failure, Left Ventricular Dysfunction	Approved renewal
eplerenone	Cardiac Failure, Left Ventricular Dysfunction	Approved renewal
eplerenone	cardiac resynchronisation therapy not suitable, intolerance to spironolactone, Severe dilated cardiomyopathy	Approved
eplerenone	central serous chorioretinopathy, intolerance to funded alternative	Approved
eplerenone	dilated cardiomyopathy, gynaecomastia, intolerance to funded alternative	Approved
eplerenone	dilated cardiomyopathy, gynaecomastia, intolerance to funded alternative	Approved renewal
eplerenone	end stage heart failure, intolerance to funded alternative, prior cerebrovascular accidents	Approved
eplerenone	heart failure, gynaecomastia, intolerance to spironolactone, Left Ventricular Dysfunction, lowered ejection fraction	Approved
eplerenone	heart failure, gynaecomastia, intolerance to spironolactone, Left Ventricular Dysfunction, lowered ejection fraction	Approved renewal
eplerenone	severe left ventricular systolic dysfunction	Approved
eplerenone	severe left ventricular systolic dysfunction	Approved renewal
erwinia asparaginase	acute lymphoblastic leukaemia, allergic reaction to PegAsparaginase	Approved
erwinia asparaginase	acute lymphoblastic leukaemia, allergy to alternatives	Approved
erwinia asparaginase	allergic reaction to PegAsparaginase, Lymphoblastic T-cell lymphoma	Approved
erwinia asparaginase (crisantaspase)	ALL, allergic reaction to PegAsparaginase	Approved
erwinia asparaginase (crisantaspase)	NK/T cell lymphoma	Approved
erwinia asparaginase (crisantaspase)	NK/T cell lymphoma, allergy to alternatives	Approved
erwinia asparaginase (crisantaspase)	NK/T cell lymphoma, allergy to pegaspargase	Approved
erythropoietin	anaemia, transfusion dependent, t cell LGL	Approved
erythropoietin alfa	anaemia, congenital nephrotic syndrome	Approved
erythropoietin alfa	anaemia, congenital nephrotic syndrome	Approved renewal
erythropoietin alfa	chronic anaemia, chronic kidney disease, membranous glomerulonephritis	Approved
erythropoietin alfa	chronic anaemia, chronic kidney disease, membranous glomerulonephritis	Approved renewal
erythropoietin alfa	chronic anaemia, chronic kidney disease, membranous glomerulonephritis	Approved renewal
erythropoietin alfa	symptomatic anaemia, metastatic melanoma	Approved
erythropoietin beta	anaemia, bilateral PE, renal calculus	Declined
erythropoietin beta	myelodysplasia sideroblastic anaemia, chronic atrial fibrillation, chronic iron deficiency secondary to gastro intestinal bleeding, congestive heart failure, red cell antibodies, red cell crossmatch difficult, transfusion dependent	Approved
erythropoietin beta	Red cell aplasia, chronic graft versus host disease, hurler's syndrome, post bone marrow transplant	Approved
essential amino acid mix	arginase deficiency, essential amino acid deficiency, multiple vitamin deficiency, reduced bone density, Zinc Deficiency	Approved renewal
essential amino acid mix	arginase deficiency, essential amino acid deficiency, multiple vitamin deficiency, reduced bone density, Zinc Deficiency	Approved renewal
essential amino acid mix	hypoalbuminaemia and hypoproteinaemia, severe atopic dermatitis	Approved
essential amino acid mix	Ornithine transcarbamylase deficiency, developmental delay	Approved
essential amino acid mix	urea cycle disorder	Approved
etanercept	idopathic pneumonia syndrome, deteriorating respiratory function, post allogenic transplant	Approved
etanercept	juvenile idiopathic arthritis	Approved
ethanol	recurrent infection, haemophilia A, prophylaxis	Approved
etoricoxib	Behcet's disease, oral ulceration, painful arthropathy	Declined
everolimus	hypoglycaemia due to insulinoma, liver metastases, metastatic pancreatic neuroendocrine tumour	Approved
everolimus	metastatic atypical carcinoid, carcinoid syndrome, metastatic neuroendocrine tumour, neuroendocrine tumour	Declined
everolimus	metastatic insulinoma, persistant hypoglycaemia	Approved
everolimus	metastatic neuroendocrine tumour, ACTH secreting tumour, bilateral hip replacement, chronic infection of hip joint replacement, cushing's syndrome, FGF23 secreting tumour, osteomalacia	Declined
everolimus	tuberous sclerosis, intellectual disability, rash, renal angiomyolipoma, risk of haemorrhage, subependymal giant cell astrocytomas	Declined
ex tyr anamix infant powder	tyrosinemia type II	Approved
febuxostat	Chronic gout, allopurinol hypersensitivity, kidney stone, sclerosing cholangitis, Ulcerative Colitis	Approved
febuxostat	chronic tophaceous gout, amputation of leg, chronic kidney disease, obesity	Approved
febuxostat	gout, Hepatitis B, hypertension, Unable to tolerate funded medicaton	Approved
febuxostat	gout, probable renal calculi, renal impairment	Approved
febuxostat	severe tophaceous gout, allopurinol hypersensitivity, Atrial fibrillation, chronic kidney disease, ischaemic heart disease, previous nephrolithiasis	Approved
febuxostat	severe tophaceous gout, allopurinol hypersensitivity, congestive heart failure, persistent hyperuricemia	Approved
febuxostat	severe tophaceous gout, bone destruction, chronic kidney disease, intolerant to allopurinol, nephrectomy	Approved
febuxostat	severe tophaceous gout, congestive heart failure, intolerant to allopurinol, persistent hyperuricemia	Approved renewal
febuxostat	tophaceous gout, acute renal failure, bilateral forniceal narrowing, degenerative disc disease, diffuse annular bulging, facet hypertrophy, iatrogenic Cushing’s syndrome, pulmonary embolism	Approved
felbamate	Itractable epilepsy and non-convulsive status, Lennox-Gastaut variant, Neurodegenerative disease of unknown aetiology	Approved
felbamate	Itractable epilepsy and non-convulsive status, Lennox-Gastaut variant, Neurodegenerative disease of unknown aetiology	Approved renewal
felbamate	Itractable epilepsy and non-convulsive status, Lennox-Gastaut variant, Neurodegenerative disease of unknown aetiology	Approved renewal
fenofibrate	atypical teratoid rhabdoid tumour (ATRT), constipation, deafness, gastrostomy, recurrent sinusitis, Vomiting	Approved
ferric carboxymaltose	anaemia, end-stage renal disease, intolerance to alternatives, on transplant list	Approved
ferric carboxymaltose	iron deficiency, end stage renal failure	Approved
ferric carboxymaltose	iron deficiency, end stage renal failure	Approved renewal
fexofenadine	indolent systemic mastocytosis, mast cell activation syndrome	Approved
fexofenadine	indolent systemic mastocytosis, mast cell activation syndrome	Approved renewal
filgrastim	colitis, severe neutropaenia	Approved
filgrastim	Glycogen Storage Disease type 1b, congenital neutropaenia	Approved
filgrastim	menorrhagia, severe neutropaenia, uterine fibroid	Approved
filgrastim	systemic lupus erythematosus, neutropaenia, Thrombocytopaenia	Approved
flucytosine	candida parapsilosis infection, Rheumatoid Arthritis	Approved
flucytosine	cryptococcal infection	Approved
flucytosine	Cryptococcal Meningitis, hepatitis C, HIV	Approved
flucytosine	persitent candida vulvovaginitis	Approved
flunarizine	ATP1A3 related neurologic disorder, dystonia, hemiplegia	Approved
fluoxetine (Prozac)	Depression	Declined
food thickener (Nutilis 900)	chronic dysphagia, spastic quadriplegia	Declined
fortijuice	allergy to dairy, Oesophageal carcinoma	Approved
fortijuice	bowel cancer, epilepsy, global cognitive delay	Approved
fosfomycin	cholangitis, ESBL producer, unfit for surgery	Approved
fosfomycin	ESBL Klebsiella UTI, prosthetic hip infection	Approved
fosfomycin	proteus mirabilis UTI, diabetes, end-stage renal failure on CAPD, ESBL producer, HIV, hypertension, infected renal abscess	Approved
fosfomycin	Recurrent ESBL E.coli UTI	Approved
fosfomycin	Recurrent ESBL E.coli UTI	Approved
fosfomycin	Recurrent ESBL E.coli UTI, chronic leg ulcers, ischaemic heart disease, renal failure	Approved
fosfomycin	Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome	Approved
fosfomycin	Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome	Approved
fosfomycin	Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome	Approved renewal
fosfomycin	Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome	Approved renewal
fosfomycin	Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome	Approved renewal
fosfomycin	recurrent urinary tract infections	Approved
fosfomycin	recurrent UTI, urinary catheter	Approved
fructose	congenital glucose galactose malabsorption	Approved
fumagillin	microsporidia keratosis	Approved
gabapentin	neuropathic pain	Approved
gabapentin	nodular prurigo, Depression, eczema, obesity	Approved
gabapentin	nystagmus, severe oscillopsia, Myeloproliferative disorder	Approved
gabapentin	pubic symphysis diastasis, pregnant	Approved
galactomin 19	congenital glucose galactose malabsorption	Approved
ganciclovir	anterior uveitis, Cytomegalovirus, fluctuating refraction and vision, ocular hypertension	Approved
ganciclovir	anterior uveitis, Cytomegalovirus, fluctuating refraction and vision, ocular hypertension	Approved
ganciclovir	bacterial keratitis, herpetic corneal ulcer	Approved
ganciclovir	Cytomegalovirus	Approved
ganciclovir	Cytomegalovirus	Approved renewal
ganciclovir	herpes simplex infection, central corneal melt, graft failure	Approved
gefitinib	EGFR positive, non-small cell carcinoma of lung	Approved
gemcitabine	angiosarcoma of breast, breast cancer	Approved
gemcitabine	cervical cancer, metastatic lung cancer, metastatic mediastinum	Approved
gemcitabine	metastatic uterine leiomyo-sarcoma	Approved
gemcitabine	metastatic uterine leiomyo-sarcoma, impaired left ventricle function	Approved
gentamicin	intestinal failure, small intestinal bacterial overgrowth, failure to thrive, fatigue, gastrojejunostomy tube, muscle pain, severe gastroesophageal reflux	Approved
gentamicin	intestinal failure, small intestinal bacterial overgrowth, failure to thrive, fatigue, gastrojejunostomy tube, muscle pain, severe gastroesophageal reflux	Approved renewal
gentamicin	small intestinal bacterial overgrowth	Approved
gentamicin	small intestinal bacterial overgrowth	Approved
glucose	recurrent severe hypoglycaemia, Glycogen Storage Disease type 1b, neutropaenia, oral aversion	Approved
glucose	recurrent severe hypoglycaemia, Glycogen Storage Disease type 1b, neutropaenia, oral aversion	Approved renewal
glucose gel	hypoglycaemia, fructose 1,6-bisphosphatase deficiency	Approved
glucose gel	hypoglycaemia, fructose 1,6-bisphosphatase deficiency	Approved renewal
glucose gel	hypoglycaemia, Glycogen Storage Disease type 1b	Approved
glucose gel	hypoglycaemia, Glycogen Storage Disease type 1b	Approved renewal
glucose gel	hypoglycaemia, Glycogen Storage Disease type 1b	Approved renewal
glucose test strips	diabetes type 1, developmental delay, poorly controlled diabetes	Approved
glucose test strips	diabetes type 1, developmental delay, poorly controlled diabetes	Approved renewal
glucose test strips	diabetes type 1, developmental delay, poorly controlled diabetes	Approved renewal
glyceryl trinitrate	angina, funded alternative unsuitable	Approved
glyceryl trinitrate	ischaemic heart disease, Atrial fibrillation, Osteoarthritis	Approved renewal
glyceryl trinitrate (Nitrolingual Pump Spray)	ischaemic heart disease, Atrial fibrillation, Osteoarthritis	Approved
glyceryl trinitrate (Nitrolingual Pump Spray)	paroxysmal af, aortic stenosis, Osteoarthritis, STEMI	Approved
glyceryl trinitrate (Nitrolingual Pumpspray)	ischaemic heart disease, Osteoarthritis	Approved
glycopyrrolate	excessive  pooling oral secretions due to Bulbar palsy, Motor Neurone disease	Approved
haemophilus influenzae type b vaccination	acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient	Approved
haemophilus influenzae type b vaccination	post allogeneic stem cell transplant	Approved
histidine-tryptophan-ketoglutarate	cardiac surgery, Valve Replacement, Liver Failure, renal failure	Approved
histidine-tryptophan-ketoglutarate	double coronary byoass graft, upcoming aortic valve replacement surgery, possible interposition aortic graft, possible limited hemi-arch replacement	Approved
hpv recombinant vaccine	recurrent respiratory papillomatosis	Approved
hpv recombinant vaccine	Severe recurrent respiratory papillomatosis refractory to surgical debulking	Approved
hpv recombinant vaccine	Severe recurrent respiratory papillomatosis refractory to surgical debulking	Approved
hyaluronic acid	post enucleation socket syndrome	Approved
hyaluronic acid	post enucleation socket syndrome	Approved
hyaluronic acid 20mg/ml and lidocaine 3 mg/ml	post enucleation socket syndrome	Approved renewal
hydromorphone	chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved
hydromorphone	chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved
hydromorphone	chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved renewal
hydromorphone	chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved renewal
hydroxybutyrate	Alternating hemiplegia of childhood, glucose transporter abnormality	Declined
hydroxybutyrate	Alternating hemiplegia of childhood, glucose transporter abnormality	Declined
hydroxyurea	cerebral sickling, sickle cell anaemia	Approved
hydroxyurea	Myeloproliferative disorder, Budd Chiari Syndrome, liver transplant	Approved
hydroxyurea	Myeloproliferative disorder, Budd Chiari Syndrome, liver transplant	Approved renewal
hydroxyzine hydrochloride	adjustment disorder, Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved
hydroxyzine hydrochloride	adjustment disorder, Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved renewal
hypromellose 0.3%, dextran 70 0.1%	conjunctivitis sicca, dry eyes, keratitis	Approved
hypromellose 0.3%, dextran 70 0.1%	sjogrens syndrome, conjunctivitis sicca, dry eyes, keratitis	Approved renewal
ibrutinib	AL amyloidosis, waldenstrom's macroglobulinaemia	Declined
ibrutinib	splenic marginal zone lymphoma, post splenectomy	Declined
icatibant	hereditary angioedema, congenital absence of thyroid gland	Approved
icatibant	hereditary angioedema, congenital absence of thyroid gland	Approved renewal
idebenone	MELAS	Approved
imatinib	Hypereosinophilic Syndrome, secondary myelofibrosis, unacceptable side effects of steroid	Approved
imatinib	Myeloproliferative neoplasm, eosinophilia, PDGFRA abnormality	Approved
imatinib	philadelphia-positive precursor B cell acute lymphoblastic leukaemia	Approved
imatinib	systemic mastocytosis, breast cancer in remission, diabetes type 2, previous IgA nephropathy	Approved
imiquimod	extramammary Paget's Disease	Approved
imiquimod	Genital Herpes, aciclovir resistant, HIV infection	Approved
imiquimod	recurrent squamous cell carcinoma	Approved
indomethacin	congenital nephrotic syndrome, oedema	Approved
indomethacin	congenital nephrotic syndrome, proteinuria	Approved
indomethacin	hemicrania continua	Approved
indomethacin	hemicrania continua	Approved
indomethacin	paroxysmal hemicrania, severe headaches	Approved
indomethacin	paroxysmal hemicrania, severe headaches	Approved renewal
infatrini	failure to gain weight, abnormal pulmonary venous drainage, aortic coarctation, dextroposition of the heart, multiple VSDs, transposition of the great arteries	Approved
infatrini	failure to thrive	Approved
infatrini	failure to thrive, Cleft palate, faltering growth, nasopharyngeal tube, pierre robin syndrome, stickler syndrome	Approved
infatrini	failure to thrive, congenital heart disease, Previous heart failure, unrestricted pulmonary blood flow	Approved
infatrini	failure to thrive, developmental delay, Feeding difficulties, swallowing dysfunction, very premature birth	Approved
infatrini	failure to thrive, heart failure	Approved
infatrini	failure to thrive, lower respiratory tract infection, micrognathia, previous nissen fundoplication, retrognathia, upper airway obstruction	Approved
infatrini	faltering growth, Central hypotonia, Gastrooesophageal reflux, nystagmus	Approved
infatrini	faltering growth, Central hypotonia, Gastrooesophageal reflux, nystagmus	Approved renewal
infatrini	faltering growth, global development delay, preterm, very low birth weight	Approved
infatrini	faltering growth, global development delay, preterm, very low birth weight	Approved renewal
infatrini	Growth Failure, Congestive Heart Failure, ventricular septal defect	Approved
infliximab	Behcet's disease, Cutaneous Vasculitis, optic neuritis, oral ulceration, vasculitic skin lesions	Approved
infliximab	Behcet's disease, severe ulceration of bowel, diabetes type 2, Hypothyroidism, psychotic depression	Approved
infliximab	Behcet's disease, severe ulceration of bowel, diabetes type 2, Hypothyroidism, psychotic depression	Approved renewal
infliximab	bilateral chronic uveitis, granulomatous uveitis, cystoid macular oedema, keratopathy, sarcoidosis	Approved
infliximab	cardiac sarcoidosis, severe heart failure	Approved
infliximab	Crohn's diease	Approved
infliximab	Erythema Nodosum Leprosum, multibacillary leprosy	Approved renewal
infliximab	juvenile idiopathic arthritis, uveitis, cataract, cystoid macular oedema, keratopathy, ocular hypertension	Approved
infliximab	neuro tuberculosis	Approved
infliximab	neurosarcoidosis	Approved
infliximab	neurosarcoidosis	Approved renewal
infliximab	neurosarcoidosis, dyslipidaemia, IHD	Approved
infliximab	neurosarcoidosis, dyslipidaemia, IHD	Approved renewal
infliximab	neurosarcoidosis, Hydrocephalus, Panhypopituitarism	Approved
infliximab	neurosarcoidosis, Hydrocephalus, Panhypopituitarism	Approved renewal
infliximab	neurosarcoidosis, Hydrocephalus, Panhypopituitarism	Approved renewal
infliximab	pyoderma gangrenosum	Approved
infliximab	pyoderma gangrenosum	Approved renewal
infliximab	pyoderma gangrenosum, anaemia	Approved
infliximab	uveitis, juvenile idiopathic arthritis	Approved renewal
insulin	type 1 diabetes, multiple suicide attempts, psychotic depression	Approved
insulin pump	Cystic fibrosis, considered for lung transplant, insulin-dependent diabetes mellitus, pancreatic loss	Approved
insulin pump consumables	Cystic fibrosis, considered for lung transplant, insulin-dependent diabetes mellitus, pancreatic loss	Approved
interferon gamma-1b	chronic granulomatous disease, lung abscess, splenic abscesses	Approved
interferon gamma-1b	Mycobacterium Avium Intracellulare infection, lymphopaenia	Approved
interferon gamma-1b	Mycobacterium Avium Intracellulare infection, lymphopaenia	Approved
irinotecan	adenocarcinoma	Approved
irinotecan and oxaliplatin	pancreatic cancer	Approved
isoleucine	Maple syrup urine disease	Approved
isotretinoin	mycosis fungoides	Approved
isotretinoin	mycosis fungoides, sezary syndrome	Approved
isradipine	hypertension, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved
isradipine	hypertension, Chronic Idiopathic Intestinal Pseudo-obstruction	Approved renewal
itraconazole	chronic ear infection aspergillus	Approved
itraconazole	fungal prophylaxis, chronic granulomatous disease	Approved
itraconazole	fungal prophylaxis, chronic granulomatous disease	Approved
itraconazole	microsporum canis infection	Approved
ivabradine	sinus tachycardia	Approved
ketamine	acute myeloblastic leukaemia, bone marrow transplant, pain management, palliative care	Approved
ketamine	chronic neuropathic pain, Multiple Sclerosis	Approved
ketamine	Fistulating Anus, pain, rectal carcinoma	Approved
ketamine	metastatic cervical cancer, palliative pain care	Approved
ketamine	neuropathic pain, metastatic uterine leiomyo-sarcoma	Approved
ketamine	pain, adenocarcinoma, metastatic disease	Approved
ketamine	pain, palliative care	Approved
ketamine	palliative pain care, lung cancer, stage IV	Approved
ketamine	palliative pain care, lung cancer, stage IV	Approved renewal
ketamine	Prostate carcinoma, Metastatic Bone Disease, pathological fracture, spinal cord compression	Approved
ketamine	uncontrolled cancer pain	Approved
ketamine	uncontrolled cancer pain, metastatic lung cancer	Approved
ketocal 3:1 (Nutricia)	pyruvate dehydrogenase deficiency, developmental delay, seizures	Approved
ketoconazole	cushing's syndrome, hypercortisolism, poor tolerance to metyrapone	Approved
ketoconazole	hypercalcaemia, renal impairment, renal stones	Approved
ketotifen	mast cell activation syndrome, mastocytosis, Anaphylaxis, asthma, eczema, multiple drug allergies, peripheral neuropathy, rhinitis	Approved
ketotifen	mast cell activation syndrome, mastocytosis, anaphylaxis, conjunctivitis, monoclonal, rhinitis	Approved
ketotifen	mast cell activation syndrome, mastocytosis, anaphylaxis, conjunctivitis, monoclonal, rhinitis	Approved renewal
ketotifen	multiple food allergies, poor weight gain	Approved
klean-prep	chronic constipation, restricted diet due to food allergies	Approved renewal
lamivudine	aplastic anaemia, Agranulocytosis, HBV	Approved
lamivudine	diffuse large B-cell lymphoma, hepatitis B core antigen positive	Approved
lamivudine	donor core positive for hepatitis B, Congenital biliary atresia, post liver transplant	Approved
lamivudine	Hepatitis B	Approved
lamivudine	Hepatitis B	Approved renewal
lamivudine	hepatitis B core antibody positive, awaiting stem cell transplant, Multiple Myeloma	Approved
lamivudine	Hepatitis B prophylaxis prior to CHOP chemotherapy, acute myeloid leukaemia, hepatits C virus, liver fibrosis	Approved
lamivudine	Hepatitis B, follicular lymphoma	Approved
lamivudine	HIV, congestive heart failure, end-stage renal failure	Approved renewal
l-arginine	hyperammonaemia, urea cycle disorder	Approved
l-arginine	MELAS	Approved
l-arginine	MELAS	Approved
l-arginine	MELAS	Approved
l-arginine	MELAS	Approved renewal
l-arginine	MELAS, Cardiomyopathy, Seizures	Approved
l-arginine	MELAS, stroke-like episodes, epilepsy, obsessive-complusive disorder features, sensorineural hearing loss	Approved
l-arginine	MELAS, stroke-like episodes, epilepsy, obsessive-complusive disorder features, sensorineural hearing loss	Approved renewal
l-arginine	MELAS, Wolff-Parkinson-White syndrome	Approved
l-arginine	mitochondrial DNA deletion, stroke-like episodes, MELAS	Approved
l-arginine	non-syndromic mitochondrial disease, basal ganglia calcification, intermittent psychiatric disturbance	Approved
l-arginine	Pyridoxine responsive seizures, Down's syndrome	Approved
l-arginine	Pyridoxine responsive seizures, Down's syndrome	Approved renewal
laronidase	hurler's syndrome, dysostosis multiplex, Hydrocephalus, lumbar gibbus, obstructive sleep apnoea	Approved
laronidase	hurler's syndrome, peri- BMT	Approved
l-carnitine	Brown-Vialetto-Van Laere Syndrome	Approved
l-carnitine	bulbar palsy, carnitine deficiency, global development delay, Incontinence, refractory epilepsy, respiratory infection	Approved
l-carnitine	carnitine deficiency, glut-1 deficiency	Approved
l-carnitine	carnitine deficiency, glut-1 deficiency	Approved renewal
l-carnitine	carnitine deficiency, Undiagnosed neurological problem, gastrostomy feeding, global development delay, medically refractory seizures	Approved
l-carnitine	carnitine uptake disorder	Approved
l-carnitine	carnitine uptake disorder	Approved
l-carnitine	carnitine uptake disorder	Approved
l-carnitine	carnitine uptake disorder	Approved
l-carnitine	carnitine uptake disorder	Approved renewal
l-carnitine	carnitine uptake disorder	Approved renewal
l-carnitine	carnitine uptake disorder	Approved renewal
l-carnitine	carnitine uptake disorder	Approved renewal
l-carnitine	carnitine-acylcarnitine translocase deficiency	Approved
l-carnitine	carnitine-acylcarnitine translocase deficiency	Approved renewal
l-carnitine	carnitine-acylcarnitine translocase deficiency	Approved renewal
l-carnitine	glutaric aciduria type 1	Approved
l-carnitine	glutaric aciduria type 1	Approved renewal
l-carnitine	holocarboxylase synthetase deficiency	Approved
l-carnitine	holocarboxylase synthetase deficiency	Approved
l-carnitine	holocarboxylase synthetase deficiency	Approved renewal
l-carnitine	holocarboxylase synthetase deficiency	Approved renewal
l-carnitine	holocarboxylase synthetase deficiency	Approved renewal
l-carnitine	holocarboxylase synthetase deficiency	Approved renewal
l-carnitine	low L- carnatine secondary to ketogenic diet, doose syndrome, epileptic encephalopathy	Approved
l-carnitine	methylmalonic acidemia	Approved
l-carnitine	methylmalonic acidemia, brain injury, hyperammonaemia	Approved
l-carnitine	methylmalonic acidemia, brain injury, hyperammonaemia	Approved
l-carnitine	methylmalonic acidemia, brain injury, hyperammonaemia	Approved renewal
l-carnitine	multiple acyl-coenzyme A dehydrogenase deficiency	Approved
l-carnitine	possible carnitine uptake disorder, abnormal result on newborn screening test	Approved
l-carnitine	Propionic Acidaemia	Approved
lenalidomide	IgA multiple myeloma, bilateral diaphramatic paralysis secondary to bortezomib	Approved
lenalidomide	Multiple Myeloma	Declined
lenalidomide	myelodysplastic syndrome with 5q deletion	Approved
lenalidomide	myelodysplastic syndrome with 5q deletion, anaemia, JAK-2 positive, myeloproliferative neoplasms	Approved
lenalidomide	Myeloma, cervical spondylosis, chronic inflammatory demyelinating polyneuropathy, lumbar spondylosis	Declined
lenalidomide	plasma cell myeloma, muscle wasting, severe peripheral neuropathy	Approved
lenalidomide	plasma cell myeloma, muscle wasting, severe peripheral neuropathy	Approved renewal
lenalidomide	plasma cell myeloma, Painful peripheral Neuropathy	Approved
lenalidomide	plasma cell myeloma, Painful peripheral Neuropathy	Approved renewal
lenalidomide	refractory multiple myeloma, hyperlipidaemia, hypertension, neuropathic pain	Declined
lenalidomide	relapsed chronic lymphocytic leukaemia	Declined
leuprorelin	metastatic prostate cancer, Haemophilia A	Approved
levamisole	steroid dependent nephrotic syndrome, frequent flare-ups	Approved
levetiracetam	temporal lobe epilepsy, Dysembryoplastic neuroepithelial tumor	Approved
levocetirizine	chronic urticaria	Approved
levofloxacin	drug reaction, MDR tuberculosis	Approved renewal
levonorgestrel	dysmenorrhea, heavy menstrual bleeding, chronic vaginal discharge, Didelphic uterus	Approved
levonorgestrel	heavy menstrual bleeding, on warfarin, Post Liver Transplant, pulmonary hypertension	Approved
levonorgestrel	menorrhagia	Approved
levonorgestrel	menorrhagia	Approved
levonorgestrel	menorrhagia, endometriosis, frozen pelvis	Approved
levonorgestrel (Mirena)	allergy to alternatives, menorrhagia	Approved
levonorgestrel (Mirena)	contraception, Morbid Obesity	Approved
levonorgestrel (Mirena)	dysfunctional uterine bleeding, menorrhagia, contraception, Morbid Obesity	Approved
levonorgestrel (Mirena)	dysmenorrhea	Approved
levonorgestrel (Mirena)	dysmenorrhea, menorrhagia, previous bowel surgery	Approved
levonorgestrel (Mirena)	heavy menstrual bleeding, adenomyosis, hypertension, pelvic pain, very high BMI	Approved
levonorgestrel (Mirena)	irregular menstrual bleeding, menorrhagia	Approved
levonorgestrel (Mirena)	menorrhagia	Approved
levonorgestrel (Mirena)	menorrhagia, Morbid Obesity	Approved
levonorgestrel (Mirena)	menorrhagia, pelvic pain, endometriosis	Approved
levonorgestrel (Mirena)	menorrhagia, pelvic pain, Severe endometriosis	Approved
levothyroxine	Hashimoto's thyroiditis, Hypothyroidism	Approved
lignocaine 2%	Epidermolysis Bullosa, ulceration of anal canal	Approved
lignocaine hydrochloride	pain, acromegaly, Calciphylaxis, end-stage renal failure, severe ulceration	Approved
linezolid	adverse reaction to daptomycin, allergy to vancomycin, Staphylococcus epidermidis infection	Approved
linezolid	complex congenital heart disease, mediastinitis MRSA, respiratory infection, tracheobronchomalacia	Approved
linezolid	corynebacterium infection, GORD, hypertension, infected hip joint replacement	Approved
linezolid	corynebacterium infection, Infected Knee Joint, multi antibiotic resistance	Approved
linezolid	corynebacterium infection, resistant microorganisms	Approved
linezolid	enterococcus faecalis infection, multidrug resistant staph infection	Approved
linezolid	infected hip joint replacement, Klebsiella infection	Approved
linezolid	MDR Cellulitis, Renal Impairment	Approved
linezolid	MDR tuberculosis	Approved
linezolid	MDR tuberculosis	Approved
linezolid	MDR tuberculosis, hearing loss, psoas abscess, Spinal Abscess	Approved
linezolid	MDR tuberculosis, pulmonary tuberculosis	Approved
linezolid	multidrug-resistant TB	Approved
linezolid	multidrug-resistant tuberculosis	Approved
linezolid	multidrug-resistant tuberculosis	Approved
linezolid	multidrug-resistant tuberculosis	Approved renewal
linezolid	mycobacterium infection	Approved
liothyronine	dependent T3 replacement	Approved
liothyronine	dependent T3 replacement	Approved renewal
liothyronine	Hypothyroidism, post thyroidectomy, radioiodine ineffective	Approved
liothyronine	Hypothyroidism, post thyroidectomy, radioiodine ineffective	Approved renewal
lipistart	Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency, excessive weight gain, low zinc and iron, rhabdomyolysis	Approved
liposomal doxorubicin	kaposi's sarcoma, AIDS	Approved
lorazepam	medically refractory seizures	Approved
lorenzo's oil	adrenoleukodystrophy	Approved
l-ornithine l aspartate	hepatic encephalopathy, end stage liver disease	Approved
l-ornithine l aspartate	hepatic encephalopathy, end stage liver disease	Approved renewal
l-ornithine l aspartate	hepatic encephalopathy, Hepatitis C, liver cirrhosis	Approved
l-ornithine l aspartate	hepatic encephalopathy, refractory to other treatments	Approved
l-ornithine l aspartate	hepatic encephalopathy, refractory to other treatments	Approved renewal
low protein baking mix	methylmalonic acidemia	Approved
low protein pasta	methylmalonic acidemia	Approved
macrogol	anxiety, Central sensitisation syndrome, chronic abdominal pain, Chronic Nausea, Chronic severe constipation, Gastrooesophageal reflux, gastrostomy feeding, Past history of rheumatic fever	Approved
magnesium chloride	Gitelman's syndrome, hypokalaemia, hypomagnesaemia	Approved renewal
magnesium chloride	short bowel syndome, allergy to sulphur, endometriosis complications	Approved
magnesium oxide	renal wasting of magnesium, cycling vomiting, hypertension, low magnesium, menieres disease	Approved
mannitol	Cystic fibrosis, CF related diabetes, depression, steroid-induced osteopenia	Approved
mannitol	Cystic fibrosis, CF related diabetes, depression, steroid-induced osteopenia	Approved renewal
mct peptide	Langerhans cell histiocytosis, enteropathy, poor growth, probable lymphangiectasia	Approved
mechlorethamine	mycosis fungoides	Approved
melatonin	Insomnia, delerium, Long term wean from ventilator following pseudomonas bronchopneumonia	Approved
mepacrine	cutaneous systemic lupus erythematosus	Approved
mepacrine	discoid lupus erythematosis, systemic lupus erythematosus	Approved
mepacrine	discoid lupus erythematosis, systemic lupus erythematosus	Approved renewal
mepacrine	Refractory giardiasis	Approved
mepacrine	Refractory giardiasis	Approved
mepacrine	SLE, Arthritis, hepatosteatosis	Approved
mepacrine	systemic lupus erythematosus, arthralgia, glomerulonephritis, multiple fractures, myalgia, osteoporosis, pericarditis	Approved
mepacrine	systemic lupus erythematosus, arthralgia, glomerulonephritis, multiple fractures, myalgia, osteoporosis, pericarditis	Approved renewal
metformin with sitagliptin	diabetes type 2	Declined
methylphenidate extended release (Ritalin LA)	narcolepsy	Approved
methylphenidate sr	hypotension, tetraplegia	Approved
metoclopramide	intractable vomiting, chronic fatigue syndrome, short bowel	Approved
metronidazole	bacterial infection, necrotic pelvic tumour, stage IV sigmoid adenocarcinoma	Approved
metronidazole	deep tissue infection, Invasive squamous cell carcinoma	Approved
mexiletine	annular tear	Approved
mexiletine	asthma, pelvic athropathy in pregnancy	Approved
mexiletine	cardiac arrhythmias, Hypertrophic cardiomyopathy	Approved
mexiletine	Chest Pain, neuropathic pain in pregnancy, SLE	Approved
mexiletine	endometriosis, pelvic pain	Approved
mexiletine	myotonia congenita, Thomsen's condition	Approved
mexiletine	neuropathic pain in pregnancy, lumbar disc prolapse	Approved
mexiletine	pain, painful arthropathy, pregnancy	Approved
micronised progesterone	cervical incompetence	Approved
micronised progesterone	pregnancy, cervical incompetence	Approved
mifepristone	relapsed meningioma	Approved
milrinone	severe dilated cardiomyopathy of unknown aetology, heart failure, severe left ventricular impairment	Approved
minims prednisolone	conjunctivitis sicca, dry eyes, keratitis	Approved
mitotane	adrenal cortical carcinoma	Approved
mitotane	adrenal cortical carcinoma	Approved
mitotane	adrenal cortical carcinoma	Approved
mitotane	adrenal cortical carcinoma, metastatic disease	Approved
mitotane	adrenal cortical carcinoma, metastatic disease	Approved renewal
mitotane	adrenocortical carcinoma	Approved
mitotane	adrenocortical carcinoma	Approved
mitotane	adrenocortical carcinoma	Approved
mitotane	adrenocortical carcinoma	Approved
mitotane	adrenocortical carcinoma	Approved
mitotane	adrenocortical carcinoma	Approved renewal
mitotane	adrenocortical carcinoma, Atrial fibrillation, cushing's syndrome, severe hypertension	Approved
mitotane	adrenocortical carcinoma, cushing's syndrome	Approved
mitotane	adrenocortical carcinoma, liver metastases, pituitary dependent Cushings syndrome, seizures	Approved
mitotane	carcinoma of adrenal gland, liver metastases	Approved
mitotane	grade 4, metastatic adrenocortical carcinoma, unresectable	Approved
mitotane	lung metastases, metastatic adenocarcinoma	Approved
mitotane	metastatic adrenocortical carcinoma	Approved
mitotane	metastatic adrenocortical carcinoma	Approved
mitotane	metastatic adrenocortical carcinoma	Approved
mitotane	metastatic adrenocortical carcinoma, cushing's syndrome	Approved
mitotane	metastatic adrenocortical carcinoma, history of, oesophageal cancer	Approved
mitotane	metastatic adrenocortical carcinoma, obesity, obstructive sleep apnoea	Approved
montelukast	angioneurotic oedema	Approved
montelukast	asthma, Asperger's syndrome, atopy, autism spectrum disorder	Declined
montelukast	asthma, atopic eczema, gastro-oesophageal reflux disease	Declined
montelukast	asthma, Hypothyroidism, ischaemic heart disease	Approved
montelukast	bronchiolitis obliterans syndrome, Graft Versus Host Disease	Approved
montelukast	bronchiolitis obliterans, acute myeloid leukaemia, chronic graft versus host disease	Approved
montelukast	cold urticaria, Anaphylaxis	Approved
montelukast	diabetes type 2, multiple drug allergies, multiple food allergies, Samter's triad, severe asthma	Approved
montelukast	Graft versus host disease of lungs, GvHD post allogeneic transplant, relapsed AML	Approved
montelukast	Graft versus host disease of lungs, GvHD post allogeneic transplant, relapsed AML	Approved renewal
montelukast	Graft versus host disease of lungs, history allogeneic stem cell transplant, history of acute lymphoblastic leukemia	Approved
montelukast	systemic mastocytosis	Approved
montelukast	systemic mastocytosis	Approved
montelukast	systemic mastocytosis	Approved
montelukast	systemic mastocytosis	Approved renewal
morphine/bupivicaine/clonidine	bowel cancer, uncontrolled pain	Approved
morphine/bupivicaine/clonidine	metastatic colon cancer, metastatic disease, severe pain	Approved
moxifloxacin	asbestosis, MDR pneumococcal bacteraemia	Approved
moxifloxacin	bacteraemia, enterococcus faecalis infection	Approved
moxifloxacin	bronchiectasis, Chronic back pain, chronic renal impairment, clostridium infection, severe COPD	Approved
moxifloxacin	bronchiectasis, multi drug resistant streptococcus pneumoniae infection	Approved
moxifloxacin	cellulitis	Approved
moxifloxacin	cellulitis, ulceration	Approved
moxifloxacin	cerebellar brain abscess, nocardia farcinica infection	Approved
moxifloxacin	community acquired pneumonia	Approved
moxifloxacin	deep soft tissue infection	Approved
moxifloxacin	Discitis	Approved
moxifloxacin	fungal empyema, Streptococcus pneumoniae infection	Approved
moxifloxacin	Genital mycoplasma infection	Approved
moxifloxacin	Infection due to Mycobacterium abscessus	Approved
moxifloxacin	Infection due to Mycobacterium abscessus	Approved renewal
moxifloxacin	lower respiratory tract infection, adenocarcinoma of the oesophagus	Approved
moxifloxacin	meningitis	Approved
moxifloxacin	multi antibiotic resistant streptococcus pneumoniae chest infection	Approved
moxifloxacin	multi antibiotic resistant streptococcus pneumoniae chest infection, Bilateral chronic bronchiectasis	Approved
moxifloxacin	multi drug resistant streptococcus pneumoniae infection, severe COPD	Approved
moxifloxacin	multi resistant staphylococcus epidermidis, prosthetic joint infection	Approved
moxifloxacin	multidrug-resistant streptococcus pneumoniae infection, COPD, infective exacerbation	Approved
moxifloxacin	multidrug-resistant streptococcus pneumoniae infection, eye infection	Approved
moxifloxacin	multidrug-resistant streptococcus pneumoniae infection, eye infection	Approved renewal
moxifloxacin	multidrug-resistant streptococcus pneumoniae pneumonia	Approved
moxifloxacin	multidrug-resistant streptococcus pneumoniae pneumonia, community acquired pneumonia	Approved
moxifloxacin	Mycobacterium Avium Intracellulare infection, bronchiectasis, Cystic fibrosis	Approved
moxifloxacin	Mycobacterium fortuitum infection, Osteomyelitis	Approved
moxifloxacin	mycobacterium marinum infection, GORD, SVT	Approved
moxifloxacin	mycobacterium xenopi infection	Approved
moxifloxacin	mycoplasma genitalium infection	Approved
moxifloxacin	mycoplasma genitalium infection	Approved
moxifloxacin	mycoplasma genitalium infection	Approved
moxifloxacin	mycoplasma genitalium infection	Approved
moxifloxacin	mycoplasma genitalium infection, bacterial vaginosis	Approved
moxifloxacin	mycoplasma genitalium infection, persistant non gonococcal urethritis	Approved
moxifloxacin	mycoplasma genitalium infection, unresponsive to azithromycin	Approved
moxifloxacin	Mycoplasmal pelvic inflammatory disease	Approved
moxifloxacin	pneumococcal meningitis, mastoiditis, Otitis Media	Approved
moxifloxacin	pneumonia, Underlying CLL	Approved
moxifloxacin	presumed tuberculous meningitis	Approved
moxifloxacin	presumed tuberculous meningitis	Approved
moxifloxacin	Staphylococcus epidermidis infection, Prosthetic Knee Joint Infection	Approved
moxifloxacin	Streptococcal pneumonia, fungal empyema	Approved
moxifloxacin	Streptococcus pneumoniae infection, COPD	Approved
moxifloxacin	Tuberculous meningitis	Approved
moxifloxacin	Tuberculous meningitis	Approved
moxifloxacin	wound infection, mediastinitis, Staphylococcus epidermidis infection	Approved
moxifloxacin (Avelox)	Genital mycoplasma infection	Approved
moxifloxacin iv	discitis	Approved
msud amino 5	Maple syrup urine disease	Approved
multivitamins	Epidermolysis Bullosa, inadequate nutrition, recurrent mouth ulceration	Approved
mycophenolate	Batten's disease	Approved
mycophenolate	systemic sclerosis, Rapidly progressing	Approved
mycophenolate mofetil	autoimmune hepatitis	Approved
mycophenolate mofetil	autoimmune lymphoproliferative syndrome	Approved
mycophenolate mofetil	systemic lupus erythematosus, lupus nephritis class IIIa	Approved renewal
mycophenolic acid	lupus nephritis, end stage renal failure, post renal transplant	Approved renewal
naloxone hydrochloride	Chait tube, G tube, ileostomy, J tube, morphine related itch, progressive gut failure, TPN dependent	Approved
naltrexone	progressive familial intrahepatic cholestasis, pruritus, awaiting liver transplant	Approved
nanovm powder (4-8 years)	myoclonic astatic epilepsy, Intractable Epilepsy	Approved
nanovm powder (4-8 years)	myoclonic astatic epilepsy, Intractable Epilepsy	Approved renewal
naproxen/esomeprazole	Gastric reflux, Osteoarthritis	Declined
nasal spray bottle plus consumables	fentanyl nasal spray delivery	Approved
natalizumab	Multiple Sclerosis	Declined
natalizumab	relapsing remitting Multiple Sclerosis	Declined
natalizumab	relapsing remitting Multiple Sclerosis, intolerance to funded alternative	Declined
natamycin	fungal keratitis	Approved
neomycin	short bowel syndome, multiple central line infections, small bowel bacterial overgrowth	Approved
nicorandil	refractory angina	Approved
nicorandil	refractory angina, ischaemic heart disease	Approved
nilotinib	Chronic Myeloid Leukaemia	Approved
nilotinib	Chronic Myeloid Leukaemia	Approved
nilotinib	Chronic Myeloid Leukaemia	Approved renewal
nilotinib	Chronic Myeloid Leukaemia	Approved renewal
nilotinib	Chronic Myeloid Leukaemia	Approved renewal
nilotinib	Chronic Myeloid Leukaemia, Ca Thyroid currently in remission	Approved
nilotinib	Chronic Myeloid Leukaemia, chronic phase, interstitial lung disease, Unable to tolerate funded medicaton	Approved
nilotinib	Chronic Myeloid Leukaemia, imatinib and dasatinib refractory	Approved
nilotinib	Chronic Myeloid Leukaemia, imatinib refractory, intolerant to dasatinib	Approved
nilotinib	Chronic Myeloid Leukaemia, intolerance to imatinib/dasatinib	Approved
nilotinib	Chronic Myeloid Leukaemia, intolerance to imatinib/dasatinib	Approved
nilotinib	Chronic Myeloid Leukaemia, post burn scarring, PTSD	Approved
nilotinib	CML, intolerant to dasatinib, resistant to imatinib	Approved
nilotinib	CML, intolerant to dasatinib, resistant to imatinib	Approved renewal
nimodipine	reversible cerebral vasoconstriction syndrome	Approved
nimodipine	reversible cerebral vasoconstriction syndrome	Approved
nitazoxanide	cryptosporidium	Approved
nitazoxanide	Giardiasis	Approved
nitazoxanide	metronidazole resistant recurrent giardiasis	Approved
nitazoxanide	refractory giardiasis	Approved
nitazoxanide	refractory giardiasis	Approved renewal
nivolumab	metastatic melanoma	Approved
obinutuzumab	17p deleted chronic lymphocytic leukaemia, hepatitis B reactivation, shingles	Declined
octreotide	Complex muscular disease, GIT pseudo-obstruction	Approved
octreotide	high output ileostomy	Approved
octreotide	metastatic endometrial cancer, profound diarrhoea post radiotherapy	Approved
octreotide	Pancreatic neuroendocrine tumor, deafness, speech difficulties	Approved
octreotide	Pleural Effusion, advanced adenocarcinoma of the lung	Approved
octreotide	post pancreatectomy for cancer	Approved
octreotide	progressive gut failure, Chait tube, G tube, j tube, palliative care, severe abdominal pain, TPN dependent	Approved
octreotide lar	gastrointestinal failure, Chronic Nausea, diaphragmatic hernia, gastric dysmotility, lung hypoplasia, possible mitochondrial disorder, total parenteral nutrition dependent, Vomiting	Approved
octreotide lar	protein losing enteropathy, congenital heart disease, hypoalbuminaemia, hypogammaglobulinaemia	Approved
octreotide lar	recurrent meningioma, somatostatin receptor expression	Approved
octreotide short acting	dumping syndrome	Approved
oestradiol	Hypopituitarism, Septo-optic dysplasia	Approved
olanzapine	bipolar affective disorder, psychotic symptoms	Approved
olanzapine	Schizophrenia	Approved
olanzapine	Schizophrenia	Approved renewal
olanzapine (Zyprexa)	psychotic disorder, drug reaction, papular urticaria	Approved
olanzapine inj	bipolar affective disorder type 1	Approved
omalizumab	anaphylactic reaction to bee venom, Anaphylaxis, failed bee venom immunotherapy	Approved renewal
omalizumab	chronic severe asthma	Approved
omalizumab	chronic urticaria	Declined
omalizumab	chronic urticaria, hypertension, intolerance to cyclosporin, osteoporosis, Steroid dependent	Declined
optifast	Morbid Obesity, charcot's neuroarthropathy, diabetes type 2, Immobile	Declined
oral elemental feed 1kcal/ml	Food sensitivities, Ehlers danlos syndrome, Jejunostomy	Approved
oral feed 1.5kcal/ml (Fortisip)	inadequate nutrition, primary biliary cirrhosis	Approved
oxaliplatin	Adenocarcinoma of the stomach, chronic renal impairment	Approved
oxaliplatin	gastroesophageal junction carcinoma	Approved
oxaliplatin	metastatic small bowel adenocarcinoma	Approved
oxaliplatin	Stage  II (T4bNOMO) adenocarcinoma of  bowel invading liver (completely resected)	Approved
oxandrolone	bone marrow failure, Fanconi Anaemia	Approved
oxandrolone	bone marrow failure, Fanconi Anaemia	Approved renewal
oxcarbazepine	epilepsy	Approved
oxcarbazepine	epilepsy	Approved renewal
oxcarbazepine	epilepsy	Approved renewal
oxcarbazepine	Intractable epilepsy, mild hemipharesis, neuronal migration defect, previous surgery	Approved
oxybutynin	neurogenic bladder, Spina Bifida	Approved
palivizumab	chronic neonatal lung disease, Cytomegalovirus Hepatitis, Premature birth, previous intraventricular haemorrhage, sepsis	Approved
palivizumab	neonatal chronic lung disease	Approved
palivizumab	prophylaxis of RSV, congenital heart block, neonatal chronic lung disease, very premature birth	Declined
pancreatin (Pancrex V)	Cystic fibrosis, pancreatic insufficiency	Approved
papillomavirus vaccine	prevention of human papilloma virus	Approved
papillomavirus vaccine	recurrent respiratory papillomatosis	Approved
papillomavirus vaccine	recurrent respiratory papillomatosis	Approved
papillomavirus vaccine	recurrent respiratory papillomatosis	Approved
papillomavirus vaccine	recurrent respiratory papillomatosis	Approved
papillomavirus vaccine	recurrent respiratory papillomatosis	Approved
papillomavirus vaccine	recurrent respiratory papillomatosis	Approved
papillomavirus vaccine	recurrent respiratory papillomatosis, HPV virus	Approved
papillomavirus vaccine	respiratory papillomatosis, Down's syndrome	Approved
para-amino salicylic acid	MDR tuberculosis	Approved
para-amino salicylic acid	multidrug-resistant TB	Approved
para-amino salicylic acid	multidrug-resistant tuberculosis	Approved
paracetamol	pain, Chronic Nausea, chronic vomiting, gastrointestinal failure, IV nutrition dependent, possible mitochondrial disorder	Approved
paracetamol	severe headaches, terminal bowel cancer	Approved
paracetamol (Perfalgan)	intestinal dysmotility, tracheo-oesophageal fistula	Approved
paraffin (Duoleum Ointment)	Nethertons Syndrome, lack of skin integrity	Approved
paraffin liquid 50%/white soft paraffin 50%	atopic dermatitis, atopic eczema	Approved
paraffin liquid 50%/white soft paraffin 50%	atopic eczema	Approved
paraffin liquid and soft white paraffin	eczema	Approved renewal
paraffin liquid and white soft paraffin	congenital ichthyosis, preterm	Approved
paraffin liquid/soft white paraffin (Duoleum)	severe eczema, diarrhoea, failure to thrive	Approved
paraffin liquid/white soft ointment 50%	congenital bullous ichthyosiform erythroderma	Approved
paromomycin	entamoeba histolytica intestinal colonisation	Approved
paromomycin	entamoeba histolytica intestinal colonisation	Approved
paromomycin	entamoeba histolytica intestinal colonisation	Approved
paromomycin	metronidazole resistant recurrent giardiasis	Approved
paromomycin	metronidazole resistant recurrent giardiasis	Approved
paromomycin	Resistant trichomoniasis, Depression	Approved
paromomycin	Resistant trichomoniasis, funded is contraindicated, peripheral neuropathy from funded alternative	Approved
pasireotide	acromegaly, diabetes type 2, hypertension, Hypopituitarism	Declined
pazopanib	acute pancreatitis secondary to sunitinib	Approved
pazopanib	bilateral non-pigmented retinal tumours, Pancreatic neuroendocrine tumor, renal cell carcinoma	Approved renewal
pazopanib	desmoplastic small round cell tumour	Declined
pazopanib	follicular carcinoma of thyroid, bone metastases, liver metastases	Approved
pazopanib	metastatic sarcoma, soft tissue sarcoma	Declined
pazopanib	thyroid carcinoma	Approved
pediasure	failure to thrive, gastrostomy feeding, Growth hormone deficiency, nausea, nephropathic cystinosis, renal fanconi syndrome, Vomiting	Approved
pegasparaginase	Acute Lymphoblastic Leukaemia	Declined
pegasparaginase	Acute Lymphoblastic Leukaemia	Declined
pegasparaginase	Lymphoblastic T-cell lymphoma	Declined
pegvisomant	pituitary adenoma, pituitary gigantism	Approved
pegvisomant	pituitary adenoma, pituitary gigantism	Approved renewal
pegylated inteferon	Chronic Myeloid Leukaemia, pregnancy	Approved
pegylated interferon	essential thrombocythaemia	Approved
pegylated interferon	essential thrombocythaemia	Approved renewal
pegylated interferon	essential thrombocythaemia	Approved renewal
pegylated interferon alfa	essential thrombocythaemia, CALR mutation positive	Approved
pegylated interferon alpha-2a	Chronic Myeloid Leukaemia, intolerance to alternatives	Approved
pembrolizumab	adenocarcinoma of the bladder, metastatic adenocarcinoma	Declined
pembrolizumab	Hodgkin's lymphoma, Allogeneic stem cell transplant, bridge to transplant, refractory disease, relapsed lymphoma	Declined
pembrolizumab	metastatic vaginal melanoma, aortic stenosis, history of hodgkins disease, low grade B-cell non-hodgkin's lymphoma, low grade bronchogenic neoplasm of the lung	Declined
pemetrexed	malignant epithelioid peritoneal mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved
pemetrexed	Malignant mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved
pemetrexed	malignant mesothelioma	Approved renewal
pemetrexed	malignant mesothelioma, Atrial fibrillation, hypertension, impaired glucose tolerance, polymyalgia rheumatica, severe COPD	Approved
pemetrexed	malignant mesothelioma, hypertension, not eligible for ACC	Approved
pemetrexed	malignant mesothelioma, not eligible for ACC	Approved
pemetrexed	malignant mesothelioma, peritoneal mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma	Approved
pemetrexed	malignant pleural mesothelioma, asthma, diabetes type 2, hypertension	Approved
pemetrexed	malignant pleural mesothelioma, asthma, diabetes type 2, hypertension	Approved renewal
pemetrexed	malignant pleural mesothelioma, previous asbestos exposure	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved
pemetrexed	mesothelioma	Approved renewal
pemetrexed	mesothelioma, breast cancer	Approved
pemetrexed	mesothelioma, neuropathy	Approved
pemetrexed	mesothelioma, not eligible for ACC	Approved
pemetrexed	mesothelioma, not eligible for ACC, previous asbestos exposure	Approved
pemetrexed	mesothelioma, previous asbestos exposure	Approved
pemetrexed	mesothelioma, Prostate cancer, renal cancer	Approved
pemetrexed	mesothelioma, Rheumatoid Arthritis	Approved
pemetrexed	mesothelioma, Sarcomatoid pleural tumour	Approved
pemetrexed	peritoneal mesothelioma	Approved
pemetrexed	peritoneal mesothelioma	Approved
pemetrexed	peritoneal mesothelioma	Approved
pemetrexed	peritoneal mesothelioma	Approved
pemetrexed	peritoneal mesothelioma	Approved renewal
pemetrexed	peritoneal mesothelioma, breast cancer in remission	Approved
pemetrexed	pleural mesothelioma	Approved
pemetrexed	pleural mesothelioma	Approved
pemetrexed	pleural mesothelioma	Approved
pemetrexed	pleural pulmonary mesothelioma	Approved
pemetrexed	pleural pulmonary mesothelioma, autosomal dominant polycystic kidney disease	Approved
pemetrexed	sarcomatous mesothelioma, infiltrating ductal carcinoma	Approved
peptide based oral feed	short gut syndrome, abnormal liver function, Premature birth	Approved
peptide based oral feed	short gut syndrome, abnormal liver function, Premature birth	Approved renewal
phosphate ions	osteopaenia	Approved
pimecrolimus	atopic dermatitis, food allergies, rickets	Approved
pimecrolimus	severe eczema, intra ocular pressure, unacceptable long term effects of steroids	Approved
pimecrolimus	severe psoriasis	Approved
pipobroman	adverse reaction to hydroxyurea, essential thrombocythaemia	Approved
pipobroman	adverse reaction to hydroxyurea, essential thrombocythaemia	Approved renewal
pipobroman	adverse reaction to hydroxyurea, essential thrombocytosis, JAK-2 positive	Approved
pipobroman	diabetes, essential thrombocythaemia, severe vascular ulceration	Approved
pipobroman	diabetes, essential thrombocythaemia, severe vascular ulceration	Approved renewal
pipobroman	diabetes, essential thrombocythaemia, severe vascular ulceration	Approved renewal
pipobroman	diabetes, essential thrombocythaemia, severe vascular ulceration	Approved renewal
pipobroman	essential thrombocythaemia	Approved
pipobroman	essential thrombocythaemia	Approved
pipobroman	essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis	Approved
pipobroman	essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis	Approved renewal
pipobroman	essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis	Approved renewal
pipobroman	essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis	Approved renewal
pipobroman	essential thrombocythaemia, asthma, hypertension, ischaemic heart disease, JAK-2 positive, MGUS, osteoarthritis	Approved
pipobroman	essential thrombocythaemia, asthma, hypertension, ischaemic heart disease, JAK-2 positive, MGUS, osteoarthritis	Approved renewal
pipobroman	essential thrombocythaemia, Heart failure on anagrelide, Non-responsive to anagrelide, Skin ulcers on hydroxyurea	Approved
pipobroman	essential thrombocythaemia, polycythaemia vera	Approved
pipobroman	essential thrombocythaemia, polycythaemia vera	Approved renewal
pipobroman	essential thrombocythaemia, polycythaemia vera	Approved renewal
pipobroman	essential thrombocythaemia, polycythaemia vera	Approved renewal
pipobroman	essential thrombocythaemia, previous TIAs	Approved
pipobroman	essential thrombocythaemia, previous TIAs	Approved renewal
pipobroman	essential thrombocythaemia, previous TIAs	Approved renewal
pipobroman	essential thrombocytosis, JAK-2 positive, diverticulosis, Emphysema, hypertension, primary hypogonadism, secondary pancreatitis to azathioprine, Ulcerative Colitis	Approved
pipobroman	essential thrombocytosis, JAK-2 positive, diverticulosis, Emphysema, hypertension, primary hypogonadism, secondary pancreatitis to azathioprine, Ulcerative Colitis	Approved renewal
pipobroman	essential thrombocytosis, polycythaemia rubra vera	Approved
pipobroman	essential thrombocytosis, polycythaemia rubra vera	Approved renewal
pipobroman	polycythaemia rubra vera	Approved
pipobroman	polycythaemia rubra vera	Approved
pipobroman	polycythaemia rubra vera	Approved
pipobroman	polycythaemia rubra vera	Approved renewal
pipobroman	polycythaemia vera	Approved
pipobroman	polycythaemia vera, ventricular arrhythmias	Approved
pipobroman	polycythaemia vera, ventricular arrhythmias	Approved renewal
pipobroman	Primary Thrombocythaemia	Approved
pirfenidone	dyskeratosis congenita, Kartagener's syndrome, progressive lung fibrosis	Approved
pirfenidone	idiopathic pulmonary fibrosis	Declined
pirfenidone	idiopathic pulmonary fibrosis	Declined
pirfenidone	idiopathic pulmonary fibrosis, hypogonadism, Hypothyroidism	Approved
plerixafor	autologous stem cell transplant	Approved
plerixafor	autologous stem cell transplant, failed stem cell mobilisation, Multiple Myeloma	Approved
plerixafor	autologous stem cell transplant, stem cell harvest	Approved
plerixafor	diffuse B cell lymphoma, for stem cell mobilisation	Approved
plerixafor	failed stem cell mobilisation	Approved
plerixafor	failed stem cell mobilisation	Approved
plerixafor	failed stem cell mobilisation	Approved
plerixafor	failed stem cell mobilisation, autologous stem cell transplant	Approved
plerixafor	failed stem cell mobilisation, autologous stem cell transplant, Multiple Myeloma	Approved
plerixafor	failed stem cell mobilisation, awaiting stem cell transplant, T-cell lymphoma	Approved
plerixafor	failed stem cell mobilisation, diffuse large b-cell lymphoma	Approved
plerixafor	failed stem cell mobilisation, diffuse large b-cell lymphoma	Approved
plerixafor	failed stem cell mobilisation, diffuse large b-cell lymphoma, peripheral stem cell harvesting	Approved
plerixafor	failed stem cell mobilisation, follicular lymphoma	Approved
plerixafor	failed stem cell mobilisation, for stem cell mobilisation	Approved
plerixafor	failed stem cell mobilisation, for stem cell mobilisation, diffuse large b-cell lymphoma	Approved
plerixafor	failed stem cell mobilisation, for stem cell mobilisation, Myeloma	Approved
plerixafor	failed stem cell mobilisation, for stem cell mobilisation, Myeloma	Approved
plerixafor	failed stem cell mobilisation, lymphoma	Approved
plerixafor	failed stem cell mobilisation, Multiple Myeloma	Approved
plerixafor	failed stem cell mobilisation, Multiple Myeloma	Approved
plerixafor	failed stem cell mobilisation, Multiple Myeloma	Approved
plerixafor	failed stem cell mobilisation, Multiple Myeloma	Approved
plerixafor	failed stem cell mobilisation, Multiple Myeloma	Approved
plerixafor	failed stem cell mobilisation, Myeloma for stem cell transplant	Approved
plerixafor	failed stem cell mobilisation, Non-hodgkin's lymphoma	Approved
plerixafor	failed stem cell mobilisation, relapsed folicular lymphoma	Approved
plerixafor	for stem cell mobilisation	Approved
plerixafor	for stem cell mobilisation	Approved
plerixafor	for stem cell mobilisation	Approved
plerixafor	for stem cell mobilisation, diffuse large b-cell lymphoma	Approved
plerixafor	for stem cell mobilisation, failed stem cell mobilisation, relapsed Hodgkin's lymphoma	Approved
plerixafor	for stem cell mobilisation, Hodgkin's lymphoma	Approved
plerixafor	for stem cell mobilisation, mantle cell lymphoma	Approved
plerixafor	for stem cell mobilisation, mantle cell lymphoma	Approved
plerixafor	for stem cell mobilisation, Multiple Myeloma	Approved
plerixafor	for stem cell mobilisation, Multiple Myeloma	Approved
plerixafor	for stem cell mobilisation, Testicular cancer, failed stem cell mobilisation	Approved
plerixafor	relapsed Hodgkin's lymphoma	Approved
plerixafor	Stem Cell Transplant, relapsed multiple myeloma	Approved
plerixafor	triple hit lymphoma, failed stem cell mobilisation	Approved
pneumococcal conjugate vaccine (pcv13)	acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient	Approved
pneumococcal conjugate vaccine (pcv13)	awaiting cochlear implant, prophylaxis to prevent infection, sensorineural hearing loss	Approved
pneumococcal conjugate vaccine (pcv13)	high risk of infection, pneumococcus infection, Rheumatic Heart Disease	Approved
pneumococcal conjugate vaccine (pcv13)	high risk of re-infection, prophylaxis to prevent infection, COPD, Severe pneumonia, strep pneumonia septicaemia	Approved
pneumococcal conjugate vaccine (pcv13)	immunisation, pneumococcal bacteraemia	Approved
pneumococcal conjugate vaccine (pcv13)	pneumococcal meningitis, prophylaxis to prevent infection	Approved
pneumococcal conjugate vaccine (pcv13)	pneumococcus infection, bacteraemia, intensive care admissions, prophylaxis to prevent infection	Approved
pneumococcal conjugate vaccine (pcv13)	post splenectomy, prophylaxis to prevent infection, adenocarcinoma, Emphysema, severe COPD	Approved
pneumococcal conjugate vaccine (pcv13)	post transplant reimmunisation, Acute Myeloid Leukaemia, post allo-transplant	Approved
pneumococcal conjugate vaccine (pcv13)	preventing infection of immunocompromised patient, awaiting  renal transplant, renal failure	Approved
pneumococcal conjugate vaccine (pcv13)	prophylaxis to prevent infection	Approved
pneumococcal conjugate vaccine (pcv13)	recent ICU for pneumonia, complex effusion/ empyema	Approved
pneumococcal conjugate vaccine (pcv13)	splenectomy	Approved
pneumococcal conjugate vaccine (pcv13)	Streptococcus pneumoniae infection, meningitis, monoclonal gammopathy, Septic arthritis, smouldering myeloma	Approved
pneumococcal polysaccaride vaccine	acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient	Approved
pneumococcal polysaccaride vaccine	pneumococcal meningitis, prophylaxis to prevent infection	Approved
pneumococcal polysaccaride vaccine	pneumococcus infection, bacteraemia, intensive care admissions, prophylaxis to prevent infection	Approved
pneumococcal polysaccaride vaccine	post allogeneic stem cell transplant	Approved
pneumococcal polysaccaride vaccine	post allogeneic stem cell transplant	Approved
pneumococcal polysaccaride vaccine	preventing infection of immunocompromised patient, awaiting  renal transplant, renal failure	Approved
pneumococcal polysaccharide conjugate vaccine 13	post allogeneic stem cell transplant	Approved
pneumococcal polysaccharide vaccine 13 (Prevenar 13)	compound skull fracture, prophylaxis	Approved
pneumococcal polysaccharide vaccine 23 (Pneumovax 23)	prophylaxis, compound skull fracture	Approved
poly(hexamethylenebiguanide) hydrochloride	acanthamoeba keratitis	Approved
poly(hexamethylenebiguanide) hydrochloride	acanthamoeba keratitis	Approved
poly(hexamethylenebiguanide) hydrochloride	acanthamoeba keratitis	Approved
poly(hexamethylenebiguanide) hydrochloride	acanthamoeba keratitis	Approved
poly(hexamethylenebiguanide) hydrochloride	acanthamoeba keratitis, pellucid marginal degeneration	Approved
polyethylene glycol	chronic constipation, restricted diet due to food allergies	Approved
polyethylene glycol	chronic constipation, restricted diet due to food allergies	Approved renewal
polyethylene glycol	chronic constipation, restricted diet due to food allergies	Approved renewal
polyethylene glycol	corneal ulcers, brain stem schwanoma, facial nerve palsy	Approved
pomalidomide	Myeloma, epilepsy	Declined
ponatinib	Chronic Myeloid Leukaemia, T315l mutation, asbestosis, Pleural Effusion	Declined
ponatinib	Philadelphia positive acute lymphoblastic leukemia, T315l mutation	Declined
ponatinib	Philidelphia positive ALL, T315l mutation	Declined
posaconazole	adverse reaction to voriconazole, Pulmonary Aspergillosis, chronic lymphocytic leukaemia	Approved
posaconazole	Altenaria sp. infection, adverse reaction to alternatives, post renal transplant	Approved
posaconazole	aspergillus bronchitis, Cystic fibrosis	Approved
posaconazole	bronchopulmonary aspergillosis, Unable to tolerate funded medicaton	Approved renewal
posaconazole	BSLT for sarcoidosis, aspergillus in lung	Approved
posaconazole	BSLT for sarcoidosis, aspergillus in lung	Approved renewal
posaconazole	fungal prophylaxis, Graft Versus Host Disease, Stem Cell Transplant	Approved
posaconazole	fungal prophylaxis, Graft Versus Host Disease, Stem Cell Transplant	Approved renewal
posaconazole	high risk of infection, adverse reaction to voriconazole, Invasive Aspergillus infection, post lung transplant, stent surgery planned	Approved
posaconazole	Invasive Aspergillosis, intolerance to alternatives, post lung transplant	Approved
posaconazole	invasive fungal infection, severe pulmonary haemorrhage	Approved
posaconazole	invasive rhino-cerebral mucormycosis, Rhizopus oryzae infection, acute kidney injury, adverse reaction to alternatives, hepato-renal syndrome	Approved
posaconazole	mucormycosis, acute kidney injury	Approved
posaconazole	paecilomyces lung infection	Approved
posaconazole	prophylaxis antifungal, Post Liver Transplant, Severe Aplastic Anaemia	Approved
posaconazole	Pulmonary Aspergillosis, Acute Lymphoblastic Leukaemia, immunosuppressed secondary to chemotherapy	Approved
posaconazole	pulmonary mucomycosis, leukaemia	Approved
posaconazole	recurrent aspergillus infection, adverse reaction to voriconazole, chronic lung allograft dysfunction (CLAD), Cystic Fibrosis	Approved
potassium chloride	Bartter syndrome, Gitelman's syndrome	Approved
potassium chloride	brainstem infarct, Cardiomyopathy, gastrostomy, locked-in syndrome, PEG feeding	Approved
potassium chloride	cystinosis, hypokalaemia, renal fanconi syndrome, failure to thrive, global development delay	Approved
potassium chloride	cystinosis, hypokalaemia, renal fanconi syndrome, failure to thrive, global development delay	Approved renewal
potassium chloride	Gitelman's syndrome, pregnancy	Approved
potassium chloride	Gitelman's syndrome, pregnancy	Approved renewal
potassium chloride	hypokalaemia , enlarged left kidney, pulmonary hypoplasia, renal dysplasia right kidney, severe pelvicalyceal dilatation	Approved
potassium chloride	hypokalaemia, atrial fibrillation, CHF, gout, hypertension, previous CVA, temporal arteritis	Approved
potassium chloride	hypokalaemia, chronic peritoneal dialysis, end-stage renal failure, hypoxic ischemic injury	Approved
potassium chloride	hypokalaemia, enlarged left kidney, pulmonary hypoplasia, renal dysplasia right kidney, severe pelvicalyceal dilatation	Approved
potassium chloride	hypokalaemia, ileostomy, Total Colectomy	Approved
potassium chloride	hypokalaemia, J tube feeding requires dispersible tab, PEG tube drainage	Approved
potassium chloride	hypokalaemia, Kearns Sayres, mitochondrial disorder, renal disease	Approved renewal
potassium citrate	cystinuria	Approved
potassium citrate	cystinuria	Approved
potassium citrate	distal renal tubular acidosis, severe hypokalaemia, renal stones, sjogrens syndrome	Approved
potassium citrate	distal renal tubular acidosis, severe hypokalaemia, renal stones, sjogrens syndrome	Approved renewal
potassium citrate	electrolyte imbalance, chronic kidney disease, Cystinosis, Growth Failure	Approved renewal
potassium citrate	electrolyte imbalance, chronic kidney disease, Growth Failure, nephropathic cystinosis	Approved renewal
potassium citrate	hypercalciuria, Hyperoxaluria, recurrent nephrolithiasis	Approved
potassium citrate	hypocalcaemia, hypocitraturia, Ankylosing spondylitis, chronic kidney disease, dyslipidaemia, hypertension, nephrolithiasis, Ulcerative Colitis	Approved
potassium citrate	hypocitraturia, nephrolithiasis, Alagille's syndrome, chronic kidney disease, Chronic Liver Disease, hypersplenism	Approved
potassium citrate	hypocitraturia, recurrent nephrolithiasis	Approved
potassium citrate	hypocitraturia, recurrent nephrolithiasis, dyslipidaemia, hypertension, intolerance to alternatives	Approved
potassium citrate	hypocitraturia, recurrent nephrolithiasis, dyslipidaemia, hypertension, intolerance to alternatives	Approved renewal
potassium citrate	hypocitraturia, recurrent nephrolithiasis, dyslipidaemia, hypertension, intolerance to alternatives	Approved renewal
potassium citrate	kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia	Approved
potassium citrate	kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia	Approved
potassium citrate	kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia	Approved renewal
potassium citrate	kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia	Approved renewal
potassium citrate	nephrocalcinosis, developmental delay, Genetic testing re undiagnosed syndrome, hearing loss, hypercalciuria presumed idiopathic, short stature	Approved
potassium citrate	Proximal tubular acidosis, arthrogryposis renal dysfunction cholestasis syndrome	Approved
potassium citrate	recurrent nephrolithiasis, Dent's disease	Approved
potassium citrate	renal dysplasia	Approved
potassium citrate	renal dysplasia	Approved renewal
potassium citrate	renal dysplasia	Approved renewal
potassium citrate	uric acid renal stone	Approved
potassium dihydrogen phosphate	osteopaenia of prematurity	Approved
potassium dihydrogen phosphate	osteopenia of prematurity	Approved
potassium perchlorate	amiodarone induced thyrotoxicosis, paroxysmal af	Approved
prasugrel	cerebral aneurysm, clopidogrel resistance, stent implant	Approved
prasugrel	clopidogrel resistance, inracranial aneurysm requiring stent, breast carcinoma	Approved
prasugrel	clopidogrel resistance, inracranial aneurysm requiring stent, breast carcinoma	Approved renewal
prasugrel	clopidogrel resistance, intracranial stent	Approved
prasugrel	intracranial stent thrombosis	Approved
prednisolone	atypical CNS inflammatory disorder, polymyalgia rheumatica, diabetes type 2, previous DVT	Approved renewal
prednisolone	decompensating corneal graft, epitheliopathy, previous graft rejection	Approved
prednisolone	decompensating corneal graft, epitheliopathy, previous graft rejection	Approved renewal
prednisolone	eczema, epilepsy, florrid dermatitis, intellectual disability	Approved
prednisolone	mucous build up, eosinophilic oesophagitis, PEG feeding	Approved
prednisolone	nephrotic syndrome, Cornelia de Lange syndrome, gastrostomy feeding, Severe cerebral palsy, unable to swallow, wheelchair bound	Approved
prednisolone	nephrotic syndrome, Cornelia de Lange syndrome, gastrostomy feeding, Severe cerebral palsy, unable to swallow, wheelchair bound	Approved renewal
prednisolone	oesophageal cancer, Hypothyroidism, palliative care	Approved
prednisolone	polymyalgia rheumatica, Crohn's diease, ileostomy	Approved
prednisolone	polymyalgia rheumatica, diabetes type 2, previous DVT	Approved
prednisolone	polymyalgia rheumatica, diabetes type 2, previous DVT	Approved renewal
prednisolone	rectal bleeding, developmental delay, severe crohn's disease, Total Colectomy	Approved
prednisolone eye drops	chronic keratinisation of lid margins, common variable immunodeficiency, keratopathy, vernal blepharoconjunctivitis	Approved
prednisolone eye drops	linear IgA dermatosis, cicatricial conjunctivitis	Approved
prednisolone minims	chronic blepharo kerato conjuntivitis	Approved renewal
prednisolone minims	chronic blepharo kerato conjuntivitis	Approved renewal
prednisolone minims	corneal decompensation, ocular inflammation, glaucoma	Approved renewal
prednisolone minims	keratitis	Approved
prednisolone sodium phosphate	allergic eye disease, corneal ulcers, Herpes Simplex Keratitis	Approved
prednisolone sodium phosphate	allergic eye disease, corneal ulcers, Herpes Simplex Keratitis	Approved renewal
prednisolone sodium phosphate	atopic keratoconjunctivitis	Approved
prednisolone sodium phosphate	atopic keratoconjunctivitis	Approved renewal
prednisolone sodium phosphate	chronic blepharo kerato conjuntivitis	Approved
prednisolone sodium phosphate	chronic blepharo kerato conjuntivitis	Approved
prednisolone sodium phosphate	corneal decompensation, ocular inflammation, glaucoma	Approved
prednisolone sodium phosphate	ocular surface inflammatory disease, Failed corneal transplant	Approved
prednisolone sodium phosphate	Penetrating keratoplasty, topical preservative sensitivity	Approved
prednisolone sodium phosphate	Ulcerative Colitis, ileostomy bag, Nephrotic Syndrome	Approved renewal
pregabalin	chronic neuropathic pain, chronic musculoskeletal pain, intermittant visceral pain, pompe disease, respiratory failure	Approved
pregabalin	chronic pain syndrome	Approved
pregabalin	generalised pain, mucolipidosis type 3, Neuropathic pain	Declined
pregabalin	low grade malignant nerve sheath tumour, neuropathic pain	Approved
pregabalin	Neuropathic pain, bronchiectasis, dystonia, global development delay, kernicterus, scoliosis, spasticity	Approved
pregabalin	pain, schwannomatosis	Approved
premature birth formula (S-26 LBW Gold  RTF)	Premature birth	Approved
primaquine	malaria	Approved
primidone	epilepsy, asthma, hypertension, osteoporosis, post polio exhaustion	Approved renewal
pristinamycin	Methicillin-resistant Staphylococcus aureus	Approved
pristinamycin	Methicillin-resistant Staphylococcus aureus	Approved renewal
pristinamycin	multidrug-resistant organism, mycoplasma genitalium infection	Approved
pristinamycin	mycoplasma genitalium infection	Approved
pristinamycin	mycoplasma genitalium infection	Approved
pristinamycin	mycoplasma genitalium infection	Approved
progesterone	cervical incompetence	Approved
progesterone	cervical incompetence, risk of pre-term labour	Approved
progesterone	history of preterm labour	Approved
progesterone	history of preterm labour, pregnant, Previous LLETZ	Approved
progesterone	Prevent miscarriage, twin pregnancy	Approved
progesterone	prevention of preterm labour, allergy to alternatives	Approved
progesterone	recurrent previous miscarraige	Approved
progesterone	risk of pre-term labour	Approved
progesterone	risk of pre-term labour	Approved
progesterone	risk of pre-term labour	Approved
progesterone	risk of pre-term labour, cervical incompetence, short cervix	Approved
progesterone	risk of pre-term labour, pregnant, previous miscarraige, short cervix	Approved
progesterone	short cervix	Approved
progesterone	short cervix, risk of pre-term labour	Approved
progesterone	threatened premature labour	Approved
progesterone	threatened premature labour, Bicornuate Uterus, Two Cervices	Approved
progesterone	threatened premature labour, history of preterm labour, pregnant	Approved
progesterone	threatened premature labour, history of preterm labour, pregnant	Approved
progesterone	threatened premature labour, history of preterm labour, previous still birth	Approved
progesterone	threatened premature labour, pregnant, short cervix	Approved
progesterone (Utrogestan)	cervical incompetence	Approved
progesterone (Utrogestan)	risk of pre-term labour, short cervix	Approved
progesterone (Utrogestan)	threatened premature labour, cervical incompetence, history of preterm labour	Approved
progesterone pessary	cancer of cervix, history of preterm labour	Approved
progesterone pessary	history of preterm labour	Approved
progesterone pessary	history of preterm labour	Approved
progesterone pessary	history of preterm labour	Approved
progesterone pessary	recurrent previous miscarraige	Approved
progesterone pessary	risk of pre-term labour	Approved
progesterone pessary	risk of pre-term labour	Approved
progesterone pessary	risk of pre-term labour	Approved
progesterone pessary	risk of pre-term labour	Approved
progesterone pessary	risk of pre-term labour, cervical incompetence	Approved
progesterone pessary	risk of pre-term labour, cervical incompetence, short cervix	Approved
progesterone pessary	risk of pre-term labour, history of preterm labour, short cervix	Approved
progesterone pessary	risk of pre-term labour, ovarian torsion	Approved
progesterone pessary	risk of pre-term labour, short cervix	Approved
progesterone pessary	short cervix	Approved
progesterone pessary	twin pregnancy, history of preterm labour, short cervix	Approved
propranolol	atrial flutter, Cardiomyopathy	Approved
propranolol	cardiac arrhythmias, Hypertrophic cardiomyopathy	Approved
propranolol	Cardiomyopathy, arrhythmia	Approved
propranolol	congenital cardiac condition, Premature birth, tetralogy of fallot	Approved
propranolol	haemangioma	Approved
propranolol	haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma, laryngomaiacia	Approved
propranolol	infantile haemangioma, rectal bleeding	Approved
propranolol	long QT syndrome	Approved
propranolol	paroxysmal supraventricular tachycardia	Approved
propranolol	Recurrent SVT	Approved
propranolol	subglottic haemangioma	Approved
propranolol	SVT	Approved
propranolol	tetralogy of fallot	Approved
propranolol	atrial tachycardias, supraventricular tachycardia	Approved
propranolol	congenital cardiac condition, Premature birth, tetralogy of fallot	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma	Approved
propranolol	infantile haemangioma, skin ulceration	Approved
propranolol	infantile haemangioma	Approved
prothionamide	MDR tuberculosis	Approved
prothionamide	multidrug-resistant tuberculosis	Approved
pseudoephedrine hydrochloride	severe postural hypotension, autonomic dysreflexia, tetraplegia	Approved renewal
pseudoephidrine hydrochloride	severe postural hypotension, autonomic dysreflexia, tetraplegia	Approved
pyridoxal 5 phosphate	epileptic encephalopathy, infantile spasms	Approved
pyridoxal 5-phosphate	brain malformation, epilepsy, Epileptic encephalopathy, global development delay, medically refractory seizures	Approved
pyridoxal 5-phosphate	Epileptic encephalopathy, cognitive delay, refractory epilepsy	Approved
pyridoxal 5-phosphate	Epileptic encephalopathy, epilepsy, global development delay	Approved
pyridoxal 5-phosphate	Epileptic encephalopathy, epilepsy, global development delay	Approved
pyridoxal 5-phosphate	Epileptic encephalopathy, epilepsy, global development delay	Approved renewal
pyridoxal 5-phosphate	Epileptic encephalopathy, epilepsy, global development delay	Approved renewal
pyridoxal 5-phosphate	epileptic encephalopathy, possible PNPO deficiency, nasogastric tube	Approved
pyridoxal 5-phosphate	global development delay, Intractable Epilepsy, visual impairment	Approved
pyridoxal 5-phosphate	infantile spasms, global development delay, refractory seizures	Approved
pyridoxal 5-phosphate	refractory epilepsy, global development delay	Approved
pyridoxal 5-phosphate	refractory epilepsy, global development delay, severe movement disorder	Approved
pyrimethamine	acute lymphoblastic leukemia post unrelated transplant, toxoplasmosis prophylaxis	Approved
pyrimethamine	acute ocular toxoplasmosis	Approved
pyrimethamine	AML, Graft Versus Host Disease, neutropenia	Approved
pyrimethamine	cerebral toxoplasmosis, bone marrow transplant, Congenital Immune Deficiency, immunocompromised	Approved
pyrimethamine	Cerebral toxoplasmosis, Glioblastoma Multiforme	Approved
pyrimethamine	Cerebral toxoplasmosis, Glioblastoma Multiforme	Approved renewal
pyrimethamine	cerebral toxoplasmosis, Ocular Toxoplasmosis, immunocompetent	Approved
pyrimethamine	prophylaxis of toxoplasmosis, graft vs host disease post bone marrow transplant	Approved
pyrimethamine	toxoplasmosis prophylaxis, abnormal liver function tests, chronic graft versus host disease, graft vs host disease, matched unrelated donor transplant, post stem cell transplant, Thrombocytopaenia	Approved
quinacrine	refractory giardiasis	Approved
quinacrine	SLE, Arthritis, Hashimoto's thyroiditis, Severe photosensitive rash	Approved renewal
quinacrine	SLE, Arthritis, Hashimoto's thyroiditis, Severe photosensitive rash	Approved renewal
quinacrine	systemic lupus erythematosus, epilepsy, steroid sparing agent	Approved
quinacrine	systemic lupus erythematosus, epilepsy, steroid sparing agent	Approved renewal
quinacrine	systemic lupus erythematosus, epilepsy, steroid sparing agent	Approved renewal
quinacrine	treatment resistant recurrent giardiasis	Approved
quinacrine (aka mepacrine)	SLE, Arthritis, Hashimoto's thyroiditis, Severe photosensitive rash	Approved
quinidine	brugada syndrome, inflammatory bowel disease	Approved
quinidine	early repolarisation syndrome, ventricular arrhythmias, cardiac arrest	Approved
quinidine	implantable cardioverter defribrillator (ICD), ventricular fibrillation	Approved
quinidine	ventricular arrhythmias, brugada syndrome, implantable cardioverter defribrillator (ICD)	Approved
quinidine	ventricular arrhythmias, brugada syndrome, implantable cardioverter defribrillator (ICD)	Approved renewal
quinidine	ventricular fibrillation, brugada syndrome	Approved
quinidine	ventricular fibrillation, coronary disease, implanted cardiac defibrillator, prolonged QT	Approved
raltitrexed	5FU/Capecitabine induced angina, adenocarcinoma of the colon, ischaemic heart disease	Approved
raltitrexed	5FU/Capecitabine induced angina, metastatic rectal cancer	Approved
raltitrexed	5FU/Capecitabine induced angina, metastatic rectal cancer	Approved
raltitrexed	5FU/Capecitabine induced angina, metastatic rectal cancer	Approved renewal
raltitrexed	adenocarcinoma of the colon	Approved
raltitrexed	Metastatic colon cancer with widespread peritoneal disease	Approved
raltitrexed	rectal adenocarcinoma, cardiotoxicity with capecitabine, stage IV	Approved
raltitrexed	rectal cancer, 5FU/Capecitabine induced angina	Approved
ranibizumab	diabetic macular oedema	Approved
ranibizumab	diabetic macular oedema	Approved renewal
ranibizumab	diabetic macular oedema	Approved renewal
reboxetine	ADHD, Borderline Personality disorder, Depressive disorder	Approved
regorafenib	GIST, gastrointestinal stromal tumour, metastatic tumours	Declined
ribavirin	acquired via infected blood, chronic hepatitis C	Approved
ribavirin	cHCV	Approved
ribavirin	chronic hepatitis C	Approved
ribavirin	chronic hepatitis C	Approved
ribavirin	chronic hepatitis C	Approved
ribavirin	chronic hepatitis C	Approved
ribavirin	chronic hepatitis C	Approved renewal
ribavirin	Chronic hepatitis C decompensated  cirrhosis (Genotype 1)	Approved
ribavirin	chronic Hepatitis C genotype 3	Approved
ribavirin	chronic Hepatitis C genotype 3, cirrhosis	Approved
ribavirin	chronic Hepatitis C genotype 3, liver cirrhosis	Approved
ribavirin	chronic Hepatitis C genotype 3, liver cirrhosis	Approved renewal
ribavirin	chronic Hepatitis C genotype 3A, cirrhosis, mood instability, post-traumatic epilepsy	Approved
ribavirin	chronic Hepatitis C genotype 3A, oesophageal varices	Approved
ribavirin	chronic Hepatitis C genotype 3A, oesophageal varices	Approved renewal
ribavirin	chronic hepatitis C, chronic pain, Depression, oesophageal varices	Approved
ribavirin	chronic hepatitis C, cirrhosis	Approved
ribavirin	chronic hepatitis C, cirrhosis	Approved
ribavirin	chronic hepatitis C, cirrhosis, biliary anastomic leak, hepatic artery stenosis, Post Liver Transplant	Approved
ribavirin	chronic hepatitis C, cryoglobulinaemia	Approved
ribavirin	chronic hepatitis C, cryoglobulinaemia, renal impairment	Approved
ribavirin	chronic hepatitis C, decompensated liver cirrhosis	Approved
ribavirin	chronic hepatitis C, decompensated liver cirrhosis, genotyoe 1	Approved
ribavirin	chronic hepatitis C, decompensated liver cirrhosis, HCC	Approved
ribavirin	chronic hepatitis C, decompensated liver function, hepatic encephalopathy, Recent septic right hip due to osteoarthritis	Approved
ribavirin	chronic hepatitis C, decompensated liver function, hepatic encephalopathy, Recent septic right hip due to osteoarthritis	Approved renewal
ribavirin	chronic hepatitis C, Depressive disorder	Approved
ribavirin	chronic hepatitis C, genotype 1	Approved
ribavirin	chronic hepatitis C, genotype 1	Approved
ribavirin	chronic hepatitis C, genotype 1	Approved renewal
ribavirin	chronic hepatitis C, hepatic encephalopathy, variceal bleeding	Approved
ribavirin	chronic hepatitis C, Hepatitis B, hypertension, post liver transplant diabetes, Ulcerative Colitis	Approved
ribavirin	chronic hepatitis C, Post Liver Transplant, renal dysfunction	Approved
ribavirin	chronic norovirus infection, chronic diarrhoea, Weight Loss	Approved
ribavirin	decompensated HCV cirrhosis	Approved
ribavirin	genotype 1 hepatitis C, liver cirrhosis	Approved
ribavirin	Hepatitis C	Approved
ribavirin	Hepatitis C	Approved
ribavirin	Hepatitis C	Approved
ribavirin	Hepatitis C	Approved
ribavirin	Hepatitis C	Approved
ribavirin	Hepatitis C	Approved
ribavirin	hepatitis C virus cirrhosis	Approved
ribavirin	hepatitis C virus cirrhosis, cryoglobulinaemia	Approved
ribavirin	hepatitis C virus cirrhosis, HIV infection	Approved
ribavirin	Hepatitis C, cirrhosis, liver transplant	Approved
ribavirin	Hepatitis C, cryoglobulinaemia, MGUS, rheumatoid arthritis	Approved
ribavirin	recurrent hepatitis C virus	Approved
ribavirin	recurrent hepatitis C virus, liver transplant	Approved
ribavirin	recurrent hepatitis C virus, liver transplant	Approved
ribavirin	recurrent hepatitis C virus, Post Liver Transplant	Approved
riboflavin	Brown-Vialetto-Van Laere Syndrome	Approved
riboflavin	Brown-Vialetto-Van Laere Syndrome, auditory neuropathy, cerebellar disturbance, ophthalmoplegia	Approved
riboflavin	Complex 1 deficiency secondary to NUBPL gene mutations, mitochondrial cytopathy	Approved
riboflavin	Complex 1 deficiency secondary to NUBPL gene mutations, mitochondrial cytopathy	Approved renewal
riboflavin	Complex 1 deficiency secondary to NUBPL gene mutations, mitochondrial cytopathy	Approved renewal
riboflavin	MELAS	Approved
riboflavin	MELAS	Approved renewal
riboflavin	multiple acyl-coenzyme A dehydrogenase deficiency	Approved
riboflavin	multiple acyl-coenzyme A dehydrogenase deficiency	Approved
riboflavin	multiple acyl-coenzyme A dehydrogenase deficiency	Approved renewal
riboflavin	multiple acyl-coenzyme A dehydrogenase deficiency	Approved renewal
riboflavin	multiple acyl-coenzyme A dehydrogenase deficiency, severe developmental delay	Approved
riboflavin	multiple acyl-coenzyme A dehydrogenase deficiency, severe developmental delay	Approved renewal
riboflavin	possible mitochondrial disorder	Approved renewal
riboflavin	riboflavin transporter deficiency	Approved
riboflavin	riboflavin transporter deficiency	Approved
riboflavin vitamin b2	ataxia, epilepsy, fatigue, MELAS, mitochondrial cytopathy, Wolff-Parkinson-White syndrome	Approved
riboflavin vitamin b2	ataxia, epilepsy, fatigue, MELAS, mitochondrial cytopathy, Wolff-Parkinson-White syndrome	Approved renewal
riboflavin vitamin b2	ataxia, epilepsy, fatigue, MELAS, mitochondrial cytopathy, Wolff-Parkinson-White syndrome	Approved renewal
rifaximin	bacterial infection, gastroschisis, micronutrient deficiency, Short Gut Syndrome, TPN dependent	Approved
rifaximin	bacterial infection, gastroschisis, micronutrient deficiency, Short Gut Syndrome, TPN dependent	Approved renewal
rifaximin	Cholangiocarcinoma, hepatic encephalopathy, post-operative biliary stricture	Approved
rifaximin	Chronic Bacterial Colonisation, gastroschisis, intestinal failure, multiple episodes line sepsis	Approved
rifaximin	chronic encepholapathy, awaiting liver transplant, cryptogenic cirrhosis	Approved
rifaximin	chronic hepatic encepholapathy, decompensated liver cirrhosis, hypertension, osteoporosis	Approved
rifaximin	chronic hepatic encepholapathy, liver failure due to hepatitis C virus cirrhosis	Approved
rifaximin	cirrhosis, hepatic encephalopathy	Approved
rifaximin	cirrhosis, hepatic encephalopathy	Approved
rifaximin	Clostridium Difficile Diarrhoea, bronchiolitis obliterans, diabetes mellitus, Graft vs Host Disease, IgA myeloma, Severe pneumonia	Approved
rifaximin	end stage liver failure, alcohol abuse, hepatitis C	Approved
rifaximin	hepatic encephalopathy	Approved
rifaximin	hepatic encephalopathy	Approved
rifaximin	hepatic encephalopathy	Approved
rifaximin	hepatic encephalopathy	Approved
rifaximin	hepatic encephalopathy	Approved
rifaximin	hepatic encephalopathy	Approved
rifaximin	hepatic encephalopathy	Approved
rifaximin	hepatic encephalopathy	Approved renewal
rifaximin	hepatic encephalopathy, adenocarcinoma, IVC tear	Approved
rifaximin	hepatic encephalopathy, alcohol abuse, chronic end stage liver disease, hepatitis C	Approved
rifaximin	hepatic encephalopathy, alcohol abuse, chronic end stage liver disease, hepatitis C	Approved renewal
rifaximin	hepatic encephalopathy, alcoholic hepatitis	Approved
rifaximin	hepatic encephalopathy, alcoholic liver disease	Approved
rifaximin	hepatic encephalopathy, alcoholic liver disease	Approved renewal
rifaximin	hepatic encephalopathy, alcoholic liver disease, chronic hepatitis B virus cirrhosis	Approved
rifaximin	hepatic encephalopathy, alcoholic liver disease, copd, oesophageal varices	Approved
rifaximin	hepatic encephalopathy, alcoholic liver disease, gastric bypass, gastric ulcer	Approved
rifaximin	hepatic encephalopathy, alcoholic liver disease, liver cirrhosis	Approved
rifaximin	hepatic encephalopathy, ALD, cirrhosis	Approved
rifaximin	hepatic encephalopathy, ALD, diabetes mellitus, HCC, hyperlididaemia, Hypothyroidism	Approved
rifaximin	hepatic encephalopathy, ascites, liver cirrhosis, Portal Hypertension	Approved
rifaximin	hepatic encephalopathy, asthma, Cirrhosis, dyslipidaemia, hypertension, ischaemic heart disease, Myasthenia Gravis	Approved
rifaximin	hepatic encephalopathy, augmentin induced liver injury	Approved
rifaximin	hepatic encephalopathy, autism spectrum disorder, down's syndrome, end stage liver disease secondary to Hepatitis C	Approved
rifaximin	hepatic encephalopathy, autism spectrum disorder, down's syndrome, end stage liver disease secondary to Hepatitis C	Approved renewal
rifaximin	hepatic encephalopathy, autoimmune hepatitis, Cirrhosis	Approved
rifaximin	hepatic encephalopathy, autoimmune liver disease, autoimmune thyroid disease, Portal Hypertension	Approved
rifaximin	hepatic encephalopathy, autoimmune liver disease, autoimmune thyroid disease, Portal Hypertension	Approved
rifaximin	hepatic encephalopathy, autosomal dominant polycystic kidney disease, congenital hepatic fibrosis, Portal Hypertension	Approved
rifaximin	hepatic encephalopathy, Budd Chiari Syndrome, polycystic kidney disease	Approved
rifaximin	hepatic encephalopathy, cardiac dysrhythmia, chronic abdominal pain, chronic diarrhoea, diabetes type 2, diabetic retinopathy, diuretic resistant ascites, gout, microalbuminuria, neuropathy, primary myelofibrosis, splenomegaly	Approved
rifaximin	hepatic encephalopathy, chronic hepatitis C	Approved
rifaximin	hepatic encephalopathy, chronic renal impairment, HCV cirrhosis, previous CVA	Approved
rifaximin	hepatic encephalopathy, cirrhosis, hepatitis C, Portal Hypertension, Thrombocytopaenia	Approved
rifaximin	hepatic encephalopathy, cirrhosis, Portal Hypertension, transplant planned	Approved
rifaximin	hepatic encephalopathy, cryptogenic cirrhosis	Approved
rifaximin	hepatic encephalopathy, cryptogenic cirrhosis with diuretic resistant ascites	Approved
rifaximin	hepatic encephalopathy, decompensated liver cirrhosis, hepatitis C	Approved
rifaximin	hepatic encephalopathy, decompensated liver cirrhosis, hepatitis C	Approved renewal
rifaximin	hepatic encephalopathy, diabetes type 2, Hepatitis B, ischa cardio, liver cirrhosis, Non-alcoholic steatohepatitis, renal failure	Approved
rifaximin	hepatic encephalopathy, diabetes type 2, hernia	Approved
rifaximin	hepatic encephalopathy, diabetes type 2, hernia	Approved renewal
rifaximin	hepatic encephalopathy, diuretic resistant ascites, liver cirrhosis, primary biliary cirrhosis, TIPSS	Approved
rifaximin	hepatic encephalopathy, encephalopathy, GI bleed, Hepatitis B, liver cirrhosis, TIPSS	Approved
rifaximin	hepatic encephalopathy, end stage liver disease	Approved
rifaximin	hepatic encephalopathy, end stage liver disease	Approved
rifaximin	hepatic encephalopathy, end stage liver disease	Approved
rifaximin	hepatic encephalopathy, end stage liver disease secondary to Hepatitis C	Approved
rifaximin	hepatic encephalopathy, end stage liver disease secondary to Hepatitis C	Approved renewal
rifaximin	hepatic encephalopathy, end stage liver disease secondary to Hepatitis C	Approved renewal
rifaximin	hepatic encephalopathy, end stage liver disease, NASH	Approved
rifaximin	hepatic encephalopathy, hepatic venous outflow obstruction, post liver transplant, TIPSS	Approved
rifaximin	hepatic encephalopathy, hepatic venous outflow obstruction, post liver transplant, TIPSS	Approved renewal
rifaximin	hepatic encephalopathy, hernia, hyponatraemia	Approved
rifaximin	hepatic encephalopathy, IHD, Liver disease	Approved
rifaximin	hepatic encephalopathy, liver cirrhosis	Approved
rifaximin	hepatic encephalopathy, liver cirrhosis	Approved
rifaximin	hepatic encephalopathy, liver cirrhosis	Approved
rifaximin	hepatic encephalopathy, liver cirrhosis, multifocal hepatocellular carcinoma	Approved
rifaximin	hepatic encephalopathy, liver cirrhosis, NASH	Approved
rifaximin	hepatic encephalopathy, liver cirrhosis, Portal Hypertension	Approved
rifaximin	hepatic encephalopathy, liver cirrhosis, Portal Hypertension	Approved renewal
rifaximin	hepatic encephalopathy, liver cirrhosis, TIPSS	Approved
rifaximin	hepatic encephalopathy, liver failure due to hepatitis C virus cirrhosis	Approved
rifaximin	hepatic encephalopathy, Liver Failure, post liver transplant	Approved
rifaximin	hepatic encephalopathy, Portal Hypertension	Approved
rifaximin	hepatits C virus cirrhosis, Liver Failure	Approved
rifaximin	hepatits C virus cirrhosis, Liver Failure	Approved renewal
rifaximin	recurrent clostidium difficile infection, bronchiectasis, cerebral palsy, gastro tube fed, gastro-oesophageal reflux disease, spastic quadriplegia	Approved
rifaximin	recurrent severe hepatic encephalopathy, hepatitis C, Liver Transplant	Approved
rifaximin	small intestinal bacterial overgrowth	Approved
rifaximin	small intestinal bacterial overgrowth, gastroschisis, micronutrient deficiency, Short Gut Syndrome, TPN dependent	Approved renewal
rituximab	acute neuromyelitis optica	Approved
rituximab	amegakaryocytic thrombocytopaenia, diabetes, hyperlipidaemia, hypertension, retinopathy	Approved
rituximab	ANCA negative, pauci immune crescentic glomerulonephritis	Approved
rituximab	ANCA positive vasculitis, bronchiectasis, squamous cell skin cancer	Approved
rituximab	ANCA positive vasculitis, granulomatous polyangiitis, Wegener's Granulomatosis	Approved
rituximab	ANCA positive vasculitis, PR3-positive, Autoimmune hypothyroidism, diabetes type 1, focal glomerulonephritis, recurrent pulmonary haemorrhage, relapse on mycophenolate	Approved
rituximab	Anti Hu associated paraneoplastic encephalitis, sensory neuropathy, ovarian carcinoma	Approved
rituximab	antibody mediated, lung transplant rejection	Approved
rituximab	anti-nmda receptor encephalitis	Approved
rituximab	anti-nmda receptor encephalitis	Approved
rituximab	antisynthetase syndrome, asthma, hypertension, multiple PE	Approved renewal
rituximab	antisynthetase syndrome, dermatomyositis, interstitial lung disease	Approved
rituximab	antisynthetase syndrome, respiratory involvement	Approved
rituximab	autoimmune encephalomyelitis, Neuroblastoma, sensory neuropathy	Approved
rituximab	autoimmune haemolytic anaemia	Approved
rituximab	autoimmune haemolytic anaemia, Atrial fibrillation, Renal Impairment	Approved
rituximab	autoimmune haemolytic anaemia, chronic leg ulcers	Approved
rituximab	autoimmune haemolytic anaemia, Chronic Liver Disease, jaundice, Portal Hypertension	Approved
rituximab	autoimmune haemolytic anaemia, chronic lympocytic leukaemia	Approved
rituximab	autoimmune haemolytic anaemia, diabetes, NHL	Approved
rituximab	autoimmune haemolytic anaemia, evans syndrome, Refractory ITP	Approved
rituximab	autoimmune haemolytic anaemia, Pancytopenia, relapsed hairy cell leukaemia	Approved
rituximab	autoimmune haemolytic anaemia, previous CLL	Approved
rituximab	autoimmune hepatitis, systemic lupus erythematosus	Approved
rituximab	autoimmune limbic encephalitis, GABA-B receptor antibody mediated	Approved
rituximab	autoimmune neutropaenia, ITP	Approved
rituximab	autoimmune pancreatitis, IgG4 related disease, myocarditis, diabetes type 2, hepatosteatosis, HLA B27 uveitis	Approved
rituximab	autoimmune retinopathy	Approved
rituximab	autoimmune retinopathy, punctate inner choroidopathy	Approved
rituximab	CANOMAD: Chronic Ataxic Neuropathy Ophthalmoplegia IgM paraprotein cold Agglutinins Disialosyl antibodies	Approved renewal
rituximab	cerebral vasculitis	Approved
rituximab	chronic graft versus host disease, Sclerodermoid chronic graft-versus-host disease, AML, matched unrelated stem cell transplant, Scleroderma	Approved
rituximab	chronic immune mediated thrombocytopaenia, diabetes type 2, Leiomyosarcoma, thymoma	Approved
rituximab	chronic inflammatory demyelinating polyneuropathy	Approved
rituximab	chronic inflammatory demyelinating polyneuropathy	Approved
rituximab	chronic lymphocytic leukaemia, autoimmune haemolytic anaemia	Approved
rituximab	cicatricial pemphigoid	Approved
rituximab	cicatricial pemphigoid	Approved renewal
rituximab	cicatricial pemphigoid, severe ocular cicatricial	Approved
rituximab	cicatricial pemphigoid, severe ocular cicatricial, ulceration of mouth	Approved
rituximab	cold agglutinin disease requiring regular transfusions	Approved
rituximab	cold haemagglutinin disease	Approved
rituximab	cold haemagglutinin disease	Approved
rituximab	cold haemagglutinin disease, congestive heart failure	Approved
rituximab	cryoglobulinaemic vasculitis, Hepatitis C	Approved
rituximab	diffuse scleroderma, Severe Polyarticular Arthritis, interstitial lung disease, intolerence to Humira	Approved
rituximab	fibrillary glomerulonephritis, diabetes type 2, dyslipidaemia, hypertension, paroxysmal af	Approved
rituximab	Focal Segmental Glomerulosclerosis, post kidney transplant, immunosuppression post transplant, intolerance to funded alternative, proteinuria	Approved
rituximab	Follicular bronchiolitis, polynesian castlemans disease, idiopathic plasmacytic lymphadenopathy	Approved
rituximab	follicular non-hodgkin's lymphoma, lymphoma, relapsed lymphoma	Approved
rituximab	glomerulonephritis, JAK-2 positive, Myeloproliferative disorder	Approved
rituximab	granulomatous angiitis of CNS, primary cerebral vasculitis	Approved
rituximab	granulomatous angiitis of CNS, primary cerebral vasculitis	Approved renewal
rituximab	granulomatous polyangiitis, GORD, hypertension, renal impairment	Approved
rituximab	granulomatous polyangiitis, neutropenia, subglottic stenosis	Approved
rituximab	Graves' thyrotoxicosis, thyroid-related orbitopathy, thyroidectomy	Approved
rituximab	GvHD, acute lymphoblastic leukaemia, membranous nephropathy, post stem cell transplant, pulmonary fibrosis	Approved
rituximab	GvHD, fasciitis, steroid refractory, synovitis, T cell lymphoma	Approved
rituximab	GvHD, fasciitis, steroid refractory, synovitis, T cell lymphoma	Approved renewal
rituximab	haemophagocytic lymphocytosis, high epstein�Barr virus load, Hodgkin's lymphoma	Approved
rituximab	Hodgkin's lymphoma	Approved
rituximab	Hyper IgG4 disease	Approved
rituximab	idiopathic thrombocytopaenic purpura, SLE	Approved
rituximab	IgG4 related disease	Approved
rituximab	immune thrombocytopaenia, renal impairment	Approved
rituximab	immune thrombocytopaenic purpura	Approved
rituximab	immune thrombocytopaenic purpura, anaemia of chronic renal disease, cognitive impairment, hyperuricaemia, Myocardial Infarction	Approved
rituximab	immune thrombocytopaenic purpura, diabetes type 2, dyslipidaemia, hypertension, steatohepatitis	Approved
rituximab	immune thrombocytopaenic purpura, osteopenia	Approved
rituximab	ITP	Approved
rituximab	ITP, bleeding problems	Approved
rituximab	membranoproliferative glomerulonephritis, recurrent disease, ESRF, post kidney transplant, steroid resistance	Approved
rituximab	membranous glomerulonephritis, Nephrotic Syndrome	Approved renewal
rituximab	mucous membrane pemphigoid	Approved
rituximab	multicentric castlemans disease	Approved
rituximab	multicentric castlemans disease	Approved renewal
rituximab	Myasthenia Gravis	Approved
rituximab	Myasthenia Gravis	Approved
rituximab	Myasthenia gravis	Approved
rituximab	Myasthenia gravis	Approved renewal
rituximab	NEMO immune deficiency, chronic GvH post BMT, EBV encephalitis, EBV viremia	Approved
rituximab	nephrotic syndrome, Focal Segmental Glomerulosclerosis, post renal transplant	Approved
rituximab	nephrotic syndrome, severe recurrent membranous nephropathy, Second renal transplant	Approved
rituximab	nephrotic syndrome, steroid resistance	Approved
rituximab	neuromyelitis optica	Approved
rituximab	neuromyelitis optica	Approved
rituximab	neuromyelitis optica	Approved
rituximab	neuromyelitis optica	Approved
rituximab	neuromyelitis optica	Approved renewal
rituximab	neuromyelitis optica, aquarporin-4 antibody positive	Approved
rituximab	Neurosarcoidosis, Cauda Equina syndrome, Gadolinium enhancement of the lower spinal cord	Approved
rituximab	Neurosarcoidosis, Cauda Equina syndrome, Gadolinium enhancement of the lower spinal cord	Approved renewal
rituximab	Neurosarcoidosis, Cauda Equina syndrome, Gadolinium enhancement of the lower spinal cord	Approved renewal
rituximab	neurosarcoidosis, pancytopaenia, paraparesis	Approved
rituximab	nmda receptor encephalitis	Approved
rituximab	nmda receptor encephalitis	Approved
rituximab	nmda receptor encephalitis	Approved
rituximab	nmda receptor encephalitis	Approved
rituximab	opsoclonus myoclonus syndrome	Approved
rituximab	orbital disease, sinus IgG4 related disease	Approved
rituximab	orbital disease, sinus IgG4 related disease	Approved renewal
rituximab	pemphigus vulgaris	Approved
rituximab	Pemphigus Vulgaris	Approved
rituximab	pemphigus vulgaris, diabetes type 2, hypertension, Morbid Obesity, previous hepatitis B	Approved
rituximab	post transplant GvHD, Sclerodermoid chronic graft-versus-host disease	Approved
rituximab	primary cerebral vasculitis, coeliac disease	Approved
rituximab	pulmonary rheumatoid nodules, risk of further lung collapse	Approved
rituximab	pulmonary rheumatoid nodules, risk of further lung collapse	Approved renewal
rituximab	pure red cell aplasia secondary to chronic lymphocytic leukaemia	Approved
rituximab	pure red cell aplasia secondary to chronic lymphocytic leukaemia	Approved
rituximab	Rasmussen's encephalitis, focal seizures	Approved
rituximab	Rasmussen's encephalitis, focal seizures	Approved renewal
rituximab	recurrent severe GVHD	Approved
rituximab	Refractory ITP, obesity, SLE	Approved
rituximab	refractory myasthenia gravis	Approved
rituximab	refractory myasthenia gravis	Approved renewal
rituximab	relapsed chronic lymphocytic leukaemia, febrile	Approved
rituximab	relapsed hairy cell leukaemia, legionella pneumonia	Approved
rituximab	relapsing remitting Multiple Sclerosis	Declined
rituximab	Rheumatoid Arthritis, felty's syndrome, latent cmv infection, Pancytopenia	Approved
rituximab	rheumatoid vasculitis, Painful Leg Ulcers, peripheral ulcerative keratitis	Approved
rituximab	scleroderma related interstitial lung disease	Approved
rituximab	Sclerodermatous graft versus host disease post allogeneic stem cell transplant failing multiple lines of immunosuppression, Burkitt lymphoma, diabetes, EBV reactivation, myelodysplasia therapy related	Approved
rituximab	Sclerodermoid chronic graft-versus-host disease, diabetes type 2, dyslipidaemia, hypertension, ineffective alternatives	Approved
rituximab	Sclerodermoid chronic graft-versus-host disease, MDS, pneumocystis jiroveci pneumonia, reactivation of CMV	Approved
rituximab	seropositive rhuematoid vasculitis, osteoporosis	Approved
rituximab	seropositive rhuematoid vasculitis, osteoporosis	Approved renewal
rituximab	severe bullous pemphigoid	Approved
rituximab	severe bullous pemphigoid, steriod induced macular eye disease	Approved
rituximab	Severe Polyarticular Arthritis	Approved
rituximab	Severe thrombocytopaenia	Approved
rituximab	SLE, amputation of arm, amputation of leg, avascular necrosis of hips, Chronic Bronchitis, Coronary Artery Disease, previous DVT and PE	Approved
rituximab	SLE, nephritis	Approved
rituximab	steroid dependent nephrotic syndrome	Approved
rituximab	Steroid Resistant Nephrotic Syndrome	Approved
rituximab	Steroid Resistant Nephrotic Syndrome	Approved renewal
rituximab	sub-glottic stenosis, Wegener's Granulomatosis	Approved
rituximab	systemic lupus erythematosus, severe neuropsychiatric complications	Approved
rituximab	Thrombotic thrombocytopaenic purpura	Approved
rituximab	warm autoimmune haemolytic anaemia	Approved
rituximab	warm autoimmune haemolytic anaemia, Cerebrovascular accident, pancreatitis	Approved
rituximab	warm autoimmune haemolytic anaemia, history of, ITP, lower extremety DVT, splenectomy, steroid induced diabetes mellitus	Approved
rituximab	Wegener's Granulomatosis	Approved
rituximab	Wegener's Granulomatosis, sub-glottic stenosis	Approved
rituxumab	neuromyelitis optica	Approved
ropivacaine	severe pain unresponsive to alternates, Advanced Metastatic Breast cancer, Infected Knee Joint, pain secondary to femur fracture	Approved
rose bengal	metastatic melanoma	Approved
rose bengal	metastatic melanoma	Approved
rufinamide	atypical absence seizures, medically refractory seizures, myoclonic seizures, epileptic encephalopathy	Approved
rufinamide	atypical absence seizures, medically refractory seizures, myoclonic seizures, epileptic encephalopathy	Approved renewal
rufinamide	epilepsy, frontal lobe seizures	Approved renewal
rufinamide	epilepsy, frontal lobe seizures	Approved renewal
rufinamide	Epileptic encephalopathy, global development delay, severe drop seizures	Approved
rufinamide	Epileptic encephalopathy, Intractable Epilepsy	Approved
rufinamide	Epileptic encephalopathy, Intractable Epilepsy	Approved renewal
rufinamide	epileptic encephalopathy, medically refractory seizures, autism spectrum disorder	Approved
rufinamide	epileptic encephalopathy, medically refractory seizures, developmental regression, HLAB1502 allele positive	Approved
rufinamide	epileptic encephalopathy, medically refractory seizures, developmental regression, HLAB1502 allele positive	Approved renewal
rufinamide	epileptic encephalopathy, refractory seizures, autism spectrum disorder, severe drop seizures	Approved
rufinamide	Intractable epilepsy, autism spectrum disorder, Hypomelanosis of Ito, intellectual disability	Approved
rufinamide	Intractable epilepsy, autism, Lennox-Gastaut syndrome	Approved
rufinamide	Intractable epilepsy, autism, Lennox-Gastaut syndrome	Approved renewal
rufinamide	Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy	Approved
rufinamide	Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy	Approved renewal
rufinamide	Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy	Approved renewal
rufinamide	Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy	Approved renewal
rufinamide	Intractable epilepsy, cognitive impairment, Hydrocephalus	Approved
rufinamide	Intractable epilepsy, GORD, neutropenia, osteoporosis, severe developmental delay	Approved
rufinamide	Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy	Approved
rufinamide	Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy	Approved renewal
rufinamide	Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy	Approved renewal
rufinamide	Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy	Approved renewal
rufinamide	Lennox-Gastaut syndrome	Approved
rufinamide	Lennox-Gastaut syndrome, Chromosomal abnormality, epilepsy	Approved renewal
rufinamide	Lennox-Gastaut syndrome, learning difficulties	Approved
rufinamide	Lennox-Gastaut syndrome, learning difficulties	Approved renewal
rufinamide	Lennox-Gastaut syndrome, learning difficulties	Approved renewal
rufinamide	Lennox-Gastaut syndrome, learning difficulties	Approved renewal
rufinamide	Lennox-Gastaut syndrome, nonconvulsive status epilepticus, refractory epilepsy, Astrocytoma Grade 2, atonic attacks, drop attacks, frequent cyanotic spells	Approved
rufinamide	Lennox-Gastaut syndrome, nonconvulsive status epilepticus, refractory epilepsy, Astrocytoma Grade 2, atonic attacks, drop attacks, frequent cyanotic spells	Approved renewal
rufinamide	Lennox-Gastaut syndrome, refractory epilepsy	Approved
rufinamide	Lennox-Gastaut syndrome, refractory epilepsy	Approved
rufinamide	Lennox-Gastaut syndrome, refractory seizures, autism, intellectual disability	Approved
rufinamide	medically refractory seizures, intellectual disability	Approved
rufinamide	myoclonic astatic epilepsy, refractory epilepsy	Approved
rufinamide	myoclonic astatic epilepsy, refractory epilepsy	Approved renewal
rufinamide	refractory epilepsy	Approved
rufinamide	refractory epilepsy	Approved renewal
rufinamide	refractory epilepsy	Approved renewal
rufinamide	refractory epilepsy, Lennox-Gastaut syndrome	Approved
rufinamide	refractory epilepsy, severe drop seizures, tonic seizures, Lennox-Gastaut syndrome, severe autism	Approved
rufinamide	refractory epilepsy, severe drop seizures, tonic seizures, Lennox-Gastaut syndrome, severe autism	Approved renewal
rufinamide	refractory epilepsy, severe drop seizures, tonic seizures, Lennox-Gastaut syndrome, severe autism	Approved renewal
rufinamide	Refractory seizure disorder, severe drop seizures, subcortical band heterotopia, challenging behaviour, intellectual disability	Approved
rufinamide	Refractory seizure disorder, severe drop seizures, subcortical band heterotopia, challenging behaviour, intellectual disability	Approved renewal
rufinamide	Refractory seizure disorder, severe drop seizures, subcortical band heterotopia, challenging behaviour, intellectual disability	Approved renewal
sevalamer	end-stage renal disease, hyperphosphataemia, secondary hyperparathyroidism	Approved
sevelamer	end stage renal disease, Steroid Resistant Nephrotic Syndrome	Approved
sevelamer	end stage renal disease, Steroid Resistant Nephrotic Syndrome	Approved renewal
sevelamer	end stage renal failure, hyperphosphataemia, hypoplastic kidney, Unable to tolerate funded medicaton, diabetes type 2, diabetic neuropathy, gout, hypercalcaemia, hypertension, Hypothyroidism	Approved
sevelamer	end stage renal failure, hyperphosphataemia, hypoplastic kidney, Unable to tolerate funded medicaton, diabetes type 2, diabetic neuropathy, gout, hypercalcaemia, hypertension, Hypothyroidism	Approved renewal
sevelamer	hyperphosphataemia, ANCA positive vasculitis, chronic peritoneal dialysis, Chronic Renal Failure	Approved
sevelamer	hyperphosphataemia, ANCA positive vasculitis, chronic peritoneal dialysis, Chronic Renal Failure	Approved renewal
sevelamer	painful dystrophic calcification, tertiary hyperparathyroidism, tumoural calcinosis, CF related diabetes, Cystic fibrosis, end stage kidney disease, liver transplant, surgery contraindicated	Approved renewal
sevelamer	secondary hyperparathyroidism, end-stage renal disease, hyperphosphataemia	Approved
sevelamer	severe hyperparathyroidism, ineffective alternatives, surgery contraindicated	Approved
sildenafil	bridge to transplant, Chronic Renal Failure	Approved renewal
sildenafil	bridge to transplant, Chronic Renal Failure	Approved renewal
sildenafil	bridge to transplant, PAH secondary to lung disease, interstitial lung disease	Approved
sildenafil	bridge to transplant, PAH secondary to lung disease, interstitial lung disease	Approved renewal
sildenafil	bridge to transplant, PAH secondary to lung disease, interstitial lung disease	Approved renewal
sildenafil	constrictive pericarditis, pulmonary hypertension, left heart disease, pericardiectomy, Right Heart Failure	Approved
sildenafil	CREST syndrome, raynauds phenomenon	Approved
sildenafil	CREST syndrome, raynauds phenomenon	Approved renewal
sildenafil	diffuse cutaneous systemic sclerosis, Scleroderma, ulceration	Approved
sildenafil	end stage heart failure, pulmonary hypertension	Approved
sildenafil	end stage left heart disease, on transplant list, Severe dilated cardiomyopathy, left ventricular impairment, LV thrombus, Renal Impairment	Approved
sildenafil	familial dilated cardiomyopathy, left heart disease	Approved
sildenafil	haemangioma, lymphangioma of tongue	Approved
sildenafil	pulmonary arterial hypertension, congenital systemic pulmonary shunts	Approved
sildenafil	pulmonary hypertension, Cardiac Transplant, Severe dilated cardiomyopathy	Approved
sildenafil	pulmonary hypertension, lung transplant candidate, pulmonary fibrosis	Approved
sildenafil	raynauds phenomenon	Approved
sildenafil	raynauds phenomenon	Approved
sildenafil	raynaud's syndrome	Approved
sildenafil	raynaud's syndrome, critical ischaemia left foot, discoid lupus, Peripheral Vascular disease, secondary non-healing ulcer	Approved
sildenafil	reactive pulmonary hypertension, congenital diaphragmatic hernia	Approved
sildenafil	Scleroderma, digital ischaemia	Approved
sildenafil (Avigra)	PAH, complex congenital heart disease, cyanosis	Approved
sirolimus	adenoma sebaceum, tuberous sclerosis	Approved
sirolimus	adenoma sebaceum, tuberous sclerosis	Approved renewal
sirolimus	CNS lesions, renal angiomyolipoma, arteriovenous malformations, intractable seizures, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas	Approved
sirolimus	facial angiofibromas, ADHD, epilepsy, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, epilepsy, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, renal angiomyolipoma, subependymal giant cell astrocytomas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, renal angiomyolipoma, subependymal giant cell astrocytomas, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas, subungual angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved
sirolimus	facial angiofibromas, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas, tuberous sclerosis	Approved renewal
sirolimus	facial angiofibromas, tuberous sclerosis, attention deficit hyperactivity disorder, epilepsy, Mild to Moderate Intellectual Impairment	Approved
sirolimus	facial angiofibromas, tuberous sclerosis, epilepsy, mental handicap	Approved
sirolimus	facial angiofibromas, tuberous sclerosis, epilepsy, mental handicap	Approved renewal
sirolimus	gastrointestinal bleeding, Blue Rubber Bleb Naevus Syndrome (BRBNS)	Approved
sirolimus	gastrointestinal bleeding, Blue Rubber Bleb Naevus Syndrome (BRBNS)	Approved
sirolimus	Gorham-Stout disease	Approved
sirolimus	hyperinsulinemic hypoglycaemia, hyperinsulinism in infant	Approved
sirolimus	hyperinsulinemic hypoglycaemia, hyperinsulinism in infant	Approved
sirolimus	hyperinsulinemic hypoglycaemia, hyperinsulinism in infant	Approved
sirolimus	hyperinsulinemic hypoglycaemia, hyperinsulinism in infant	Approved
sirolimus	lymphovascular malformation	Approved
sirolimus	lymphovascular malformation	Approved renewal
sirolimus	metastatic uterine perivascular epithelioid cell tumour	Approved
sirolimus	PASLI-R1 syndrome	Approved
sirolimus	PASLI-R1 syndrome	Approved renewal
sirolimus	perivascular epithelioid cell tumour	Approved
sirolimus	perivascular epithelioid cell tumour	Approved renewal
sirolimus	PIK3CA-related segmental overgrowth, Klippel-Trenaunay Syndrome	Approved
sirolimus	pulmonary lymphangioleiomyomatosis	Approved
sirolimus	renal angiomyolipoma, risk of haemorrhage, tuberous sclerosis, intellectual disability, rash	Approved
sirolimus	renal angiomyolipoma, severe tuberous sclerosis	Approved
sirolimus	renal angiomyolipoma, severe tuberous sclerosis	Approved renewal
sirolimus	renal angiomyolipoma, severe tuberous sclerosis, arteriovenous malformations, nephrectomy, risk of haemorrhage	Approved
sirolimus	renal angiomyolipoma, tuberous sclerosis	Approved
sirolimus	renal angiomyolipoma, tuberous sclerosis, Extensive skin disease	Approved
sirolimus	renal angiomyolipoma, tuberous sclerosis, Extensive skin disease	Approved renewal
sirolimus	tuberous sclerosis	Approved
sirolimus	tuberous sclerosis	Approved
sirolimus	tuberous sclerosis	Approved
sirolimus	tuberous sclerosis	Approved renewal
sirolimus	tuberous sclerosis, renal angiomyolipoma	Approved
sirolimus ointment	facial angiofibromas, tuberous sclerosis	Approved
sirolimus ointment	facial angiofibromas, tuberous sclerosis	Approved
sitagliptin	allergy to insulin, diabetes type 2, hypertension	Approved
slow sodium	hyponatraemia secondary to SIADH	Approved
sodium benzoate	Citrullinaemia type 1	Approved renewal
sodium benzoate	hyperammonaemia	Approved
sodium benzoate	hyperammonaemia, urea cycle disorder	Approved
sodium benzoate	non-ketotic hyperglycinaemia	Approved
sodium benzoate	OTC Deficiency, urea cycle disorder	Approved
sodium benzoate	Propionic Acidaemia	Approved
sodium benzoate	secondary hyperammonaemia, Portal Hypertension, portal vein thrombosis, Portosystemic connections, tetralogy of fallot repair	Approved
sodium chloride	appendectomy, hyponatraemia, partial cystectomy, post right hemicolectomy, post thyroidectomy, right uretic JJ stent, severe COPD, stroke, tonsillectomy	Approved
sodium chloride	Congestive Heart Failure, restrictive cardiomyopathy, hyponatraemia	Approved
sodium chloride	corneal oedema	Approved
sodium chloride	Crohns Disease, bowel resection	Approved
sodium chloride	Crohns Disease, bowel resection	Approved renewal
sodium chloride	Crohn's disease, bowel resection	Approved renewal
sodium chloride	hyponatraemia, enlarged left kidney, pulmonary hypoplasia, renal dysplasia right kidney, severe pelvicalyceal dilatation	Approved
sodium chloride	hyponatraemia, Schizophrenia, small bowel fistula	Approved
sodium chloride	SIADH, Small Cell lung Cancer	Approved
sodium chloride (Muro 128)	decompensating corneal graft	Approved
sodium chloride (Slow Sodium)	hyponatraemia, Pancreatic neuroendocrine tumor, SIADH	Approved
sodium chloride (Slow Sodium)	low sodium levels, Crohn's diease, Hodgkin's lymphoma	Approved
sodium chloride (Slow Sodium)		Approved
sodium chloride solution	Cystic fibrosis, meconium ileus at birth	Approved
sodium citrate	metabolic acidosis, reflux nephropathy	Approved
sodium dihydrogen phosphate	metabolic bone disease of the neonate, Premature birth	Approved
sodium dl 3 hydroxybutyrate	glut-1 deficiency, Behavioural problems, epilepsy, intellectual disability	Approved
sodium phenylbutyrate	carnitine-acylcarnitine translocase deficiency, PEG feeding	Approved
sodium phenylbutyrate	hyperammonia, multiple oesophageal varices, portal hypertension, portal vein thrombosis, Portosystemic connections	Approved
sodium phenylbutyrate	hyperammonia, multiple oesophageal varices, portal hypertension, portal vein thrombosis, Portosystemic connections	Approved renewal
sodium phenylbutyrate	OTC Deficiency, urea cycle disorder	Approved
sodium picosulfate	chronic constipation, epilepsy, malone's appendicostomy for antegrade continence enema	Approved renewal
sodium picosulfate	Chronic severe constipation, anxiety, developmental delay, epilepsy, Paediatric autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS)	Approved
sodium picosulfate	familial mitochondrial myopathy, idiopathic intestinal pseudo obstruction	Approved
sodium picosulfate	slow transit constipation, appendicostomy	Approved
sodium picosulfate magnesium oxide citric acid	constipation, Hirschsprung's disease	Approved
sofosbuvir	chronic Hepatitis C genotype 3A, Diabetes Mellitus	Declined
sofosbuvir	HCV cirrhosis, Hepatocellular carcinoma, HIV infection, Kaposi's sarcoma	Declined
sofosbuvir plus ledipasvir	chronic Hepatitis C genotype 3A, hepatits C virus cirrhosis, acquired via infected blood products, haemophilia, hepatocellular carcinoma, Post Liver Transplant	Declined
sofosbuvir plus ledipasvir	chronic hepatitis C, hepatic fibrosis, acquired via infected blood products, von Willebrand disease	Declined
sofosbuvir plus ledipasvir	chronic hepatitis C, liver cirrhosis, methadone maintenance, prior depression	Declined
sofosbuvir plus ledipasvir	chronic hepatitis C, liver fibrosis, acquired via infected blood products, haemophilia, Head Injury, secondary epilepsy	Declined
sofosbuvir plus ledipasvir	decompensated HCV cirrhosis, Head Injury, hepatocellular carcinoma, hypertension	Declined
sofosbuvir plus ledipasvir	genotype 1 hepatitis C, acquired via infected blood products, liver fibrosis	Declined
sofosbuvir plus ledipasvir	genotype 1 hepatitis C, hepatitis C virus cirrhosis, acquired via infected blood	Declined
sofosbuvir plus ledipasvir	genotype 1 hepatitis C, hepatitis C virus cirrhosis, acquired via infected blood	Declined
sofosbuvir plus ledipasvir	genotype 1 hepatitis C, hepatitis C virus cirrhosis, acquired via infected blood products	Declined
sofosbuvir plus ledipasvir	genotype 1 hepatitis C, liver fibrosis, acquired via infected blood	Declined
sofosbuvir plus ledipasvir	genotype 1 hepatitis C, liver fibrosis, acquired via infected blood	Declined
sofosbuvir plus ledipasvir	genotype 1 hepatitis C, liver fibrosis, acquired via infected blood products	Declined
sofosbuvir plus ledipasvir	hepatitis C virus cirrhosis, acquired via infected blood products, chronic Hepatitis C genotype 3A, haemophilia, Post Liver Transplant	Declined
sofosbuvir plus ledipasvir	hepatitis C virus cirrhosis, acquired via infected blood products, chronic kidney disease	Declined
somatropin	GH deficiency, adverse reaction to alternatives, hypoglycaemia, Panhypopituitarism	Approved
sorafenib	aggressive fibromatosis, desmoid tumour	Approved
sorafenib	aggressive fibromatosis, desmoid tumour	Approved renewal
sorafenib	follicular carcinoma of thyroid, hurthle cell carcinoma of the thyroid	Declined
sorafenib	follicular carcinoma of thyroid, refractory thyroid cancer, metastatic to lungs	Declined
sorafenib	Metastatic Thyroid cancer, papillary carcinoma of the thyroid, refractory to radiotherapy	Declined
sorafenib	papillary carcinoma of the thyroid	Declined
spiramycin	foetal toxoplasmosis infection, maternal toxoplasmosis	Approved
spiramycin	foetal toxoplasmosis infection, maternal toxoplasmosis	Approved
spiramycin	maternal toxoplasmosis	Approved
spiramycin	toxoplasmosis in pregnancy	Approved
spiramycin	toxoplasmosis in pregnancy	Approved
stanozolol	hereditary angioedema	Approved renewal
stanozolol	hereditary angioedema, intolerance to alternatives	Approved
stiripentol	dravet's syndrome, severe myoclonic epilepsy of infancy, learing impairment	Approved
streptozocin	duodenal tumour, neuroendocrine tumour, unresectable, diabetes type 2, gout	Approved
streptozocin	duodenal tumour, neuroendocrine tumour, unresectable, diabetes type 2, gout	Approved renewal
streptozocin	hypoglycaemia due to insulinoma, metastatic pancreatic neuroendocrine tumour, liver metastases	Approved
streptozocin	metastatic atypical carcinoid, neuroendocrine tumour	Approved
streptozocin	metastatic neuroendocrine tumour	Approved
streptozocin	metastatic neuroendocrine tumour	Declined
streptozocin	metastatic pancreatic carinoma, hypoglycaemia	Approved
streptozocin	metastatic pancreatic neuroendocrine tumour	Declined
streptozocin	Pancreatic neuroendocrine tumor	Approved
sulfadiazine	cerebral toxoplasmosis, Ocular Toxoplasmosis, immunocompetent	Approved
sulindac	desmoid fibromatosis	Approved
sulindac	desmoid fibromatosis	Approved
sulindac	desmoid fibromatosis	Approved
sulphadiazine	Cerebral toxoplasmosis, Glioblastoma Multiforme	Approved
sulphadiazine	Cerebral toxoplasmosis, Glioblastoma Multiforme	Approved renewal
sulthiame	continuous spike wave in slow wave sleeep, Epileptic encephalopathy, Landau-Kleffner Syndrome	Approved renewal
sulthiame	electrical status epilepticus in slow wave sleep, epileptic encephalopathy	Approved
sulthiame	electrical status epilepticus in slow wave sleep, epileptic encephalopathy	Approved renewal
sulthiame	epilepsy aphasia disorder, epileptic encephalopathy	Approved
sulthiame	Intractable Epilepsy, cerebral palsy, dystonia, Excessive drooling, Insomnia, intellectual handicap, scoliosis	Approved
sulthiame	Lennox-Gastaut syndrome, drop attacks, Intellectual Handicap, mild cerebral palsy, myoclonic seizures, tonic clonic seizures	Approved
sunitinib	angiosarcoma of the pericardium	Approved
sunitinib	ascites, GIST relapse, imatinib refractory, peritoneal metastases	Approved
sunitinib	extraskeletal myxoid chondrosarcoma	Approved
sunitinib	imatinib refractory GIST	Approved
sunitinib	imatinib refractory, nilotinib resistance, GIST relapse	Approved
sunitinib	metastatic translocation renal variant renal tumour, extensive nodal disease	Approved
sunitinib	progressive metastatic gastrointestinal stromal tumour	Approved
sunitinib	refractory to chemotherapy, thymic carcinoma	Declined
tacrolimus	angio immunoblastic T cell lymphoma, aplastic anaemia	Approved
tacrolimus	angio immunoblastic T cell lymphoma, aplastic anaemia	Approved renewal
tacrolimus	aplastic anaemia	Approved
tacrolimus	aplastic anaemia	Approved
tacrolimus	aplastic anaemia	Approved renewal
tacrolimus	Corneal stem cell failure, possible graft versus host disease, Stevens-Johnson Syndrome	Approved
tacrolimus	Crohn's disease	Approved
tacrolimus	Crohns Disease, coeliac disease, refractory to other treatments, refractory to standard treatments	Approved
tacrolimus	Crohn's disease, coeliac disease, refractory to other treatments, refractory to standard treatments	Approved renewal
tacrolimus	Crohn's disease, coeliac disease, refractory to other treatments, refractory to standard treatments	Approved renewal
tacrolimus	Crohn's disease, poor growth	Approved
tacrolimus	Crohn's disease, poor growth	Approved renewal
tacrolimus	Crohns Disease, sclerosing cholangitis	Approved
tacrolimus	dermatitis of the vulva/external genitalia, Staphylococcus aureus infection, velocardiofacial (DiGeorge) syndrome	Approved renewal
tacrolimus	dermatitis of thh vulva/external genitalia, Staphylococcus aureus infection	Approved
tacrolimus	Erythoderma psoriasis	Approved
tacrolimus	Focal Segmental Glomerulosclerosis, cyclosporin dependent, gingival hyperplania, Nephrotic Syndrome, short stature, steroid dependent, tremor	Approved
tacrolimus	Focal Segmental Glomerulosclerosis, cyclosporin dependent, gingival hyperplania, Nephrotic Syndrome, short stature, steroid dependent, tremor	Approved renewal
tacrolimus	Focal Segmental Glomerulosclerosis, cyclosporin dependent, gingival hyperplania, Nephrotic Syndrome, short stature, steroid dependent, tremor	Approved renewal
tacrolimus	Focal Segmental Glomerulosclerosis, cyclosporin ineffective, renal dysfunction	Approved
tacrolimus	Focal Segmental Glomerulosclerosis, Nephrotic Syndrome	Approved renewal
tacrolimus	Focal Segmental Glomerulosclerosis, Nephrotic Syndrome	Approved renewal
tacrolimus	Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome	Approved
tacrolimus	Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome	Approved
tacrolimus	Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment	Approved
tacrolimus	Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment	Approved renewal
tacrolimus	Ig A nephropathy	Approved
tacrolimus	Ig A nephropathy	Approved renewal
tacrolimus	Ig A nephropathy	Approved renewal
tacrolimus	immunosuppression secondary to liver transplant, Refractory rejection	Approved
tacrolimus	liver transplant, Cognitive deficit, previous graft rejection	Approved renewal
tacrolimus	metastatic Crohn's disease of skin	Approved
tacrolimus	minimal change nephrotic syndrome, steroid dependent nephrotic syndrome, asthma, cerebral palsy, Chronic lung disease, developmental delay	Approved
tacrolimus	Nephrotic Syndrome	Approved
tacrolimus	Nephrotic Syndrome	Approved
tacrolimus	nephrotic syndrome	Approved
tacrolimus	Nephrotic Syndrome	Approved renewal
tacrolimus	Pure Red Cell Aplasia	Approved
tacrolimus	pyoderma gangrenosum, Crohn's disease, post surgery	Approved
tacrolimus	Renal Impairment, Severe Aplastic Anaemia	Approved renewal
tacrolimus	Renal Impairment, Severe Aplastic Anaemia	Approved renewal
tacrolimus	severe acquired aplastic anaemia	Approved
tacrolimus	Severe Aplastic Anaemia	Approved
tacrolimus	Severe Aplastic Anaemia	Approved
tacrolimus	Severe Aplastic Anaemia, anaemia, Thrombocytopaenia	Approved
tacrolimus	Severe Aplastic Anaemia, liver impairment	Approved
tacrolimus	severe atopic dermatitis	Approved
tacrolimus	steroid dependent minimal change glomerulonephritis	Approved
tacrolimus	steroid dependent minimal change glomerulonephritis, frequently relapsing, possible follicular carcinoma of thyroid	Approved
tacrolimus	steroid dependent nephrotic syndrome	Approved
tacrolimus	steroid dependent nephrotic syndrome	Approved
tacrolimus	steroid dependent nephrotic syndrome	Approved
tacrolimus	steroid dependent nephrotic syndrome	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome	Approved
tacrolimus	Steroid Resistant Nephrotic Syndrome	Approved
tacrolimus	Steroid Resistant Nephrotic Syndrome	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome, cyclophosphamide toxicity, cyclosporin unsuitable	Approved
tacrolimus	Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis	Approved
tacrolimus	Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis	Approved
tacrolimus	Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome, gum hypertrophy, hirsutism, renal impairment	Approved
tacrolimus	Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment	Approved
tacrolimus	Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment	Approved renewal
tacrolimus	Steroid Resistant Nephrotic Syndrome, hypoalbuminaemia, minimal change nephrotic syndrome	Approved
tacrolimus	Steroid Resistant Nephrotic Syndrome, hypoalbuminaemia, minimal change nephrotic syndrome	Approved renewal
tacrolimus	ulcerative proctitis	Approved
tacrolimus	ulcerative proctitis	Approved renewal
tacrolimus ointment	hypertrophic conjunctival spring catarrh, glaucoma	Approved
tacrolimus ointment	metastatic Crohn's disease of skin	Approved renewal
tacrolimus ointment	metastatic Crohn's disease of skin	Approved renewal
tacrolimus ointment	non-healing wound, post surgery, protectomy, severe crohn's disease	Approved
tacrolimus ointment	Refractory to steroids, vulval crohn's disease	Approved
taurolidine	recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent	Approved
taurolidine	recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent	Approved renewal
taurolidine	recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent	Approved renewal
taurolidine	recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent	Approved renewal
taurolidine	recurrent port infections, haemophilia	Approved
telaprevir	hepatitis C	Approved
temozolomide	anaplastic astrocytoma	Approved
temozolomide	anaplastic ependymoma, Spinal Metastases	Approved
temozolomide	duodenal gastrinoma, metastatic neuroendocrine tumour, unresectable, zollinger-ellison syndrome	Approved
temozolomide	Ewings sarcoma	Approved
temozolomide	ewings sarcoma, metastatic	Approved
temozolomide	insulinoma, metastatic pancreatic neuroendocrine tumour	Approved
temozolomide	intermediate grade NET, hypertension	Approved
temozolomide	intermediate grade NET, liver metastases	Approved
temozolomide	liver metastases, lung cancer, neuroendocrine tumour	Approved
temozolomide	liver metastases, lung cancer, neuroendocrine tumour	Approved renewal
temozolomide	meningioma	Approved
temozolomide	metastatic carcinoid tumour, hepatomegaly, liver metastases	Approved
temozolomide	metastatic ewings sarcoma	Approved
temozolomide	metastatic ewings sarcoma	Approved
temozolomide	metastatic ewings sarcoma	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour	Approved renewal
temozolomide	metastatic neuroendocrine tumour, carcinoid syndrome	Approved
temozolomide	metastatic neuroendocrine tumour, carcinoid syndrome	Approved
temozolomide	metastatic neuroendocrine tumour, carcinoid syndrome	Approved
temozolomide	metastatic neuroendocrine tumour, cushing's syndrome	Approved
temozolomide	metastatic neuroendocrine tumour, Hypercalcaemia of Malignancy	Approved
temozolomide	metastatic neuroendocrine tumour, hypercholesterolaemia	Approved
temozolomide	metastatic neuroendocrine tumour, hypercholesterolaemia, hypertension, ischaemic heart disease	Approved
temozolomide	metastatic neuroendocrine tumour, hypertension	Approved
temozolomide	metastatic neuroendocrine tumour, hypertension, pernicious anaemia	Approved
temozolomide	metastatic neuroendocrine tumour, hypertension, pernicious anaemia	Approved renewal
temozolomide	metastatic neuroendocrine tumour, hypertension, pernicious anaemia	Approved renewal
temozolomide	metastatic neuroendocrine tumour, intermediate grade NET	Approved
temozolomide	metastatic neuroendocrine tumour, liver metastases, peritoneum metastases, small bowel metastases	Approved
temozolomide	metastatic neuroendocrine tumour, Lung Metastases, relapse following chemotherapy, tracheal compression	Approved
temozolomide	metastatic neuroendocrine tumour, neuroendocrine tumour	Approved
temozolomide	metastatic neuroendocrine tumour, neuroendocrine tumour, intermediate grade NET	Approved
temozolomide	metastatic neuroendocrine tumour, neuroendocrine tumour, intermediate grade NET	Approved renewal
temozolomide	metastatic neuroendocrine tumour, stage IV, hypertension	Approved
temozolomide	metastatic neuroendocrine tumour, widespread metastases	Approved
temozolomide	metastatic neuroendocrine tumour, widespread metastases	Approved renewal
temozolomide	metastatic neuroendocrine tumour, widespread metastases	Approved renewal
temozolomide	metastatic pancreatic neuroendocrine tumour	Approved
temozolomide	metastatic pancreatic neuroendocrine tumour	Approved
temozolomide	metastatic pancreatic neuroendocrine tumour	Approved
temozolomide	metastatic pancreatic neuroendocrine tumour	Approved
temozolomide	metastatic pancreatic neuroendocrine tumour	Approved
temozolomide	metastatic pancreatic neuroendocrine tumour, atrial fibrillation, dyslipidaemia, hyperkalaemia, hypertension, previous st jude mitral replacement	Approved
temozolomide	metastatic paraganglioma, metastatic neuroendocrine tumour	Approved
temozolomide	metastatic small cell neuroendocrine carcinoma of anorectal junction	Approved
temozolomide	neuroendocrine cancer	Approved
temozolomide	neuroendocrine cancer	Approved renewal
temozolomide	neuroendocrine cancer, Hypothyroidism	Approved
temozolomide	neuroendocrine cancer, liver metastases	Approved
temozolomide	neuroendocrine tumour	Approved
temozolomide	neuroendocrine tumour, intermediate grade NET	Approved
temozolomide	Pancreatic neuroendocrine tumor	Approved
temozolomide	Pancreatic neuroendocrine tumor	Approved
temozolomide	Pancreatic neuroendocrine tumor	Approved
temozolomide	Pancreatic neuroendocrine tumor	Approved
temozolomide	Pancreatic neuroendocrine tumor	Approved
temozolomide	Pancreatic neuroendocrine tumor	Approved
temozolomide	Pancreatic neuroendocrine tumor	Approved renewal
temozolomide	Pancreatic neuroendocrine tumor	Approved renewal
temozolomide	Pancreatic neuroendocrine tumor	Approved renewal
temozolomide	Pancreatic neuroendocrine tumor, Angina, liver metastases, pacemaker, renal cell carcinoma	Approved
temozolomide	Pancreatic neuroendocrine tumor, Insulin-Dependent Diabetes Mellitus, pancreatectomy	Approved
temozolomide	Pancreatic neuroendocrine tumor, Insulin-Dependent Diabetes Mellitus, pancreatectomy	Approved renewal
temozolomide	Pancreatic neuroendocrine tumor, Insulin-Dependent Diabetes Mellitus, pancreatectomy	Approved renewal
temozolomide	Pancreatic neuroendocrine tumor, liver metastases	Approved
temozolomide	Pancreatic neuroendocrine tumor, non insulin-dependent diabetes mellitus	Approved
temozolomide	Pancreatic neuroendocrine tumor, Portal Hypertension, portal vein thrombosis, splenomegaly	Approved
temozolomide	pituitary macroadenoma	Approved
temozolomide	primary CNS lymphoma	Approved
temozolomide	primary CNS lymphoma, relapsed lymphoma	Approved
temozolomide	pulmonary neuroendocrine tumour	Approved
temozolomide	recurrent medulloblastoma	Approved
temozolomide	recurrent medulloblastoma	Approved
temozolomide	recurrent pancreatic neuroendocrine tumour, insulinoma, liver metastases	Approved
temozolomide	relapsed CNS lymphoma	Approved
temozolomide	relapsed Ewings sarcoma	Approved
temozolomide	relapsed Ewings sarcoma	Approved
temozolomide	relapsed Ewings sarcoma	Approved
temozolomide	relapsed Ewings sarcoma	Approved
temozolomide	relapsed Ewings sarcoma	Approved
temozolomide	relapsed Ewings sarcoma	Approved
temozolomide	relapsed neuroblastoma, metastatic neuroblastoma	Approved
temozolomide	rhabdomyosarcoma	Approved
teniposide	IgA multiple myeloma, plasmacytoma, Thrombocytopaenia	Approved
teniposide	IgG multiple myeloma, acute renal failure, hyperkalaemia	Approved
teniposide	Lymphoblastic T-cell lymphoma	Approved
teniposide	lytic bone lesions, Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved
teniposide	Multiple Myeloma	Approved renewal
teniposide	Multiple Myeloma	Approved renewal
teniposide	Multiple Myeloma	Approved renewal
teniposide	Multiple Myeloma, anaemia, renal impairment	Approved
teniposide	Multiple Myeloma, bone disease	Approved
teniposide	Multiple Myeloma, bone disease	Approved
teniposide	Multiple Myeloma, bone disease	Approved
teniposide	Multiple Myeloma, bone disease, Moderate renal impairment	Approved
teniposide	Multiple Myeloma, bone disease, Moderate renal impairment	Approved renewal
teniposide	Multiple Myeloma, bone disease, renal impairment	Approved
teniposide	Multiple Myeloma, Bone disease, with incipient cord compression	Approved
teniposide	Multiple Myeloma, bone metastases	Approved
teniposide	Multiple Myeloma, Crohn's diease	Approved
teniposide	Multiple Myeloma, hypertension, renal impairment, spinal stenosis	Approved
teniposide	Multiple Myeloma, intermittent AF	Approved
teniposide	Multiple Myeloma, lytic bone lesions	Approved
teniposide	Multiple Myeloma, mds, refractory anaemia with ringed sideroblasts (RARS), secondary to lenalidomide	Approved
teniposide	Multiple Myeloma, mitral valve prolapse	Approved
teniposide	Multiple Myeloma, non insulin-dependent diabetes mellitus, osteoarthritis of the spine	Approved
teniposide	Multiple Myeloma, plasma cell leukaemia	Approved
teniposide	Multiple Myeloma, plasma cell leukaemia, end-stage renal failure on dialysis	Approved
teniposide	Multiple Myeloma, renal impairment	Approved
teniposide	Myeloma	Approved
teniposide	Myeloma, cast nephropathy	Approved
teniposide	Myeloma, thoracic compression fracture	Approved
teniposide	plasma cell myeloma, back pain, haemochromatosis	Approved
teniposide	plasma cell myeloma, deep vein thrombosis, squamous cell skin cancer	Approved
teniposide	primary central nervous system lymphoma	Approved
teniposide	primary central nervous system lymphoma	Approved
teniposide	primary CNS lymphoma	Approved
teniposide	primary CNS lymphoma	Approved
teniposide	primary CNS lymphoma, chronic active hepatitis	Approved
teniposide	refractory multiple myeloma	Approved
teniposide	refractory multiple myeloma	Approved
teniposide	refractory multiple myeloma, Pancytopenia, renal impairment	Approved
teniposide	relapsed multiple myeloma	Approved
teniposide	relapsed multiple myeloma	Approved
teniposide	relapsed multiple myeloma	Approved
teniposide	relapsed multiple myeloma	Approved
teniposide	relapsed multiple myeloma	Approved
teniposide	relapsed multiple myeloma	Approved
teniposide	relapsed multiple myeloma, hypercalcaemia	Approved
teniposide	relapsed multiple myeloma, hypercalcaemia	Approved
teniposide	relapsed multiple myeloma, Renal Impairment	Approved
teniposide	relapsed myeloma, bone disease, Diabetes Mellitus	Approved
teniposide	relapsed plasma cell myeloma, hypertension	Approved
teniposide	T cell acute lymphoblastic leukemia	Approved
teniposide	T cell acute lymphoblastic leukemia	Approved
teriparatide	bisphosphonate related osteonecrosis of the jaw, stage III	Approved
teriparatide	bisphosphonate related osteoradionecrosis of the jaw	Approved
teriparatide	osteogenesis imperfecta	Approved
testosterone	hypogonadism, fibromuscular dysplasia, migraines	Approved
testosterone gel	Congenital hypopituitarism, funded alternative unsuitable	Approved
thalidomide	angioimmunoblastic T cell lymphoma	Approved
thalidomide	arteriovenous malformations, refractory intestinal bleeding	Approved
thalidomide	Behcet's disease, duodenal carcinoma, fungal pneumonia, pulmonary embolism, renal calculus	Approved
thalidomide	Behcet's disease, duodenal carcinoma, fungal pneumonia, pulmonary embolism, renal calculus	Approved renewal
thalidomide	chromosomal translocation t(11;14)(q13;q32) and nuclear cyclin D1 overexpression, relapsed mantle cell lymphoma	Approved
thalidomide	chronic anaemia, Hereditary hemorrhagic telangiectasia	Approved
thalidomide	chronic anaemia, Hereditary hemorrhagic telangiectasia	Approved renewal
thalidomide	chronic pruritus, nodular prurigo	Approved
thalidomide	chronic recurrent gastric vascular ectasia, syncope with bleeding events, cerebrovascular disease, CREST syndrome, history of stroke, primary biliary cirrhosis	Approved
thalidomide	Erythema Nodosum Leprosum	Approved
thalidomide	gastrointestinal bleeding, myelodysplasia, small bowel angiodysplasia	Approved
thalidomide	GI bleeds, cerebrovascular disease, Peripheral Vascular disease, polymyalgia, small bowel vascular ectasia, subclavian steal syndrome	Approved renewal
thalidomide	multibacillary leprosy, relapsed erythema nodosum leprosum	Approved
thalidomide	multibacillary leprosy, relapsed erythema nodosum leprosum, foot ulcer	Approved
thalidomide	recurrent GI bleeding, severe crohn's disease	Approved renewal
thalidomide	recurrent GI bleeding, severe crohn's disease	Approved renewal
thalidomide	recurrent GI bleeding, small bowel angioectasia	Approved
thalidomide	recurrent GI bleeding, small bowel angioectasia	Approved renewal
thalidomide	recurrent GI bleeding, small bowel angioectasia	Approved renewal
thalidomide	recurrent GI bleeding, small bowel angioectasia	Approved renewal
thalidomide	refractory small bowel bleeding	Approved
thalidomide	Refractory small intestinal bleeding	Approved
thalidomide	Refractory small intestinal bleeding	Approved renewal
thalidomide	severe crohn's disease	Approved
thiothixene	paranoid schizophrenia	Approved
ticagrelor	antiphospholipid syndrome, ischaemic heart disease, VF cardiac arrest	Approved
ticagrelor	Coronary Artery Disease, dyslipidaemia, post stenting	Approved
ticagrelor	coronary artery disease, multiple allergies, STEMI	Approved
ticagrelor	coronary artery disease, multiple allergies, STEMI	Approved renewal
ticagrelor	post stenting, intolerance to funded alternative	Approved
timolol and travaprost	glaucoma, allergy to preservative	Approved
timolol and travaprost	glaucoma, allergy to preservative	Approved renewal
timolol maleate eye drops	essential iris atrophy left eye, glaucoma	Approved
timolol minims	glaucoma, allergy to preservative	Approved
tinidazole	Resistant trichomoniasis	Approved
tinidazole	Resistant trichomoniasis, Depression	Approved
tizanidine	dystonia, Dopamine-2-receptor antibody encephalitis, spasticity	Approved
tobramycin	bronchiectasis, chronic colinisiation, developmental delay, hypogammaglobulinaemia, seizures	Approved
tobramycin	bronchiectasis, macrophage activation syndrome, systemic onset juvenile idiopathic arthritis	Approved
tobramycin	respiratory syncytial virus, severe chronic lung disease, bronchiolitis, possible cystic fibrosis, pseudomonas aeruginosa	Approved
tocilizumab	adult onset Stills disease, folliculis, hepatosplenomegaly, myocarditis, pericarditis	Approved
tocilizumab	castleman's disease	Declined
tocilizumab	castleman's disease	Declined
tocilizumab	juvenile idiopathic arthritis, uveitis, glaucoma, juvenile idiopathic uveitis, ocular inflammation, Positive ANA	Approved
tocilizumab	multicentric castlemans disease	Declined
tocilizumab	multicentric castlemans disease, aspiration pneumonia, Congestive Heart Failure, meningococcal septicaemia, mitral regurgitation, nephrectomy, Past history of rheumatic fever	Declined
tocilizumab	polyarticular juvenile idiopathic arthritis, Anaphylaxis to rituxumab, refractory to standard treatments, unacceptable side effects of high dose steroid treatment	Approved
tocilizumab	polyarticular juvenile idiopathic arthritis, Anaphylaxis to rituxumab, refractory to standard treatments, unacceptable side effects of high dose steroid treatment	Approved renewal
tocilizumab	polymyalgic syndrome, refractory to other treatments, obstructive sleep apnoea	Approved renewal
tocilizumab	systemic onset juvenile idiopathic arthritis, early macrophage activation syndrome	Approved
tolvaptan	SIADH, hypertension, ischaemic heart disease, post operative knee surgery, post surgery	Approved
tolvaptan	SIADH, hypertension, ischaemic heart disease, post operative knee surgery, post surgery	Approved renewal
topotecan	neuroblastoma stage 4	Approved
topotecan	neuroblastoma stage 4	Approved
topotecan	neuroblastoma stage 4	Approved renewal
topotecan	wilm's tumour, liver metastases	Approved
tramadol	pain, hydrocephalus with shunt, Spina Bifida, swallowing dysfunction	Declined
tramadol sr	pain management, Spina Bifida	Approved
tramadol sr	pain management, Spina Bifida	Approved renewal
tranexamic acid	fungating left breast primary, metastatic breast cancer, pulmonary embolism	Approved
trastuzumab	breast cancer, Her2 positive, controlled intracranial metastases, No systemic progression	Approved
trastuzumab	breast cancer, Her2 positive, locally advanced breast cancer	Approved
trastuzumab	breast cancer, Her2 positive, locally advanced breast cancer	Approved renewal
travoprost bak-free	glaucoma	Approved
travoprost bak-free	glaucoma	Approved renewal
travoprost bak-free	glaucoma, allergy to preservative	Approved
travoprost bak-free	glaucoma, allergy to preservative	Approved renewal
travoprost bak-free	glaucoma, allergy to preservative	Approved renewal
travoprost bak-free	glaucoma, asthma, multiple allergies	Approved renewal
travoprost bak-free	glaucoma, asthma, multiple allergies	Approved renewal
travoprost bak-free	primary open glaucoma, meibomian gland dysfunction	Approved renewal
travoprost bak-free	primary open glaucoma, meibomian gland dysfunction	Approved renewal
treosulphan	conditioning for stem cell transplant, Severe combined immune deficiency	Approved
treosulphan	Severe combined immune deficiency, allogeneic transplant, awaiting stem cell transplant	Approved
treprostinil	raynaud's syndrome, severe peripheral ischaemia, risk of further amputation, skin ulceration, very poor venous access	Approved
triamcinolone acetonide	macular oedema, retinal vein occlusion, allergy to preservative	Approved renewal
triamcinolone acetonide	macular oedema, vitrectomy	Approved renewal
triamcinolone hexacetonide	macular oedema, retinal vein occlusion, allergy to preservative	Approved
triamcinolone hexacetonide	macular oedema, vitrectomy	Approved
trientine	Wilson's disease	Approved
trientine	Wilson's disease, daibetes type 1	Approved
trientine dihydrochloride	Wilson's disease	Approved renewal
trientine hydrochloride	Wilson's disease, diabetes type 1	Approved renewal
trientine hydrochloride	Wilson's disease, diabetes type 1	Approved renewal
trihexyphenidyl	cerebral palsy, choreoathetoid cerebral palsy, dystonia, kernicterus	Approved
trihexyphenidyl	Complex Mitochondrial Disorder, choreoathetoid movements, excessive oral secretions, excessive sweating, global development delay, hyponatraemia, severe GI dysmotility	Approved
trihexyphenidyl	Complex Mitochondrial Disorder, choreoathetoid movements, excessive oral secretions, excessive sweating, global development delay, hyponatraemia, severe GI dysmotility	Approved renewal
trihexyphenidyl	dystonia	Approved
trihexyphenidyl	dystonia, Dopamine-2-receptor antibody encephalitis, spasticity	Approved
trihexyphenidyl	dystonia, hypoxic ischaemic encophalopathy, Neonatal Seizures	Approved
trihexyphenidyl	dystonic cerebral palsy, aspiration pneumonia, Excessive drooling, global development delay, seizures	Approved
triiodothyroacetic acid	Allan-Herndon-Dudley Syndrome	Approved
triiodothyroacetic acid	Allan-Herndon-Dudley Syndrome	Approved
triiodothyroacetic acid	Allan-Herndon-Dudley Syndrome, MCT8 thyroid transported defect, gastrostomy feeding, severe developmental delay, Severe GORD, sleep disturbance	Approved
tyr anamix infant	tyrosinaemia non-type I	Approved
tyr anamix junior	tyrosinaemia type I	Approved
tyr anamix junior	tyrosinaemia type I	Approved renewal
tyr anamix junior	tyrosinaemia type III	Approved
tyr anamix junior	tyrosinaemia type III	Approved renewal
tyr anamix junior	tyrosinaemia type III	Approved renewal
ubiquinone	Brown-Vialetto-Van Laere Syndrome	Approved
ursodeoxycholic acid	bile reflux, painful gastropathy	Approved
ursodeoxycholic acid	bile reflux, painful gastropathy	Approved renewal
ursodeoxycholic acid	biliary atresia, awaiting liver transplant, pruritus secondary to cholestasis, recurrent Cholangitis	Approved
ursodeoxycholic acid	biliary atresia, failing kasai portoenterostomy	Approved
ursodeoxycholic acid	biliary atresia, failing kasai portoenterostomy	Approved renewal
ursodeoxycholic acid	cholangiopathy, intra-hepatic stones, post liver transplant, Roux reconstruction	Approved
ursodeoxycholic acid	cholelithiasis, pancreatitis, surgery contraindicated	Approved
ursodeoxycholic acid	cholestasis, Liver disease, short bowel syndome	Approved
ursodeoxycholic acid	cholestatic hepatitis, cholestatic jaundice	Approved
ursodeoxycholic acid	chronic cholestatis, ABCB4 mutation causing premature complicated gallstone disease	Approved
ursodeoxycholic acid	deranged liver enzymes, GvHD post allogeneic transplant	Approved
ursodeoxycholic acid	intractable pruritus, Biliary Atresia, kasai procedure, liver transplant	Approved
ursodeoxycholic acid	intractable pruritus, cholestatic liver disease	Approved
ursodeoxycholic acid	intractable pruritus, primary sclerosing cholangitis, Ulcerative Colitis	Approved
ursodeoxycholic acid	liver graft verus host disease, acute myeloid leukaemia, hypertension, mild renal impairment	Declined
ursodeoxycholic acid	PBC	Approved renewal
ursodeoxycholic acid	primary biliary cirrhosis	Approved
ursodeoxycholic acid	primary biliary cirrhosis, hypertension, splenomegaly	Approved
ursodeoxycholic acid	primary sclerosing cholangitis	Approved
ursodeoxycholic acid	primary sclerosing cholangitis, autoimmune hepatitis, inflammatory bowel disease	Approved
ursodeoxycholic acid	primary sclerosing cholangitis, autoimmune hepatitis, inflammatory bowel disease	Approved renewal
ursodeoxycholic acid	primary sclerosing cholangitis, autoimmune hepatitis, inflammatory bowel disease	Approved renewal
ursodeoxycholic acid	primary sclerosing cholangitis, pancolitis	Approved renewal
ursodeoxycholic acid	progressive familial intrahepatic cholestasis	Approved
ursodeoxycholic acid	pruritus secondary to cholestasis, Liver Failure, oesophageal varices	Approved
ursodeoxycholic acid	recurrent choledocholithiasis, asthma, diabetes insipidus	Approved
ursodeoxycholic acid	recurrent intrahepatic stone disease	Approved
ursodeoxycholic acid	severe pruritus, cirrhosis, intrahepatic biliary strictures, primary sclerosing cholangitis, Ulcerative Colitis	Approved
ursodeoxycholic acid	severe pruritus, cirrhosis, intrahepatic biliary strictures, primary sclerosing cholangitis, Ulcerative Colitis	Approved renewal
ustekinumab	severe chronic plaque psoriasis, treatment refractory	Approved
ustekinumab	severe chronic plaque psoriasis, treatment refractory	Approved renewal
valaciclovir	disseminated varicella zoster virus infection, AML, bone marrow transplant, prophylaxis	Approved
valaciclovir	gingivostomatitis, immunosuppressed patient, Recurrent herpes simplex	Approved
valaciclovir	HSV keratitis with stromal disease, scarring and neovascularistion, eczema on mycophenolate, Herpes Simplex Keratitis	Approved
valaciclovir	prophylaxis to prevent infection, post bone marrow transplant, recurrent herpes zoster flares	Approved
valaciclovir	Recurrent herpes simplex, Herpes Simplex Keratitis, virus not controlled on Acyclovir	Approved
valaciclovir	shingles	Approved
valganciclovir	Active Hepatitis, Acute Lymphoblastic Leukaemia, Congenital Heart Disease, high EBV load	Approved
valganciclovir	acute leukamia post bone marrow transplant, treatment of CMV disease	Approved
valganciclovir	Acute Lymphoblastic Leukaemia, reactivation of CMV	Approved
valganciclovir	Acute Myeloid Leukaemia, CMV viraemia, post bone marrow transplant, secondary pancytopenia	Approved
valganciclovir	anterior uveitis, CMV, glaucoma, post LASIK surgery, reduced endothelial cell count, secondary cataract	Approved
valganciclovir	anterior uveitis, CMV, glaucoma, post LASIK surgery, reduced endothelial cell count, secondary cataract	Approved renewal
valganciclovir	cmv colitis	Approved
valganciclovir	CMV disease post lung transplant	Approved
valganciclovir	CMV disease post renal transplant	Approved
valganciclovir	cmv infection post allo-transplant	Approved
valganciclovir	CMV myocarditis, immunocompetent, pulmonary oedema	Approved
valganciclovir	Crohn's diease, Cytomegalovirus induced haemophagocytic lymphohistiocytosis	Approved
valganciclovir	cytomegalovirus infection, Epstein Barr Virus, post renal transplant	Approved
valganciclovir	cytomegalovirus infection, GvHD, T cell lymphoma	Approved
valganciclovir	cytomegalovirus infection, Hypothyroidism, idiopathic thrombocytopaenic purpura, polycystic kidney disease, post splenectomy, systemic lupus erythematosus	Approved
valganciclovir	high EBV replication, post renal transplant	Approved
valganciclovir	high EBV replication, post renal transplant	Approved renewal
valganciclovir	Kaposi's sarcoma associated HHV-8, castleman's disease, HIV infection	Approved
valganciclovir	Kidney Transplant, Prophylaxis of CMV	Approved
valganciclovir	post bone marrow transplant, reactivation of CMV	Approved
valganciclovir	post bone marrow transplant, reactivation of CMV	Approved
valganciclovir	Prophylaxis of CMV	Approved
valganciclovir	Prophylaxis of CMV, polycystic kidney disease, post kidney transplant	Approved
valganciclovir	reactivation of CMV	Approved
valganciclovir	reactivation of CMV, conditioned with cyclophosphamide, fludarabine treatment, post allogeneic stem cell transplant, received ATG treatment in hospital	Approved
valganciclovir	reactivation of CMV, post bone marrow transplant	Approved
valganciclovir	Renal Transplant, CMV mismatch, hypertension	Approved
valganciclovir	Severe Aplastic Anaemia, CMV	Approved
valine	Maple syrup urine disease	Approved
vancomycin	cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy	Approved
vancomycin	cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy	Approved
vancomycin	cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy	Approved renewal
vancomycin	cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy	Approved renewal
vancomycin	cataract surgery, corneal endothelial dystrophy, corneal grafting, infective crystalline keratopathy	Approved renewal
vancomycin	corneal perforation, fungal keratitis	Approved
varicella vaccine	disseminated varicella prevention, congenital bullous ichthyosiform erythroderma	Approved
varicella vaccine	prevention of chickenpox, dystonia	Approved
varicella vaccine	Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency, prophylaxis for varicella	Approved
vismodegib	nevoid basal cell carcinoma syndrome, gorlin syndrome	Approved renewal
vitamin b12	vitamin b12 deficiency, Autistic Spectrum Disorder	Approved
vitamin b12 capsule (cyanocobalamin)	methylmalonic acidemia	Approved
vitamin e	Vitamin E deficiency, biliary atresia	Approved
vitamin e (alpha tocoferil acetate)	cholestatic liver disease	Approved
voriconazole	Acute Lymphoblastic Leukaemia, allogeneic sibling stem cell transplant, CT proven chest infection, pulmonary embolism	Approved
voriconazole	Acute Lymphoblastic Leukaemia, Aspergillosis Lung Disease, Invasive Aspergillosis	Approved
voriconazole	Acute Lymphoblastic Leukaemia, aspergillus grown in sputum, Aspergilus lung infection in neutrophenic patient, intensive chemotherapy	Approved
voriconazole	acute lymphoblastic leukaemia, MUD BMT, Pulmonary Aspergillosis	Approved
voriconazole	Acute Lymphocytic leukaemia, Neutropenic sepsis of fungal origin suspected aspergillus	Approved
voriconazole	Acute Myeloid Leukaemia AML, Invasive Pulmonary Aspergillosis, metastatic breast cancer	Approved
voriconazole	Acute Myeloid Leukaemia, aspergillosis infection	Approved
voriconazole	Allergic bronchopulmonary aspergillosis	Approved
voriconazole	Allergic bronchopulmonary aspergillosis, Cystic fibrosis	Approved
voriconazole	aspergilllus infection, aspergillus tereus, immunosuppressed secondary to chemotherapy, respiratory infection	Approved
voriconazole	aspergilllus infection, bone marrow transplant	Approved
voriconazole	aspergillosis infection	Approved
voriconazole	aspergillosis infection, hypoxia, lymphoma, Neutropenic Sepsis, Severe hypoxia	Approved
voriconazole	aspergillus bronchitis, BSLT	Approved
voriconazole	aspergillus flavus	Approved
voriconazole	Atrial fibrillation, Geotrichum lung infection, hypophosphataemia, malleolus fracture, multiple pulmonary nodules, parietal subdural haemorrhage, pulmonary embolism, vasculitis	Approved
voriconazole	Atrial fibrillation, Invasive Pulmonary Aspergillosis	Approved
voriconazole	Candida glabrata infection, cervical spine arteomyelitis, diabetes, end stage renal failure, hepatitis C, Hypernatraemia	Approved
voriconazole	Candida glabrata infection, Fungal endophthalmitis, adenocarcinoma, Chorioretinitis, diverticulitis	Approved
voriconazole	cerebral cryptoccoma, probable tuberculosis	Approved
voriconazole	chronic cavitatory pulmonary aspergillus, Invasive Pulmonary Aspergillosis	Approved
voriconazole	chronic Wangiella Dermatidis infection	Approved
voriconazole	cryptococcaemia, HIV infection	Approved
voriconazole	diffuse large b-cell lymphoma, Invasive Pulmonary Aspergillosis	Approved
voriconazole	Endocarditis, pulmonary embolism, pulmonary infarction, tricuspid and aortic valve disease	Approved
voriconazole	Ewings sarcoma, systemic yeast infection	Approved
voriconazole	felty's syndrome, Chest infection, neutropaenia	Approved
voriconazole	Fungal endophthalmitis, scedosporium infection	Approved
voriconazole	fungal infection, chemotherapy, mantle cell lymphoma	Approved
voriconazole	fungal keratitis	Approved
voriconazole	Invasive Aspergillosis	Approved
voriconazole	Invasive Aspergillus infection, malignant otitis externa	Approved
voriconazole	Invasive biapical cavitary Aspergillosis	Approved
voriconazole	invasive necrotising fungal pneumonia, hypertension, metastatic calcifications, osteopaenia, previous CMV infection, Renal Transplant	Approved
voriconazole	Invasive Pulmonary Aspergillosis, T Cell ALL	Approved
voriconazole	left upper lobe mycetoma, cystic lung disease, recurrent right pneumothorax	Approved
voriconazole	multiple central line infections, Autoimmune Haemolysis, chronic graft versus host disease, Congenital Immune Deficiency, intestinal failure, thymic transplant	Approved
voriconazole	paecilomyces Prosthectic Left Hip Joint Infection, asthma, bilateral THJR, metallic aortic valve replacement, MSSA infection of left prosthetic knee joint, recent bilateral peroprosthectic neck of femur fractures, Rheumatoid Arthritis	Approved
voriconazole	presumed aspergillus chest infection, chronic lymphocytic leukaemia, hypogammaglobulinaemia	Approved
voriconazole	Pulmonary Aspergillosis	Approved
voriconazole	Pulmonary Aspergillosis	Approved
voriconazole	Pulmonary Aspergillosis, Acute Myeloid Leukaemia	Approved
voriconazole	Pulmonary Aspergillosis, Acute Myeloid Leukaemia	Approved
voriconazole	Pulmonary Aspergillosis, AML, Stem Cell Transplant	Approved
voriconazole	renal tract infection, candida albicans infection	Approved
voriconazole	Rheumatic Heart Disease, candidal endocarditis	Approved
voriconazole	risk of fungal infection, Acute megakaryoblastic leukaemia, Persistent Neutropenic Fever	Approved
voriconazole	suspected fungal infection	Approved
voriconazole eye drops	fungal keratitis, corneal perforation	Approved
whole thyroid	Graves' disease, Post-Radio-Iodine Hypothyroidism	Approved renewal
xlys low try maxamaid	glutaric aciduria type 1	Approved
zoledronic acid	sensory neuropathy, osteomyelitis	Approved
zoledronic acid	Widespread bone metastases, atrial fibrillation, COPD, hormone refractory, metastatic prostate cancer, Rheumatoid Arthritis	Approved
zonisamide	astro-ganglioglioma, symptomatic partial seizures secondary to tumor	Approved
zonisamide	astro-ganglioglioma, symptomatic partial seizures secondary to tumor	Approved renewal
zonisamide	epilepsy, focal seizures, infantile spasms, refractory to other treatments, epileptic encephalopathy, global development delay	Approved
zonisamide	epilepsy, focal seizures, infantile spasms, refractory to other treatments, epileptic encephalopathy, global development delay	Approved renewal
zonisamide	epilepsy, focal seizures, infantile spasms, refractory to other treatments, epileptic encephalopathy, global development delay	Approved renewal
zonisamide	epileptic encephalopathy, medically refractory seizures, autism	Approved
zonisamide	epileptic encephalopathy, refractory seizures	Approved
zonisamide	idiopathic generalised epilepsy	Approved
zonisamide	Intractable epilepsy	Approved
zonisamide	Intractable epilepsy	Approved renewal
zonisamide	Intractable Epilepsy, congenital heterotopia, cortical cysts, developmental delay, hemiplegia, Hydrocephalus, migraine, sensory seizures	Approved
zonisamide	Intractable Epilepsy, congenital heterotopia, cortical cysts, developmental delay, hemiplegia, Hydrocephalus, migraine, sensory seizures	Approved renewal
zonisamide	Intractable Epilepsy, congenital heterotopia, cortical cysts, developmental delay, hemiplegia, Hydrocephalus, migraine, sensory seizures	Approved renewal
zonisamide	medically refractory seizures	Approved
zonisamide	medically refractory seizures, refractory generalised epilepsy	Approved
zonisamide	refractory epilepsy	Approved
zonisamide	refractory epilepsy, complex partial seizures, grand mal seizures	Approved